0001099800-23-000034.txt : 20230728 0001099800-23-000034.hdr.sgml : 20230728 20230728163201 ACCESSION NUMBER: 0001099800-23-000034 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 98 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230728 DATE AS OF CHANGE: 20230728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 231123572 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 10-Q 1 ew-20230630.htm 10-Q ew-20230630
000109980012/312023Q2falsehttp://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20230630#AccruedAndOtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20230630#AccruedAndOtherLiabilitiesCurrent18200010998002023-01-012023-06-3000010998002023-07-25xbrli:shares00010998002023-06-30iso4217:USD00010998002022-12-31iso4217:USDxbrli:shares00010998002023-04-012023-06-3000010998002022-04-012022-06-3000010998002022-01-012022-06-3000010998002021-12-3100010998002022-06-300001099800us-gaap:CommonStockMember2022-12-310001099800us-gaap:TreasuryStockCommonMember2022-12-310001099800us-gaap:AdditionalPaidInCapitalMember2022-12-310001099800us-gaap:RetainedEarningsMember2022-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001099800us-gaap:ParentMember2022-12-310001099800us-gaap:NoncontrollingInterestMember2022-12-310001099800us-gaap:RetainedEarningsMember2023-01-012023-03-310001099800us-gaap:ParentMember2023-01-012023-03-3100010998002023-01-012023-03-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001099800us-gaap:CommonStockMember2023-01-012023-03-310001099800us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001099800us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001099800us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001099800us-gaap:CommonStockMember2023-03-310001099800us-gaap:TreasuryStockCommonMember2023-03-310001099800us-gaap:AdditionalPaidInCapitalMember2023-03-310001099800us-gaap:RetainedEarningsMember2023-03-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001099800us-gaap:ParentMember2023-03-310001099800us-gaap:NoncontrollingInterestMember2023-03-3100010998002023-03-310001099800us-gaap:RetainedEarningsMember2023-04-012023-06-300001099800us-gaap:ParentMember2023-04-012023-06-300001099800us-gaap:NoncontrollingInterestMember2023-04-012023-06-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001099800us-gaap:CommonStockMember2023-04-012023-06-300001099800us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001099800us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001099800us-gaap:CommonStockMember2023-06-300001099800us-gaap:TreasuryStockCommonMember2023-06-300001099800us-gaap:AdditionalPaidInCapitalMember2023-06-300001099800us-gaap:RetainedEarningsMember2023-06-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001099800us-gaap:ParentMember2023-06-300001099800us-gaap:NoncontrollingInterestMember2023-06-300001099800us-gaap:CommonStockMember2021-12-310001099800us-gaap:TreasuryStockCommonMember2021-12-310001099800us-gaap:AdditionalPaidInCapitalMember2021-12-310001099800us-gaap:RetainedEarningsMember2021-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001099800us-gaap:RetainedEarningsMember2022-01-012022-03-3100010998002022-01-012022-03-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001099800us-gaap:CommonStockMember2022-01-012022-03-310001099800us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001099800us-gaap:TreasuryStockCommonMember2022-01-012022-03-310001099800us-gaap:CommonStockMember2022-03-310001099800us-gaap:TreasuryStockCommonMember2022-03-310001099800us-gaap:AdditionalPaidInCapitalMember2022-03-310001099800us-gaap:RetainedEarningsMember2022-03-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-3100010998002022-03-310001099800us-gaap:RetainedEarningsMember2022-04-012022-06-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001099800us-gaap:CommonStockMember2022-04-012022-06-300001099800us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001099800us-gaap:TreasuryStockCommonMember2022-04-012022-06-300001099800us-gaap:CommonStockMember2022-06-300001099800us-gaap:TreasuryStockCommonMember2022-06-300001099800us-gaap:AdditionalPaidInCapitalMember2022-06-300001099800us-gaap:RetainedEarningsMember2022-06-300001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-3000010998002023-04-122023-04-120001099800ew:MedtronicIncMember2023-04-122023-04-120001099800ew:MedtronicIncMember2023-03-012023-03-310001099800ew:MedtronicIncMember2023-04-300001099800ew:MedtronicIncMember2023-04-012023-04-300001099800us-gaap:BankTimeDepositsMember2023-06-300001099800us-gaap:BankTimeDepositsMember2022-12-310001099800us-gaap:USTreasuryAndGovernmentMember2023-06-300001099800us-gaap:USTreasuryAndGovernmentMember2022-12-310001099800us-gaap:AssetBackedSecuritiesMember2023-06-300001099800us-gaap:AssetBackedSecuritiesMember2022-12-310001099800us-gaap:CorporateDebtSecuritiesMember2023-06-300001099800us-gaap:CorporateDebtSecuritiesMember2022-12-310001099800us-gaap:MunicipalBondsMember2023-06-300001099800us-gaap:MunicipalBondsMember2022-12-310001099800us-gaap:LimitedLiabilityCompanyMemberew:NewMarketsTaxCreditMember2023-06-30xbrli:pure0001099800us-gaap:LimitedLiabilityCompanyMember2023-01-012023-06-300001099800us-gaap:OtherNonoperatingIncomeExpenseMember2023-06-300001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2023-03-012023-03-310001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2023-03-012023-06-300001099800ew:ConvertiblePromissoryNoteMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2023-03-310001099800ew:MedicalDeviceCompanyMember2023-01-310001099800ew:MedicalDeviceCompanyMember2023-04-012023-04-300001099800ew:MedicalDeviceCompanyMember2021-12-310001099800us-gaap:EquitySecuritiesMemberew:MedicalDeviceCompanyMember2021-12-310001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2022-08-012022-08-310001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2022-08-310001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2022-06-012022-06-300001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2023-06-300001099800us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:MedicalDeviceCompanyMember2019-01-012019-12-310001099800ew:MedicalTechnologyCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-05-012022-05-310001099800ew:MedicalTechnologyCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-01-012021-12-310001099800ew:MedicalTechnologyCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-05-310001099800us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberew:MedicalTechnologyCompanyMember2023-02-280001099800us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberew:MedicalTechnologyCompanyMember2023-02-282023-02-280001099800us-gaap:FairValueInputsLevel2Member2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800ew:MeasurementInputProbabilityOfMilestoneAchievementMemberew:ContingentConsiderationLiabilityMember2023-06-300001099800ew:ContingentConsiderationLiabilityMember2023-06-300001099800ew:ContingentConsiderationLiabilityMember2022-12-310001099800us-gaap:OtherLiabilitiesMember2022-12-310001099800ew:ContingentConsiderationLiabilityMember2023-01-012023-06-300001099800us-gaap:OtherLiabilitiesMember2023-01-012023-06-300001099800us-gaap:OtherLiabilitiesMember2023-06-300001099800ew:ContingentConsiderationLiabilityMember2021-12-310001099800us-gaap:OtherLiabilitiesMember2021-12-310001099800ew:ContingentConsiderationLiabilityMember2022-01-012022-06-300001099800us-gaap:OtherLiabilitiesMember2022-01-012022-06-300001099800ew:ContingentConsiderationLiabilityMember2022-06-300001099800us-gaap:OtherLiabilitiesMember2022-06-300001099800us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-06-300001099800us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001099800us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-06-300001099800us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-06-300001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2022-12-310001099800ew:AccruedAndOtherLiabilitiesCurrentMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-06-300001099800ew:AccruedAndOtherLiabilitiesCurrentMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2022-12-310001099800us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-06-300001099800us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2022-12-310001099800us-gaap:ForeignExchangeContractMember2023-06-300001099800us-gaap:CurrencySwapMember2023-06-300001099800us-gaap:ForeignExchangeContractMember2022-12-310001099800us-gaap:CurrencySwapMember2022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-04-012022-06-300001099800us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001099800us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-04-012022-06-300001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-06-300001099800us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001099800us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-04-012023-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-04-012022-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-04-012023-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-04-012022-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:InterestIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-06-300001099800us-gaap:NetInvestmentHedgingMemberus-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-06-30iso4217:EUR0001099800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001099800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2022-04-012022-06-300001099800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001099800us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2022-01-012022-06-300001099800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001099800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-04-012022-06-300001099800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001099800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-01-012022-06-300001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001099800us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001099800us-gaap:CostOfSalesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001099800us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-01-012023-06-300001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2022-04-012022-06-300001099800us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2022-01-012022-06-300001099800us-gaap:CostOfSalesMember2023-04-012023-06-300001099800us-gaap:CostOfSalesMember2022-04-012022-06-300001099800us-gaap:CostOfSalesMember2023-01-012023-06-300001099800us-gaap:CostOfSalesMember2022-01-012022-06-300001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-06-300001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-04-012022-06-300001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-06-300001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-06-300001099800us-gaap:ResearchAndDevelopmentExpenseMember2023-04-012023-06-300001099800us-gaap:ResearchAndDevelopmentExpenseMember2022-04-012022-06-300001099800us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-06-300001099800us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-06-300001099800us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001099800ew:MarketBasedRestrictedStockUnitsMember2023-01-012023-06-300001099800srt:MinimumMemberew:MarketBasedRestrictedStockUnitsMember2023-01-012023-06-300001099800srt:MaximumMemberew:MarketBasedRestrictedStockUnitsMember2023-01-012023-06-300001099800ew:MarketBasedRestrictedStockUnitsMember2022-01-012022-06-300001099800ew:EmployeeAndNonemployeeStockOptionsMember2023-04-012023-06-300001099800ew:EmployeeAndNonemployeeStockOptionsMember2022-04-012022-06-300001099800ew:EmployeeAndNonemployeeStockOptionsMember2023-01-012023-06-300001099800ew:EmployeeAndNonemployeeStockOptionsMember2022-01-012022-06-300001099800us-gaap:EmployeeStockMember2023-04-012023-06-300001099800us-gaap:EmployeeStockMember2022-04-012022-06-300001099800us-gaap:EmployeeStockMember2023-01-012023-06-300001099800us-gaap:EmployeeStockMember2022-01-012022-06-300001099800ew:InitialDeliveryOfSharesSettledJanuary2022Member2022-01-310001099800ew:InitialDeliveryOfSharesSettledJanuary2022Member2022-01-012022-01-310001099800ew:January2022StockRepurchaseProgramSharesSoldInFebruary2022Member2022-02-012022-02-280001099800ew:InitialDeliveryOfSharesSettledFebruary2023Member2023-02-280001099800ew:InitialDeliveryOfSharesSettledFebruary2023Member2023-02-012023-02-280001099800ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member2023-03-012023-03-31ew:lawsuit0001099800us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-04-012023-06-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-012023-06-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-04-012023-06-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-012023-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-03-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-03-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-03-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-03-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-03-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2022-04-012022-06-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-012022-06-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-04-012022-06-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-012022-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-012023-06-300001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-012022-06-300001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-06-300001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-06-300001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-04-012023-06-300001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-04-012022-06-300001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-06-300001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-06-300001099800us-gaap:StockCompensationPlanMember2023-04-012023-06-300001099800us-gaap:StockCompensationPlanMember2022-04-012022-06-300001099800us-gaap:StockCompensationPlanMember2023-01-012023-06-300001099800us-gaap:StockCompensationPlanMember2022-01-012022-06-3000010998002021-01-012021-12-310001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2023-04-012023-06-300001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2022-04-012022-06-300001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2023-01-012023-06-300001099800us-gaap:OperatingSegmentsMemberew:UnitedStatesSegmentMember2022-01-012022-06-300001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2023-04-012023-06-300001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-06-300001099800ew:EuropeSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2023-04-012023-06-300001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2022-04-012022-06-300001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2023-01-012023-06-300001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2022-01-012022-06-300001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2023-04-012023-06-300001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2022-04-012022-06-300001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2023-01-012023-06-300001099800us-gaap:OperatingSegmentsMemberew:RestOfWorldSegmentMember2022-01-012022-06-300001099800us-gaap:OperatingSegmentsMember2023-04-012023-06-300001099800us-gaap:OperatingSegmentsMember2022-04-012022-06-300001099800us-gaap:OperatingSegmentsMember2023-01-012023-06-300001099800us-gaap:OperatingSegmentsMember2022-01-012022-06-300001099800us-gaap:MaterialReconcilingItemsMember2023-04-012023-06-300001099800us-gaap:MaterialReconcilingItemsMember2022-04-012022-06-300001099800us-gaap:MaterialReconcilingItemsMember2023-01-012023-06-300001099800us-gaap:MaterialReconcilingItemsMember2022-01-012022-06-300001099800us-gaap:CorporateNonSegmentMember2023-04-012023-06-300001099800us-gaap:CorporateNonSegmentMember2022-04-012022-06-300001099800us-gaap:CorporateNonSegmentMember2023-01-012023-06-300001099800us-gaap:CorporateNonSegmentMember2022-01-012022-06-300001099800country:US2023-04-012023-06-300001099800country:US2022-04-012022-06-300001099800country:US2023-01-012023-06-300001099800country:US2022-01-012022-06-300001099800srt:EuropeMember2023-04-012023-06-300001099800srt:EuropeMember2022-04-012022-06-300001099800srt:EuropeMember2023-01-012023-06-300001099800srt:EuropeMember2022-01-012022-06-300001099800country:JP2023-04-012023-06-300001099800country:JP2022-04-012022-06-300001099800country:JP2023-01-012023-06-300001099800country:JP2022-01-012022-06-300001099800ew:RestOfWorldMember2023-04-012023-06-300001099800ew:RestOfWorldMember2022-04-012022-06-300001099800ew:RestOfWorldMember2023-01-012023-06-300001099800ew:RestOfWorldMember2022-01-012022-06-300001099800ew:TranscatheterAorticValveReplacementMember2023-04-012023-06-300001099800ew:TranscatheterAorticValveReplacementMember2022-04-012022-06-300001099800ew:TranscatheterAorticValveReplacementMember2023-01-012023-06-300001099800ew:TranscatheterAorticValveReplacementMember2022-01-012022-06-300001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2023-04-012023-06-300001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2022-04-012022-06-300001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2023-01-012023-06-300001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2022-01-012022-06-300001099800ew:SurgicalHeartValveTherapyMember2023-04-012023-06-300001099800ew:SurgicalHeartValveTherapyMember2022-04-012022-06-300001099800ew:SurgicalHeartValveTherapyMember2023-01-012023-06-300001099800ew:SurgicalHeartValveTherapyMember2022-01-012022-06-300001099800ew:CriticalCareMember2023-04-012023-06-300001099800ew:CriticalCareMember2022-04-012022-06-300001099800ew:CriticalCareMember2023-01-012023-06-300001099800ew:CriticalCareMember2022-01-012022-06-300001099800ew:DaveenChopraMember2023-01-012023-06-300001099800ew:DaveenChopraMember2023-04-012023-06-300001099800ew:DaveenChopraMember2023-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended June 30, 2023
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
            For the transition period from                                    to            
Commission file number 1-15525
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
36-4316614
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)

One Edwards Way
Irvine, California 92614
(Address of principal executive offices and zip code)

(949) 250-2500
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $1.00 per shareEWNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer☒Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐    No ☒
The number of shares outstanding of the registrant's common stock, $1.00 par value, as of July 25, 2023 was 607,916,300.


EDWARDS LIFESCIENCES CORPORATION
FORM 10-Q
For the quarterly period ended June 30, 2023

TABLE OF CONTENTS


NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We intend the forward-looking statements contained in this report to be covered by the safe harbor provisions of such Acts. Statements other than statements of historical or current fact in this report or referred to or incorporated by reference into this report are "forward-looking statements" for purposes of these sections. These statements include, among other things, the expected impact of COVID-19 on our business, the expected impact of macroeconomic conditions on our business, any predictions, opinions, expectations, plans, strategies, objectives and any statements of assumptions underlying any of the foregoing relating to our current and future business and operations, including, but not limited to, financial matters, development activities, clinical trials and regulatory matters, manufacturing and supply operations, and product sales and demand. These statements can sometimes be identified by the use of the forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "goal," "continue," "seek," "pro forma," "forecast," "intend," "guidance," "optimistic," "aspire," "confident," other forms of these words or similar words or expressions or the negative thereof. Statements regarding past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "preliminary," "initial," diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negative thereof. These forward-looking statements are subject to substantial risks and uncertainties that could cause our results or future business, financial condition, results of operations or performance to differ materially from our historical results or experiences or those expressed or implied in any forward-looking statements contained in this report. These risks and uncertainties include, but are not limited to: our success in developing new products and avoiding manufacturing and quality issues; clinical trial or commercial results or new product approvals and therapy adoption; the impact of public health crises, including the COVID-19 pandemic; the impact of domestic and global conditions; competitive dynamics in the markets in which we operate; our reliance on vendors, suppliers, and other third parties; damage, failure or interruption of our information technology systems; consolidation in the healthcare industry; our ability to protect our intellectual property; our compliance with applicable regulations; our exposure to product liability claims; use of our products in unapproved circumstances; changes to reimbursement for our products; the impact of currency exchange rates; unanticipated actions by the United States Food and Drug Administration and other regulatory agencies; changes to tax laws; unexpected impacts or expenses of litigation or internal or government investigations; and other risks detailed under “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2022, as such risks and uncertainties may be amended, supplemented or superseded from time to time by our subsequent reports on Forms 10-Q and 8-K we file with the United States Securities and Exchange Commission. These forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections.

Unless otherwise indicated or otherwise required by the context, the terms "we," "our," "it," "its," "Company," "Edwards," and "Edwards Lifesciences" refer to Edwards Lifesciences Corporation and its subsidiaries.


Part I. Financial Information
Item 1.    Financial Statements
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED BALANCE SHEETS
(in millions, except par value; unaudited)
 June 30,
2023		December 31,
2022
ASSETS  
Current assets  
Cash and cash equivalents$1,042.6 $769.0 
Short-term investments (Note 4)466.7 446.3 
Accounts receivable, net of allowances of $8.1 and $7.9, respectively
754.4 643.0 
Other receivables62.5 56.1 
Inventories (Note 2)980.2 875.5 
Prepaid expenses123.2 110.0 
Other current assets217.4 195.9 
Total current assets3,647.0 3,095.8 
Long-term investments (Note 4)856.2 1,239.0 
Property, plant, and equipment, net1,662.2 1,632.8 
Operating lease right-of-use assets 84.9 92.3 
Goodwill 1,299.5 1,164.3 
Other intangible assets, net (Note 6) 431.4 285.2 
Deferred income taxes610.7 484.0 
Other assets (Note 5)412.1 299.1 
Total assets$9,004.0 $8,292.5 
LIABILITIES AND STOCKHOLDERS' EQUITY  
Current liabilities  
Accounts payable$193.0 $201.9 
Accrued and other liabilities (Note 2)939.9 795.0 
Operating lease liabilities24.3 25.5 
Total current liabilities1,157.2 1,022.4 
Long-term debt 596.7 596.3 
Contingent consideration liabilities (Note 7)— 26.2 
Taxes payable81.2 143.4 
Operating lease liabilities 63.5 69.5 
Uncertain tax positions303.7 267.5 
Litigation settlement accrual (Note 2)112.5 143.0 
Other liabilities242.7 217.5 
Total liabilities2,557.5 2,485.8 
Commitments and contingencies (Note 11)
Stockholders' equity  
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding          
— — 
Common stock, $1.00 par value, 1,050.0 shares authorized, 649.1 and 646.3 shares issued, and 607.9 and 608.3 shares outstanding, respectively
649.1 646.3 
Additional paid-in capital2,145.5 1,969.3 
Retained earnings8,237.6 7,590.0 
Accumulated other comprehensive loss (Note 12)(255.5)(254.9)
Treasury stock, at cost, 41.2 and 38.0 shares, respectively
(4,401.0)(4,144.0)
Total Edwards Lifesciences Corporation stockholders' equity6,375.7 5,806.7 
Noncontrolling interest (Note 6)70.8 — 
Total stockholders' equity6,446.5 5,806.7 
Total liabilities and equity$9,004.0 $8,292.5 
The accompanying notes are an integral part of these
consolidated condensed financial statements.
1
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(in millions, except per share information; unaudited)
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Net sales$1,530.2 $1,373.9 $2,989.8 $2,715.1 
Cost of sales343.0 269.4 672.5 568.7 
Gross profit1,187.2 1,104.5 2,317.3 2,146.4 
Selling, general, and administrative expenses468.7 409.0 905.0 779.3 
Research and development expenses270.3 250.8 531.5 479.4 
Intellectual property agreement and litigation expense (Note 3)
147.9 6.1 191.4 13.2 
Change in fair value of contingent consideration liabilities (Note 7)(26.9)(20.9)(26.2)(23.8)
Operating income, net327.2 459.5 715.6 898.3 
Interest income, net(9.1)(0.9)(17.7)(1.5)
Other income, net(2.2)(4.3)(3.8)(1.0)
Income before provision for income taxes338.5 464.7 737.1 900.8 
Provision for income taxes33.0 58.3 91.1 120.8 
Net income305.5 406.4 646.0 780.0 
Net loss attributable to noncontrolling interest (Note 6)(1.6)— (1.6)— 
Net income attributable to Edwards Lifesciences Corporation$307.1 $406.4 $647.6 $780.0 
Share information (Note 13)
    
Earnings per share:    
Basic$0.51 $0.65 $1.07 $1.26 
Diluted$0.50 $0.65 $1.06 $1.24 
Weighted-average number of common shares outstanding:    
Basic606.9 620.9 607.2 621.5 
Diluted610.3 626.7 610.6 628.1 
The accompanying notes are an integral part of these
consolidated condensed financial statements.
2
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
(in millions; unaudited)
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Net income$305.5 $406.4 $646.0 $780.0 
Other comprehensive loss, net of tax (Note 12):
Foreign currency translation adjustments(11.5)(43.2)(7.7)(53.2)
Unrealized gain (loss) on hedges5.3 31.3 (11.9)44.7 
Unrealized pension credits (costs)0.2 (0.1)0.1 (0.1)
Unrealized gain (loss) on available-for-sale investments2.1 (30.9)11.1 (68.0)
Reclassification of realized investment losses to earnings3.8 5.1 7.8 9.9 
Other comprehensive loss(0.1)(37.8)(0.6)(66.7)
Comprehensive income305.4 368.6 645.4 713.3 
Comprehensive loss attributable to noncontrolling interest(1.6)— (1.6)— 
Comprehensive income attributable to Edwards Lifesciences Corporation$307.0 $368.6 $647.0 $713.3 
The accompanying notes are an integral part of these
consolidated condensed financial statements.
3
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(in millions; unaudited)
 Six Months Ended
June 30,
 20232022
Cash flows from operating activities  
Net income$646.0 $780.0 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization71.3 68.8 
Non-cash operating lease cost13.7 13.9 
Stock-based compensation (Note 9)76.3 68.6 
Change in fair value of contingent consideration liabilities (Note 7)(26.2)(23.8)
Loss (gain) on investments, net(3.5)38.2 
Deferred income taxes(134.7)(102.4)
Other2.8 4.2 
Changes in operating assets and liabilities:  
Accounts and other receivables, net(124.3)(77.7)
Inventories(113.7)(85.8)
Accounts payable and accrued liabilities76.2 (81.7)
Income taxes31.0 49.7 
Prepaid expenses and other current assets(43.4)25.7 
Intellectual property agreement accrual(14.5)(19.7)
Long-term prepaid royalties (Note 3)(114.0)— 
Other4.7 (32.5)
Net cash provided by operating activities347.7 625.5 
Cash flows from investing activities  
Capital expenditures(109.4)(115.8)
Purchases of held-to-maturity investments (Note 4)(15.5)(180.7)
Proceeds from held-to-maturity investments (Note 4)83.5 277.5 
Purchases of available-for-sale investments (Note 4)(6.8)(114.3)
Proceeds from available-for-sale investments (Note 4)314.5 584.1 
Business combination, net of cash (Note 6)(141.2)— 
Payment for acquisition options (Note 5)(15.0)(55.5)
Issuances of notes receivable(22.5)(45.5)
Collections of notes receivable— 18.0 
Other(16.9)(8.7)
Net cash provided by investing activities70.7 359.1 
Cash flows from financing activities  
Purchases of treasury stock(256.8)(760.7)
Proceeds from stock plans102.7 86.5 
Other(0.4)(2.0)
Net cash used in financing activities(154.5)(676.2)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash11.0 27.1 
Net increase in cash, cash equivalents, and restricted cash274.9 335.5 
Cash, cash equivalents, and restricted cash at beginning of period772.6 867.4 
Cash, cash equivalents, and restricted cash at end of period$1,047.5 $1,202.9 
The accompanying notes are an integral part of these
consolidated condensed financial statements.
4
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
(in millions; unaudited)
 Common StockTreasury Stock
 SharesPar ValueSharesAmountAdditional Paid-in CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Edwards Lifesciences Corporation Stockholders' EquityNoncontrolling InterestTotal Stockholders' Equity
Balance at December 31, 2022646.3 $646.3 38.0 $(4,144.0)$1,969.3 $7,590.0 $(254.9)$5,806.7 $— $5,806.7 
Net income     340.5  340.5 — 340.5 
Other comprehensive loss, net of tax      (0.5)(0.5)(0.5)
Common stock issued under stock plans0.8 0.8   41.1   41.9 41.9 
Stock-based compensation expense    38.9   38.9 38.9 
Purchases of treasury stock  3.1 (249.5)  (249.5)(249.5)
Changes to noncontrolling interest  — 84.0 84.0 
Balance at March 31, 2023
647.1 647.1 41.1 (4,393.5)2,049.3 7,930.5 (255.4)5,978.0 84.0 6,062.0 
Net income307.1 307.1 (1.6)305.5 
Other comprehensive loss, net of tax(0.1)(0.1)(0.1)
Common stock issued under equity plans
2.0 2.0 58.8 60.8 60.8 
Stock-based compensation expense37.4 37.4 37.4 
Purchases of treasury stock0.1 (7.5)(7.5)(7.5)
Changes to noncontrolling interest— (11.6)(11.6)
Balance at June 30, 2023
649.1 $649.1 41.2 $(4,401.0)$2,145.5 $8,237.6 $(255.5)$6,375.7 $70.8 $6,446.5 
The accompanying notes are an integral part of these
consolidated condensed financial statements.

5
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY
(in millions; unaudited)
 Common StockTreasury Stock
 SharesPar ValueSharesAmountAdditional Paid-in CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Stockholders' Equity
Balance at December 31, 2021642.0 $642.0 17.9 $(2,416.9)$1,700.4 $6,068.1 $(157.7)$5,835.9 
Net income     373.6  373.6 
Other comprehensive loss, net of tax      (28.9)(28.9)
Common stock issued under stock plans0.9 0.9   36.6   37.5 
Stock-based compensation expense    32.4   32.4 
Purchases of treasury stock  3.6 (405.6)  (405.6)
Balance at March 31, 2022
642.9 642.9 21.5 (2,822.5)1,769.4 6,441.7 (186.6)5,844.9 
Net income406.4 406.4 
Other comprehensive income, net of tax(37.8)(37.8)
Common stock issued under equity plans
2.1 2.1 46.9 49.0 
Stock-based compensation expense36.2 36.2 
Purchases of treasury stock3.7 (355.1)(355.1)
Balance at June 30, 2022
645.0 $645.0 25.2 $(3,177.6)$1,852.5 $6,848.1 $(224.4)$5,943.6 
The accompanying notes are an integral part of these
consolidated condensed financial statements.
6

1.     BASIS OF PRESENTATION

The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.

The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.

In the opinion of management, the interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.

There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.

New Accounting Standards Not Yet Adopted

In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.

2.     OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS

Composition of Certain Financial Statement Captions
(in millions)

Components of selected captions in the consolidated condensed balance sheets consisted of the following:
June 30, 2023December 31, 2022
Inventories
Raw materials$181.2 $156.4 
Work in process223.0 177.4 
Finished products576.0 541.7 
$980.2 $875.5 

At June 30, 2023 and December 31, 2022, $149.7 million and $128.6 million, respectively, of the Company's finished products inventories were held on consignment.

7
June 30, 2023December 31, 2022
Accrued and other liabilities 
Employee compensation and withholdings$312.7 $268.7 
Taxes payable106.6 50.6 
Property, payroll, and other taxes56.1 45.6 
Research and development accruals70.7 66.9 
Accrued rebates130.1 116.1 
Fair value of derivatives17.8 20.7 
Accrued marketing expenses16.9 17.0 
Legal and insurance30.4 28.1 
Litigation settlement (a)
69.2 53.3 
Accrued relocation costs23.3 25.2 
Accrued professional services10.2 6.6 
Accrued realignment reserves14.4 15.6 
Other accrued liabilities81.5 80.6 
$939.9 $795.0 
_______________________________________
(a)     As of June 30, 2023, $69.2 million was accrued in "Accrued and Other Liabilities" and $112.5 million was accrued in "Litigation Settlement Accrual" on the consolidated condensed balance sheet related to a settlement agreement with Abbott Laboratories and its direct and indirect subsidiaries.

Supplemental Cash Flow Information
(in millions)
Six Months Ended
June 30,
20232022
Cash paid during the year for:
Income taxes$193.5 $173.0 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$14.3 $14.5 
Non-cash investing and financing transactions:  
Right-of-use assets obtained in exchange for new lease liabilities$6.0 $10.6 
Capital expenditures accruals$26.9 $24.6 

Cash, Cash Equivalents, and Restricted Cash
(in millions)
June 30, 2023December 31, 2022
Cash and cash equivalents$1,042.6 $769.0 
Restricted cash included in other current assets1.4 0.5 
Restricted cash included in other assets3.5 3.1 
Total cash, cash equivalents, and restricted cash$1,047.5 $772.6 

Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.

3.    INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE

On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and will pay annual royalty payments that are tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million
8
pre-tax charge in "Intellectual Property Agreement and Litigation Expense" in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in "Intellectual Property Agreement and Litigation Expense" in April 2023 related to products currently in development.

4.     INVESTMENTS

Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):
 June 30, 2023December 31, 2022
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$28.1 $— $— $28.1 $96.0 $— $— $96.0 
Available-for-sale
U.S. government and agency securities103.4 — (5.0)98.4 137.7 — (6.1)131.6 
Asset-backed securities262.5 — (10.0)252.5 380.6 — (14.0)366.6 
Corporate debt securities864.9 — (34.0)830.9 1,028.1 — (47.8)980.3 
Municipal securities2.8 — (0.2)2.6 2.7 — (0.2)2.5 
Total$1,233.6 $— $(49.2)$1,184.4 $1,549.1 $— $(68.1)$1,481.0 
The cost and fair value of investments in debt securities, by contractual maturity, as of June 30, 2023, were as follows:
Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$26.3 $26.3 $450.9 $440.4 
Due after 1 year through 5 years1.8 1.8 472.0 446.7 
Due after 5 years through 10 years— — 4.6 4.4 
Instruments not due at a single maturity date (a)
— — 306.1 292.9 
$28.1 $28.1 $1,233.6 $1,184.4 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.
Actual maturities may differ from the contractual maturities due to call or prepayment rights.
The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2023 and December 31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):

June 30, 2023
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$10.9 $(0.1)$86.2 $(4.9)$97.1 $(5.0)
Asset-backed securities50.9 (0.8)199.9 (9.2)250.8 (10.0)
Corporate debt securities23.3 (0.1)793.3 (33.9)816.6 (34.0)
Municipal securities— — 2.6 (0.2)2.6 (0.2)
$85.1 $(1.0)$1,082.0 $(48.2)$1,167.1 $(49.2)
9
December 31, 2022
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$61.6 $(1.5)$69.5 $(4.6)$131.1 $(6.1)
Asset-backed securities103.3 (1.3)254.6 (12.7)357.9 (14.0)
Corporate debt securities189.0 (5.3)784.8 (42.5)973.8 (47.8)
Municipal securities— — 2.5 (0.2)2.5 (0.2)
$353.9 $(8.1)$1,111.4 $(60.0)$1,465.3 $(68.1)

The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of June 30, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.

Investments in Unconsolidated Entities

The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "Long-term Investments" on the consolidated condensed balance sheets, and are as follows:
 June 30,
2023		December 31,
2022
 (in millions)
Equity method investments  
Carrying value of equity method investments$23.5 $21.4 
Equity securities  
Carrying value of non-marketable equity securities86.9 86.9 
Total investments in unconsolidated entities$110.4 $108.3 

During the six months ended June 30, 2023, the Company made $1.7 million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. As of June 30, 2023, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $3.1 million due to impairments and observable price changes.

During the three and six months ended June 30, 2023, the gross realized gains or losses from sales of available-for-sale investments were not material.

5.     INVESTMENTS IN VARIABLE INTEREST ENTITIES

The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to
10
consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.

Consolidated VIEs

In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. See Note 6 for additional information.

Unconsolidated VIEs

Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.

In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option to acquire the medical device company, of which $15.0 million has been paid as of June 30, 2023. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. The option and the note are included in "Other Assets" on the consolidated condensed balance sheet.
In January 2023, the Company loaned a privately-held medical device company (the "Investee") $10.0 million under a $45.0 million secured promissory note agreement. In April 2023, the Investee drew an additional $7.5 million under the promissory note. Previously, in 2021, the Company invested $39.3 million, included in "Long-term Investments," in the Investee's preferred equity securities and paid $13.1 million, included in "Other Assets," for an option to acquire the Investee. Per the agreement, the Company may be required to invest up to an additional $6.5 million in the Investee's preferred equity securities and up to an additional $14.4 million for the option to acquire the Investee.

In August 2022, the Company entered into an option agreement with a medical device company. Under the option agreement, Edwards paid $47.1 million for an option to acquire the medical device company. The $47.1 million option is included in "Other Assets" on the consolidated condensed balance sheet.

In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $32.5 million has been advanced as of June 30, 2023. In addition, in 2019 the Company paid $35.0 million for an option to acquire the medical device company. The $35.0 million option and the $32.5 million note receivable are included in "Other Assets" on the consolidated condensed balance sheet.

In May 2022, the Company entered into an option agreement with a medical technology company. Under the option agreement, Edwards paid $60.0 million for an option to acquire the medical technology company, of which $10.0 million was paid in 2021. The $60.0 million option is included in "Other Assets" on the consolidated condensed balance sheet.

In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 4.

6.     BUSINESS COMBINATION

On February 28, 2023, the Company acquired 61% of the then outstanding shares of a medical technology company in an all cash transaction. The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated condensed financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company.

11
The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination. Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):

Assets$8.1 
Goodwill133.2 
In-process research and development136.6 
Liabilities assumed(1.7)
Deferred tax liabilities(28.0)
Fair value of net assets acquired248.2 
Less: Noncontrolling interest (a)
(72.4)
Total purchase price
175.8 
Less: cash acquired(6.8)
Total purchase price, net of cash acquired (b)
$169.0 
_______________________________________
(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.
(b)     Includes $22.5 million paid in a previous year under option agreements and $5.3 million for the settlement of a pre-existing note.

Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s Rest of World segment and is not deductible for tax purposes.

Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.

7.     FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.
Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.
Level 3—Unobservable inputs that are not corroborated by market data.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. As of June 30, 2023, the fair value of the notes payable, based on Level 2 inputs, was $580.5 million.

12
Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
June 30, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$635.0 $— $— $635.0 
Available-for-sale investments:
Corporate debt securities
— 830.9 — 830.9 
Asset-backed securities
— 252.5 — 252.5 
United States government and agency securities— 98.4 — 98.4 
Municipal securities
— 2.6 — 2.6 
Investments held for deferred compensation plans125.3 — — 125.3 
Derivatives— 63.9 — 63.9 
$760.3 $1,248.3 $— $2,008.6 
Liabilities    
Derivatives$— $17.8 $— $17.8 
Other liability— — 14.0 14.0 
$— $17.8 $14.0 $31.8 
December 31, 2022    
Assets    
Cash equivalents$280.4 $— $— $280.4 
Available-for-sale investments:
Corporate debt securities
— 980.3 — 980.3 
Asset-backed securities
— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities
— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$429.6 $1,509.4 $— $1,939.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other liability— — 14.0 14.0 
$— $27.2 $40.2 $67.4 

Cash Equivalents and Available-for-sale Investments

Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond and money market mutual funds. The fair values of these investments are based on quoted market prices.

13
Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. As of June 30, 2023 the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was reduced to zero.

The following tables summarize the changes in fair value of the contingent consideration and the other liability (in millions):
 Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)— (26.2)
Balance at June 30, 2023$— $14.0 $14.0 
Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(23.8)— (23.8)
Balance at June 30, 2022$38.2 $14.0 $52.2 


8.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 June 30, 2023December 31, 2022
 (in millions)
Foreign currency forward exchange contracts$1,763.7 $1,678.4 
Cross currency swap contracts300.0 300.0 

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (b) its net
14
investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions).

All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):
  Fair Value
Derivatives designated as hedging instrumentsBalance Sheet
Location		June 30, 2023December 31, 2022
Assets   
Foreign currency contractsOther current assets$32.2 $24.9 
Cross currency swap contractsOther assets$31.7 $40.6 
Liabilities   
Foreign currency contractsAccrued and other liabilities$17.8 $20.7 
Foreign currency contractsOther liabilities$— $6.5 

The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):
    Gross Amounts
Not Offset in
the Consolidated
Balance Sheet		 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		 
  Net Amounts
Presented in the
Consolidated
Balance Sheet
June 30, 2023Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative assets      
Foreign currency contracts$32.2 $— $32.2 $(8.6)$— $23.6 
Cross currency swap contracts$31.7 $— $31.7 $— $— $31.7 
Derivative liabilities      
Foreign currency contracts$17.8 $— $17.8 $(8.6)$— $9.2 
December 31, 2022      
Derivative assets      
Foreign currency contracts$24.9 $— $24.9 $(12.0)$— $12.9 
Cross currency swap contracts$40.6 $— $40.6 $— $— $40.6 
Derivative liabilities   
Foreign currency contracts$27.2 $— $27.2 $(12.0)$— $15.2 
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):
15
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
 Three Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Three Months Ended
June 30,
 
2023202220232022
Cash flow hedges
Foreign currency contracts$23.2 $57.9 Cost of sales$13.9 $16.3 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
 Six Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Six Months Ended
June 30,
 
2023202220232022
Cash flow hedges
Foreign currency contracts$26.9 $82.6 Cost of sales$43.7 $23.6 

 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
Effectiveness Testing)
 Three Months Ended
June 30,		 Location of Gain or
(Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)		Three Months Ended
June 30,
 
2023202220232022
Net investment hedges
Cross currency swap contracts$(6.5)$19.4 Interest income, net$1.8 $2.0 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
 Six Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Six Months Ended
June 30,
 
2023202220232022
Net investment hedges
Cross currency swap contracts$(9.0)$23.3 Interest income, net$3.5 $3.6 

The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Three Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Fair value hedges
Foreign currency contractsOther income, net$11.3 $— 
16
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Six Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Fair value hedges
Foreign currency contractsOther income, net$11.3 $— 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Three Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$9.9 $26.6 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Six Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$4.5 $42.1 
The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):
 Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Three Months Ended
June 30, 2023		Six Months Ended
June 30, 2023
 Cost of salesOther income, netCost of salesOther income, net
Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded$(343.0)$2.2 $(672.5)$3.8 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
$— $(10.1)$— $(8.9)
Derivatives designated as hedging instruments
$— $10.1 $— $8.9 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
$— $1.2 $— $2.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
$13.9 $— $43.7 $— 
17
 Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Three Months Ended
June 30, 2022		Six Months Ended
June 30, 2022
 Cost of salesCost of sales
Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded$(269.4)$(568.7)
The effects of fair value and cash flow hedging:
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
$16.3 $23.6 

The Company expects that during the next twelve months it will reclassify to earnings a $9.0 million gain currently recorded in "Accumulated Other Comprehensive Loss."

9.    STOCK-BASED COMPENSATION

Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and six months ended June 30, 2023 and 2022 was as follows (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Cost of sales$6.2 $6.9 $13.2 $13.1 
Selling, general, and administrative expenses22.5 21.1 44.8 39.8 
Research and development expenses8.7 8.2 18.3 15.7 
Total stock-based compensation expense37.4 36.2 76.3 68.6 
Income tax benefit(6.8)(5.9)(11.5)(10.3)
Total stock-based compensation expense, net of tax$30.6 $30.3 $64.8 $58.3 

At June 30, 2023, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $275.0 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 34 months.

During the six months ended June 30, 2023, the Company granted 1.9 million stock options at a weighted-average
exercise price per share of $88.72, and 0.8 million restricted stock units at a weighted-average grant-date fair value per share of $88.06. During the six months ended June 30, 2023, the Company also granted 0.1 million market-based restricted stock units at a weighted-average grant-date fair value per share of $110.10. The market-based restricted stock units granted during the six months ended June 30, 2023 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a three-year performance period and may range from 0% to 175% of the target number of shares granted.
18

Fair Value Disclosures

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the six months ended June 30, 2023 and 2022 included a risk-free interest rate of 3.6% and 2.8%, respectively, and an expected volatility rate of 32.6% and 33.8%, respectively.

The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
 Option Awards
Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Risk-free interest rate3.4 %3.0 %3.4 %3.0 %
Expected dividend yieldNoneNoneNoneNone
Expected volatility32.8 %31.4 %32.8 %31.4 %
Expected term (years)5.15.05.15.0
Fair value, per option$31.03 $35.07 $31.01 $35.08 
The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
 ESPP
Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Risk-free interest rate4.7 %1.1 %4.6 %0.3 %
Expected dividend yieldNoneNoneNoneNone
Expected volatility34.8 %31.5 %31.5 %32.1 %
Expected term (years)0.60.60.60.6
Fair value, per share$22.02 $23.63 $19.03 $28.63 

10.    ACCELERATED SHARE REPURCHASE

During 2023 and 2022, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreement, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share
January 2022$250.0 1.9 $104.87 80 %February 20222.3 $110.31 
February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 

The ASR agreements were each accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "Additional Paid-in Capital" and subsequently, upon settlement, was transferred to "Treasury Stock" on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.

19
11.    COMMITMENTS AND CONTINGENCIES

The Company is reviewing and investigating whether business activities in Japan and other markets violate certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the outcome of the review and investigation or the potential impact on its financial statements.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.

The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.


20
12.    ACCUMULATED OTHER COMPREHENSIVE LOSS

The following tables summarize the activity for each component of "Accumulated Other Comprehensive Loss" (in millions):
 Foreign
Currency
Translation
Adjustments		Unrealized Gain on Hedges
Unrealized Loss on Available-for-sale Investments		Unrealized
Pension
Credits		Total
Accumulated
Other
Comprehensive
Loss
December 31, 2022$(218.8)$23.8 $(65.6)$5.7 $(254.9)
Other comprehensive gain (loss) before reclassifications4.9 6.7 9.0 (0.1)20.5 
Amounts reclassified from accumulated other comprehensive loss(1.7)(29.8)4.0 — (27.5)
Deferred income tax benefit 0.6 5.9 — — 6.5 
March 31, 2023$(215.0)$6.6 $(52.6)$5.6 $(255.4)
Other comprehensive (loss) gain before reclassifications(11.3)33.5 2.1 0.2 24.5 
Amounts reclassified from accumulated other comprehensive loss(1.8)(25.2)3.8 — (23.2)
Deferred income tax benefit (expense)1.6 (3.0)— — (1.4)
June 30, 2023$(226.5)$11.9 $(46.7)$5.8 $(255.5)

 Foreign
Currency
Translation
Adjustments		Unrealized Gain on Hedges
Unrealized Loss on Available-for-sale Investments		Unrealized
Pension
Costs		Total
Accumulated
Other
Comprehensive
Loss
December 31, 2021$(172.5)$29.7 $(6.9)$(8.0)$(157.7)
Other comprehensive (loss) gain before reclassifications(7.4)24.7 (47.6)— (30.3)
Amounts reclassified from accumulated other comprehensive loss(1.6)(7.3)4.8 — (4.1)
Deferred income tax (expense) benefit(1.0)(4.0)10.5 — 5.5 
March 31, 2022$(182.5)$43.1 $(39.2)$(8.0)$(186.6)
Other comprehensive (loss) gain before reclassifications(36.5)57.9 (20.9)(0.1)0.4 
Amounts reclassified from accumulated other comprehensive loss(2.0)(16.3)5.1 — (13.2)
Deferred income tax expense(4.7)(10.3)(10.0)— (25.0)
June 30, 2022$(225.7)$74.4 $(65.0)$(8.1)$(224.4)

21
The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,		 
 Affected Line on Consolidated Condensed
Statements of Operations
Details about Accumulated Other
Comprehensive Loss Components
2023202220232022
Foreign currency translation adjustments$1.8 $2.0 $3.5 $3.6 Other income, net
(0.4)(0.5)(0.8)(0.9)Provision for income taxes
$1.4 $1.5 $2.7 $2.7 Net of tax
Gain on hedges$13.9 $16.3 $43.7 $23.6 Cost of sales
11.3 — 11.3 — Other income, net
25.2 16.3 55.0 23.6 Total before tax
(4.8)(4.3)(11.9)(6.4)Provision for income taxes
$20.4 $12.0 $43.1 $17.2 Net of tax
Loss on available-for-sale investments$(3.8)$(5.1)$(7.8)$(9.9)Interest income, net
0.9 1.2 1.9 2.4 Provision for income taxes
$(2.9)$(3.9)$(5.9)$(7.5)Net of tax

13.    EARNINGS PER SHARE

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Basic:    
Net income attributable to Edwards Lifesciences Corporation$307.1 $406.4 $647.6 $780.0 
Weighted-average shares outstanding606.9 620.9 607.2 621.5 
Basic earnings per share$0.51 $0.65 $1.07 $1.26 
Diluted:    
Net income attributable to Edwards Lifesciences Corporation$307.1 $406.4 $647.6 $780.0 
Weighted-average shares outstanding606.9 620.9 607.2 621.5 
Dilutive effect of stock plans3.4 5.8 3.4 6.6 
Dilutive weighted-average shares outstanding610.3 626.7 610.6 628.1 
Diluted earnings per share$0.50 $0.65 $1.06 $1.24 

Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 6.7 million and 3.6 million common shares for the three months ended June 30, 2023 and 2022, respectively, and 5.9 million and 2.6 million shares for the six months ended June 30, 2023 and 2022, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.

22
14.    INCOME TAXES

The Company's effective income tax rates were 9.7% and 12.5% for the three months ended June 30, 2023 and 2022, respectively, and 12.4% and 13.4% for the six months ended June 30, 2023 and 2022, respectively. The decrease in the effective rate between the six months ended June 30, 2023 and 2022 is primarily due to an increase in the benefit from the federal research and development credit and the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation. In addition, the effective rates for the six months ended June 30, 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. The effective rates include a tax benefit from employee share-based compensation of $9.3 million and $19.8 million for the three months ended June 30, 2023 and 2022, respectively, and $12.3 million and $33.2 million for the six months ended June 30, 2023 and 2022, respectively.

In the normal course of business, the Internal Revenue Service (“IRS”) and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.

As of June 30, 2023 and December 31, 2022, the gross liability recorded for income taxes associated with uncertain tax positions was $520.0 million and $475.3 million, respectively. The Company estimates that these liabilities would be reduced by $205.1 million and $182.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $314.9 million and $293.2 million, respectively, if not required, would favorably affect the Company's effective tax rate.

The Company executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively “Surgical/TAVR”) intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all of the APAs which cover transactions with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. The execution of some or all of these APA renewals depends on many variables outside of the Company's control.

The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters. The IRS began its examination of the 2018 through 2020 tax years during the first quarter of 2022.

The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010 and on.

During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015-2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed an increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $220 million and reflects a significant departure from the transfer pricing methods the Company had previously agreed upon with the IRS for these types of transactions. The Company disagreed with the NOPA and submitted a formal protest on the matter during the fourth quarter of 2021. During the second quarter of 2022, the Company received the IRS's rebuttal to the Company's protest and was notified that the case had been transferred to the IRS Independent Office of Appeals ("Appeals"). The opening conference was held with Appeals during March 2023 and discussions with Appeals continued throughout the second quarter of 2023. While Appeals still maintains
23
jurisdiction over the matter as of June 30, 2023, the Company and Appeals have now concluded that a satisfactory resolution of this matter at the administrative level is not possible.

The Company now plans to vigorously contest the proposed adjustments through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate based on prior experience and interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOPA received or as a result of the Appeals proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018-2023 tax years. While no payment of any amount related to the NOPA has yet been required, the Company made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any potential deficiency that may be ultimately sustained.

Surgical/TAVR intercompany royalty transactions covering tax years 2018-2023 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of June 30, 2023. The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.

15.    SEGMENT INFORMATION

Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.

Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.
24

The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Segment Net Sales    
United States$895.3 $800.8 $1,744.4 $1,550.3 
Europe336.0 309.8 671.4 609.9 
Japan109.7 145.1 214.0 286.0 
Rest of World182.2 145.9 347.8 288.2 
Total segment net sales$1,523.2 $1,401.6 $2,977.6 $2,734.4 
Segment Operating Income    
United States$592.4 $549.5 $1,155.8 $1,061.0 
Europe177.7 164.5 359.4 331.1 
Japan63.4 95.9 126.8 195.4 
Rest of World80.1 54.6 150.6 114.3 
Total segment operating income$913.6 $864.5 $1,792.6 $1,701.8 
The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Net Sales Reconciliation    
Segment net sales$1,523.2 $1,401.6 $2,977.6 $2,734.4 
Foreign currency7.0 (27.7)12.2 (19.3)
Consolidated net sales$1,530.2 $1,373.9 $2,989.8 $2,715.1 
Pre-tax Income Reconciliation    
Segment operating income$913.6 $864.5 $1,792.6 $1,701.8 
Unallocated amounts:    
Corporate items(492.4)(450.4)(961.3)(869.8)
Intellectual property agreement and litigation expense(147.9)(6.1)(191.4)(13.2)
Change in fair value of contingent consideration liabilities26.9 20.9 26.2 23.8 
Foreign currency27.0 30.6 49.5 55.7 
Consolidated operating income327.2 459.5 715.6 898.3 
Non-operating income11.3 5.2 21.5 2.5 
Consolidated pre-tax income$338.5 $464.7 $737.1 $900.8 
25

Enterprise-wide Information
(in millions)

The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Net Sales by Geographic Region    
United States$895.3 $800.8 $1,744.4 $1,550.3 
Europe336.2 302.8 667.3 613.9 
Japan117.9 122.9 232.0 258.4 
Rest of World180.8 147.4 346.1 292.5 
$1,530.2 $1,373.9 $2,989.8 $2,715.1 
Net Sales by Major Product Group    
Transcatheter Aortic Valve Replacement$991.6 $906.9 $1,939.5 $1,788.2 
Transcatheter Mitral and Tricuspid Therapies47.6 27.9 89.2 54.9 
Surgical Structural Heart256.3 228.5 504.5 449.3 
Critical Care234.7 210.6 456.6 422.7 
$1,530.2 $1,373.9 $2,989.8 $2,715.1 

26
Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations        
Overview

The following discussion and analysis contains forward-looking statements within the meaning of the federal securities laws, and should be read in conjunction with the disclosures we make concerning risks and other factors that may affect our business and operating results. See “Note Regarding Forward-Looking Statements” preceding Part I, Item 1 in this Quarterly Report on Form 10-Q.

We are the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care. We conduct operations worldwide and are managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Our products are categorized into the following groups: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care.

Financial Highlights and Market Update
12001201
COVID-19 and Macroeconomic Uncertainties

While conditions related to the COVID-19 pandemic have improved compared to 2022, we have continued to experience the impacts of the COVID-19 pandemic in 2023, particularly relating to lingering headwinds in Japan and disruptions related to staffing shortages in the United States and Europe. The COVID-19 pandemic adversely impacted, and may further adversely impact, aspects of our business and markets, including our workforce and the operations of our customers, suppliers, and business partners. Our priority has been to maintain access for patients to our life-saving technologies while providing continuous front-line support to our clinician partners, and protecting the well-being of our employees. Our manufacturing operations have continued to respond to impacts related to COVID-19, and we have been able to supply our technologies around the world. Across our organization, we are proactively managing inventory, assessing alternative logistics options, and closely monitoring the supply of components to address potential supply constraints.

In addition to the impacts described above, the global economy, including the financial and credit markets, continues to experience extreme volatility and disruptions, including inflationary conditions, rising interest rates, declines in consumer confidence, and uncertainty about economic growth and stability. The severity and duration of the impact of these conditions on our business cannot be predicted. See Item 1A, "Risk Factors," of our Annual Report on Form 10-K for the year ended December 31, 2022 for additional information.

27
Financial Highlights

Despite the challenges to our business due to COVID-19 and macroeconomic factors, our net sales for the first six months of 2023 were $3.0 billion, representing an increase of $274.7 million over the first six months of 2022, driven primarily by sales of our TAVR products.

Our gross profit increased in the six months ended June 30, 2023, driven by our sales growth. Gross profit as a percentage of sales decreased primarily due to the impact of foreign currency exchange rate fluctuations. The decrease in our diluted earnings per share in the six months ended June 30, 2023 was driven by an after-tax charge of $142.2 million related to an intellectual property agreement.
Healthcare Environment, Opportunities, and Challenges

The medical technology industry is highly competitive and continues to evolve. Our success is measured both by the development of innovative products and the value we bring to our stakeholders. We are committed to developing new technologies and providing innovative patient care, and we are committed to defending our intellectual property in support of those developments. In the first six months of 2023, we invested 17.8% of our net sales in research and development.

We are dedicated to generating robust clinical, economic, and quality-of-life evidence increasingly expected by patients, clinicians, and payors in the current healthcare environment, with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes.

New Accounting Standards

Information on new accounting standards is included in Note 1 to the "Consolidated Condensed Financial Statements."

Results of Operations

Net Sales by Region
(dollars in millions)
 Three Months Ended
June 30,		Six Months Ended
June 30,
 Percent ChangePercent Change
 20232022Change20232022Change
United States$895.3 $800.8 $94.5 11.8 %$1,744.4 $1,550.3 $194.1 12.5 %
Europe336.2 302.8 33.4 11.0 %667.3 613.9 53.4 8.7 %
Japan117.9 122.9 (5.0)(4.1)%232.0 258.4 (26.4)(10.2)%
Rest of World180.8 147.4 33.4 22.8 %346.1 292.5 53.6 18.3 %
Outside of the United States634.9 573.1 61.8 10.8 %1,245.4 1,164.8 80.6 6.9 %
Total net sales$1,530.2 $1,373.9 $156.3 11.4 %$2,989.8 $2,715.1 $274.7 10.1 %

Net sales outside of the United States include the impact of foreign currency exchange rate fluctuations. The impact of foreign currency exchange rate fluctuations on net sales is not necessarily indicative of the impact on net income due to the corresponding effect of foreign currency exchange rate fluctuations on international manufacturing and operating costs, and our hedging activities.

Net Sales by Product Group
(dollars in millions)
 Three Months Ended
June 30,		Six Months Ended
June 30,
 Percent ChangePercent Change
 20232022Change20232022Change
Transcatheter Aortic Valve Replacement$991.6 $906.9 $84.7 9.3 %$1,939.5 $1,788.2 $151.3 8.5 %
Transcatheter Mitral and Tricuspid Therapies47.6 27.9 19.7 71.4 %89.2 54.9 34.3 62.6 %
Surgical Structural Heart256.3 228.5 27.8 12.2 %504.5 449.3 55.2 12.3 %
Critical Care234.7 210.6 24.1 11.4 %456.6 422.7 33.9 8.0 %
Total net sales$1,530.2 $1,373.9 $156.3 11.4 %$2,989.8 $2,715.1 $274.7 10.1 %

28
Transcatheter Aortic Valve Replacement Sales
566
Net sales of TAVR products increased for the three and six months ended June 30, 2023 driven by:

•higher sales of the Edwards SAPIEN platform in 2023, primarily the Edwards SAPIEN 3 Ultra valve in the United States;

partially offset by:

•foreign currency exchange rate fluctuations, which decreased net sales outside of the United States by $3.3 million for the three months ended June 30, 2023, primarily due to the weakening of the Japanese yen against the United States dollar, and $28.5 million for the six months ended June 30, 2023, primarily due the weakening of the Japanese yen and the Euro against the United States dollar.

During the first half of 2023, we continued to enroll our PROGRESS pivotal trial, studying moderate aortic stenosis patients. In March 2023, we launched the Edwards SAPIEN 3 Ultra RESILIA valve in Japan. In July 2023, we announced the restart of enrollment in our pivotal trial, ALLIANCE, designed to study our next generation TAVR technology, SAPIEN X4.

29
Transcatheter Mitral and Tricuspid Therapies Sales
1239
Net sales of TMTT products increased for the three and six months ended June 30, 2023 primarily due to the continued adoption of our PASCAL system in Europe and its launch in the United States.

During the first six months of 2023, we continued to enroll the CLASP IIF pivotal trial with PASCAL for patients with functional mitral regurgitation. In mitral replacement, enrollment continued in the ENCIRCLE pivotal trial for SAPIEN M3. In tricuspid, we completed the enrollment of the full cohort of the TRISCEND II pivotal trial of the EVOQUE replacement system. In the United States, in December 2022, the Food and Drug Administration approved continued access allowing hospitals that were involved in the clinical trial to continue to have EVOQUE as a therapy option. In addition, enrollment continued in the CLASP IITR pivotal trial with the PASCAL repair system in patients with symptomatic, severe tricuspid regurgitation.

30

Surgical Structural Heart Sales
2152
Net sales of Surgical products increased for the three and six months ended June 30, 2023 primarily due to increased sales of the INSPIRIS RESILIA aortic valve, primarily in the United States and Europe, and the MITRIS RESILIA valve, primarily in the United States. These increases were partially offset by the impact of foreign currency exchange rate fluctuations, which decreased net sales outside of the United States by $2.1 million for the three months ended June 30, 2023, primarily due to the weakening of the Japanese yen against the United States dollar, and $10.5 million for the six months ended June 30, 2023, primarily due to the weakening of the Japanese yen and the Euro against the United States dollar.
We are continuing to enroll patients in our MOMENTIS clinical study to demonstrate the durability of RESILIA tissue in the mitral position.

31
Critical Care Sales
2810
Net sales of Critical Care products increased for the three and six months ended June 30, 2023 primarily due to:

•increased demand for our enhanced surgical recovery products and pressure monitoring products, primarily in the United States;

partially offset by:

•foreign currency exchange rate fluctuations, which decreased net sales outside of the United States by $2.5 million and $11.3 million for the three and six months ended June 30, 2023, respectively, primarily due to the weakening of the Japanese yen against the United States dollar.






32
Gross Profit
3260
The decrease in gross profit as a percentage of net sales for the three and six months ended June 30, 2023 was driven by a 2.2 percentage point and 1.5 percentage point decrease, respectively, from the impact of foreign currency exchange rate fluctuations, primarily the strengthening of the United States dollar against the Euro.

Selling, General, and Administrative ("SG&A") Expenses
3592
SG&A expenses increased for the three and six months ended June 30, 2023 primarily due to higher field-based personnel-related costs, primarily TAVR and TMTT in the United States, and higher performance-based compensation. Foreign currency exchange rate fluctuations decreased expenses by $1.4 million and $9.9 million for the three and six months ended June 30, 2023, respectively, due to the strengthening of the United States dollar against multiple foreign currencies.
33

Research and Development ("R&D") Expenses
3972
R&D expenses increased for the three and six months ended June 30, 2023 primarily due to continued investments in our transcatheter aortic valve innovations, including increased clinical trial activity.

Intellectual Property Agreement and Litigation Expense

We incurred intellectual property agreement and litigation expenses of $147.9 million and $6.1 million during the three months ended June 30, 2023 and 2022, respectively, and $191.4 million and $13.2 million during the six months ended June 30, 2023 and 2022, respectively. On April 12, 2023, we entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") and recorded a $37.0 million charge in March 2023 and a $139.0 million charge in April 2023. For more information, see Note 3 to the "Consolidated Condensed Financial Statements."
Change in Fair Value of Contingent Consideration Liabilities

The change in fair value of contingent consideration liabilities resulted in a gain of $26.9 million and $26.2 million for the three and six months ended June 30, 2023, respectively, and a gain of $20.9 million and $23.8 million for the three and six months ended June 30, 2022, respectively. The gains in 2023 and 2022 were each due to changes in projected probabilities and timing of milestone achievement and the projected timing of cash inflows. For further information, see Note 7 to the "Consolidated Condensed Financial Statements."

Other Income, net
(in millions)
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Foreign exchange (gains) losses, net$(2.5)$1.8 $(3.8)$4.3 
Loss (gain) on investments0.3 (0.8)0.2 0.1 
Gain on insurance settlement— (3.8)— (3.8)
Other— (1.5)(0.2)(1.6)
Other income, net$(2.2)$(4.3)$(3.8)$(1.0)
The net foreign exchange (gains) losses relate to the foreign currency fluctuations primarily in our global trade and intercompany receivable and payable balances, partially offset by the gains and losses on foreign currency derivative instruments.

The loss (gain) on investments primarily represents our net share of gains and losses in investments accounted for under the equity method, and realized gains and losses on investments in equity securities.

34
The gain on insurance settlement in the three and six months ended June 30, 2022 relates to an insurance recovery for
damaged cargo shipments of heart valves.

Provision for Income Taxes

The provision for income taxes consists of provisions for federal, state, and foreign income taxes. We operate in an international environment with significant operations in various locations outside the United States which have statutory tax rates typically lower than the United States tax rate. Accordingly, the consolidated income tax rate is a composite rate reflecting the earnings in the various locations and the applicable rates.

Our effective income tax rate was 9.7% and 12.5% for the three months ended June 30, 2023 and 2022, respectively, and 12.4% and 13.4% for the six months ended June 30, 2023 and 2022, respectively. The decrease in the effective rate between the six months ended June 30, 2023 and 2022 is primarily due to an increase in the benefit from the Federal research and development credit and the Intellectual Property Agreement with Medtronic (see Note 3 to the "Consolidated Condensed Financial Statements"), partially offset by a reduced tax benefit from employee share-based compensation. In addition, the effective rates for the six months ended June 30, 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation.

In the normal course of business, the Internal Revenue Service (“IRS”) and other taxing authorities are in different stages of examining various years of our tax filings. During these audits we may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on our results of operations and financial condition. We strive to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While we have accrued for matters we believe are more likely than not to require settlement, the eventual outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.

We executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, we executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. We have filed to renew all the APAs which cover transactions with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. The execution of some or all these APA renewals depends on many variables outside of our control.

The audits of our United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters. The IRS began its examination of the 2018 through 2020 tax years during the first quarter of 2022.

The audits of our material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, we continue to address matters in India for years from 2010 and on.

During 2021, we received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015-2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between our United States and Switzerland subsidiaries. The NOPA proposed an increase to our United States taxable income, which could result in additional tax expense for this period of approximately $220 million and reflects a significant departure from the transfer pricing methods we had previously agreed upon with the IRS for these types of transactions. We have disagreed with the NOPA and submitted a formal protest on the matter during the fourth quarter of 2021. During the second quarter of 2022, we received the IRS's rebuttal to our protest and were notified that the case had been transferred to the IRS Independent Office of Appeals ("Appeals"). The opening conference was held with Appeals during March 2023 and discussions with Appeals continued throughout the second quarter of 2023. While Appeals still maintains jurisdiction over the matter as of June 30, 2023, we and Appeals have now concluded that a satisfactory resolution of this matter at the administrative level is not possible.

35
We now plan to vigorously contest the proposed adjustments through the judicial process. Final resolution of this matter is not likely within the next 12 months. We believe the amounts previously accrued related to this uncertain tax position are appropriate based on prior experience and interpretation and application of relevant tax law and accounting standards to our facts and, accordingly, have not accrued any additional amount based on the NOPA received or as a result of the Appeals proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on our consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018-2023 tax years. While no payment of any amount related to the NOPA has yet been required, we made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any potential deficiency that may ultimately be sustained.

Surgical/TAVR intercompany royalty transactions covering tax years 2018-2023 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of June 30, 2023. We have considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in our evaluation of our uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to our consolidated financial statements. Based on the information currently available and numerous possible outcomes, we cannot reasonably estimate what, if any, changes in our existing uncertain tax positions may occur in the next 12 months and, therefore, have continued to record the uncertain tax positions as a long-term liability.

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. The IRA includes, among other provisions, changes to the U.S. corporate income tax system, including a 15% minimum tax based on “adjusted financial statement income,” which is effective for tax years beginning after December 31, 2022, and a one percent excise tax on net repurchases of stock after December 31, 2022. Based upon our analysis to date, we do not expect the IRA will have a material impact on our consolidated financial statements.

Liquidity and Capital Resources

Our sources of cash liquidity include cash and cash equivalents, short-term investments, cash from operations, and amounts available under credit facilities. We believe that these sources are sufficient to fund the current and long-term requirements of working capital, capital expenditures, and other financial commitments. However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions.

As of June 30, 2023, cash and cash equivalents and short-term investments held in the United States and outside of the United States were $1,177.3 million and $332.0 million, respectively.

We have a Five-year Credit Agreement (the "Credit Agreement") which provides for a $750.0 million multi-currency unsecured revolving credit facility and matures on July 15, 2027. We may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate and extend the maturity date for an additional year, subject to agreement of the lenders. As of June 30, 2023, no amounts were outstanding under the Credit Agreement.

In June 2018, we issued $600.0 million of 4.3% fixed-rate unsecured senior notes (the "2018 Notes") due June 15, 2028. As of June 30, 2023, the carrying value of the 2018 Notes was $596.7 million.

From time to time, we repurchase shares of our common stock under share repurchase programs authorized by the Board of Directors. We consider several factors in determining when to execute share repurchases, including, among other things, expected dilution from stock plans, cash capacity, and the market price of our common stock. During the six months ended June 30, 2023, under the Board authorized repurchase program, we repurchased a total of 3.2 million shares at an aggregate cost of $249.1 million. See Part II, Item 2, “Unregistered Sales of Equity Securities and Use of Proceeds,” for additional information about our share repurchase program. As of June 30, 2023, we had remaining authority to purchase $666.5 million of our common stock under the share repurchase program.

On April 12, 2023, we entered into the Intellectual Property Agreement with Medtronic pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS, we paid Medtronic a one-time, lump sum payment of $300.0 million and will pay annual royalty payments that are tied to net sales of certain Edwards products. For more information, see Note 3 to the "Consolidated Condensed Financial Statements."

36
On February 28, 2023, we acquired a majority equity interest in a medical technology company. In addition, we amended and restated our previous option agreement with the medical technology company. The option agreement gives us the option to acquire the remaining equity interest in the medical technology company. For more information, see Note 6 to the "Consolidated Condensed Financial Statements."

At June 30, 2023, there had been no material changes in our cash requirements from known contractual and other obligations, including commitments for capital expenditures, as disclosed in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," of our Annual Report on Form 10-K for the year ended December 31, 2022.

Consolidated Cash Flows - For the six months ended June 30, 2023 and 2022:
3302 3306 3309
Net cash flows provided by operating activities of $347.7 million for the six months ended June 30, 2023 decreased $277.8 million over the same period last year primarily due to a $300.0 million payment in 2023 under the Intellectual Property Agreement, partially offset by a higher bonus payout in 2022 associated with 2021 performance.

Net cash provided by investing activities of $70.7 million for the six months ended June 30, 2023 consisted primarily of net proceeds from investments of $371.8 million, partially offset by a payment of $141.2 million to acquire a majority interest in another company (see Note 6 to the "Consolidated Condensed Financial Statements") and capital expenditures of $109.4 million.

Net cash provided by investing activities of $359.1 million for the six months ended June 30, 2022 consisted primarily of net proceeds from investments of $558.4 million, partially offset by capital expenditures of $115.8 million.

Net cash used in financing activities of $154.5 million for the six months ended June 30, 2023 consisted primarily of purchases of treasury stock of $256.8 million, partially offset by proceeds from stock plans of $102.7 million.

Net cash used in financing activities of $676.2 million for the six months ended June 30, 2022 consisted primarily of purchases of treasury stock of $760.7 million, partially offset by proceeds from stock plans of $86.5 million.

Critical Accounting Policies and Estimates

The consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated condensed financial statements and sales and expenses during the periods reported. Actual results could differ from those estimates. Information with respect to our critical accounting policies and estimates which we believe could have the most significant effect on our reported results and require subjective or complex judgments by management is contained on pages 34-36 in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," of our Annual Report on Form 10-K for the year ended December 31, 2022. There have been no significant changes from the information discussed therein.

37
Item 3.    Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk, Foreign Currency Risk, Credit Risk, and Concentrations of Risk

For a complete discussion of our exposure to interest rate risk, foreign currency risk, credit risk, and concentrations of risk, refer to Item 7A "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the year ended December 31, 2022. There have been no material changes from the information discussed therein.

Investment Risk

We are exposed to investment risks related to changes in the underlying financial condition and credit capacity of certain of our investments. As of June 30, 2023, we had $1.2 billion of investments in debt securities, of which $0.7 billion were long-term. In addition, we had $110.4 million of investments in equity instruments of public and private companies. Should these companies experience a decline in financial performance, financial condition or credit capacity, or fail to meet certain development milestones, a decline in the investments' value may occur, resulting in unrealized or realized losses. See Note 4 to the "Consolidated Condensed Financial Statements" for additional information.

Item 4.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures.    Our management, including the Chief Executive Officer and the Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of June 30, 2023. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded as of June 30, 2023 that our disclosure controls and procedures are designed at a reasonable assurance level and effective in providing reasonable assurance that the information we are required to disclose in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting. There have been no changes in our internal control over financial reporting during the quarter ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
38
Part II. Other Information
Item 1.    Legal Proceedings

We are reviewing and investigating whether business activities in Japan and other markets violate certain provisions of the Foreign Corrupt Practices Act ("FCPA"). We voluntarily notified the United States Securities and Exchange Commission ("SEC") and the United States Department of Justice ("DOJ") during 2021 that we have engaged outside counsel to conduct this review and investigation. We have provided status updates to the SEC and DOJ since that time. Any determination that our operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. We cannot currently predict the outcome of the review and investigation or the potential impact on our financial statements.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (“Edwards”) in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. We are unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amount has been accrued. We intend to vigorously defend ourselves in this litigation.

We are subject to various environmental laws and regulations both within and outside of the United States. Our operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on our financial results. Our threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million.

Item 1A.    Risk Factors

A description of the risk factors associated with our business is contained in the “Risk Factors” section of our Annual Report on Form 10-K for our fiscal year ended December 31, 2022.  There have been no material changes to our risk factors as previously reported.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities
PeriodTotal Number
 of Shares 
(or Units) 
Purchased (a)		Average
Price Paid
per Share
(or Unit)		Total Number of 
Shares (or Units) 
Purchased as Part of Publicly Announced Plans or Programs		Approximate 
Dollar Value of 
Shares that
May Yet Be 
Purchased
Under the Plans
or Programs
(in millions) (b)
April 1, 2023 through April 30, 2023258 $82.77 — $666.5 
May 1, 2023 through May 31, 202383,511 88.49 — 666.5 
June 1, 2023 through June 30, 2023— — — 666.5 
Total83,769 88.48 — 
(a)    The difference between the total number of shares (or units) purchased and the total number of shares (or units) purchased as part of publicly announced plans or programs is due to shares withheld by us to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees.

(b)    In July 2022, the Board of Directors approved a stock repurchase program providing for up to $1.5 billion of repurchases of our common stock, effective July 28, 2022. Repurchases under the program may be made on the open market, including pursuant to a Rule 10b5-1 plan, and in privately negotiated transactions. The repurchase program does not have an expiration date.


39
Item 5.    Other Information

Rule 10b5-1 Trading Plans

On May 30, 2023, Daveen Chopra, Corporate Vice President of TMTT, entered into a 10b5-1 trading plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the potential sale of 20,500 shares of the Company’s stock commencing September 6, 2023. The Plan terminates on the earlier of March 6, 2024 or the date all shares are sold.

Item 6.    Exhibits

The exhibits listed in the Exhibit Index below are filed, furnished, or incorporated by reference as part of this report on Form 10-Q.

Exhibit No.Description
3.1 
3.2 
3.3 
3.4 
31.1 
31.2 
32 
101.INS
XBRL Inline Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

40
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 EDWARDS LIFESCIENCES CORPORATION
 (Registrant)
Date: July 28, 2023By:/s/ SCOTT B. ULLEM
Scott B. Ullem
Chief Financial Officer
(Principal Financial Officer; Duly Authorized Officer)
Date: July 28, 2023By:/s/ ROBERT W.A. SELLERS
Robert W.A. Sellers
Corporate Controller
(Principal Accounting Officer)

41
 EX-31.1 2 ex-31110xqq22023.htm EX-31.1 Document

Exhibit 31.1
EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION
I, Bernard J. Zovighian, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Edwards Lifesciences Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.   The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:July 28, 2023By:/s/ BERNARD J. ZOVIGHIAN
Bernard J. Zovighian
Chief Executive Officer


 EX-31.2 3 ex-31210xqq22023.htm EX-31.2 Document

Exhibit 31.2

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION
I, Scott B. Ullem, certify that:
1.  I have reviewed this quarterly report on Form 10-Q of Edwards Lifesciences Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:July 28, 2023By:/s/ SCOTT B. ULLEM
Scott B. Ullem
Chief Financial Officer


 EX-32 4 ex-3210xqq22023.htm EX-32 Document


Exhibit 32
EDWARDS LIFESCIENCES CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Edwards Lifesciences Corporation (the "Company") on Form 10-Q for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Bernard J. Zovighian, Chief Executive Officer of the Company, and Scott B. Ullem, Corporate Vice President, Chief Financial Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

July 28, 2023/s/ BERNARD J. ZOVIGHIAN
Bernard J. Zovighian
Chief Executive Officer
July 28, 2023/s/ SCOTT B. ULLEM
Scott B. Ullem
Chief Financial Officer


 EX-101.SCH 5 ew-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - COVER link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - BUSINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - ACCELERATED SHARE REPURCHASE link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 9954701 - Disclosure - BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 9954702 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954703 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954704 - Disclosure - BUSINESS COMBINATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954705 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954706 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954707 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954708 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954709 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954710 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954711 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954712 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 9954713 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Accrued Liabilities and Long Term Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954714 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954715 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9954716 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954717 - Disclosure - INVESTMENTS - Investments in Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954718 - Disclosure - INVESTMENTS - Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954719 - Disclosure - INVESTMENTS - Investments in Continuous Loss Position (Details) link:presentationLink link:calculationLink link:definitionLink 9954720 - Disclosure - INVESTMENTS - Investments in Unconsolidated Entities (Details) link:presentationLink link:calculationLink link:definitionLink 9954721 - Disclosure - INVESTMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954722 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954723 - Disclosure - BUSINESS COMBINATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954724 - Disclosure - BUSINESS COMBINATION - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 9954725 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954726 - Disclosure - FAIR VALUE MEASUREMENTS - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954727 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in Fair Value of Contingent Consideration Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 9954728 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) link:presentationLink link:calculationLink link:definitionLink 9954729 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954730 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) link:presentationLink link:calculationLink link:definitionLink 9954731 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954732 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954733 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedge Effects on Statement of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954734 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954735 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954736 - Disclosure - STOCK-BASED COMPENSATION - Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) link:presentationLink link:calculationLink link:definitionLink 9954737 - Disclosure - ACCELERATED SHARE REPURCHASE (Details) link:presentationLink link:calculationLink link:definitionLink 9954738 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954739 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Activity for Each Component of Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 9954740 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 9954741 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954742 - Disclosure - EARNINGS PER SHARE - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954743 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 9954744 - Disclosure - SEGMENT INFORMATION - Information about Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954745 - Disclosure - SEGMENT INFORMATION - Reconciliations of Segment Net Sales to Consolidated Net Sales and Segment Pre-Tax Income to Consolidated Pre-Tax Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954746 - Disclosure - SEGMENT INFORMATION - Enterprise-Wide Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ew-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 ew-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 ew-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Business combination, net of cash (Note 6) Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options Consolidated Entities [Axis] Consolidated Entities [Axis] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Changes in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Net loss attributable to noncontrolling interest (Note 6) Net Income (Loss) Attributable to Noncontrolling Interest Amount excluded from effectiveness testing recognized in earnings based on an amortization approach Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax Pay vs Performance Disclosure [Line Items] Other liabilities Other Noncurrent Liabilities [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Research and development expenses Research and Development Expense Additional federal tax Income Tax Examination, Estimate of Possible Loss Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Investment, Name [Domain] Investment, Name [Domain] Accrued relocation costs Accrued Relocation Costs, Current Accrued Relocation Costs, Current Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Litigation settlement accrual (Note 2) Litigation settlement accrual Estimated Litigation Liability, Noncurrent Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Offsetting Assets [Table] Offsetting Assets [Table] Summary of Fair Values of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Held-to-Maturity Debt Securities, Held-to-Maturity, Maturity [Abstract] Accrued and other liabilities Accrued And Other Liabilities, Current [Member] Accrued And Other Liabilities, Current MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Instruments not due at a single maturity date Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Restatement Determination Date: Restatement Determination Date [Axis] Investment, Name [Axis] Investment, Name [Axis] Corporate debt securities Corporate debt securities Corporate debt securities Corporate Debt Securities [Member] Non-operating income Nonoperating Income (Expense)  Option Awards Employee and Nonemployee Stock Options [Member] An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Commitments and contingencies (Note 11) Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] ACCELERATED SHARE REPURCHASE Equity [Text Block] Schedule of Enterprise-Wide Information Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Geographical [Axis] Geographical [Axis] Proceeds from stock plans Proceeds from Stock Plans INCOME TAXES Income Tax Disclosure [Text Block] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Current liabilities Liabilities, Current [Abstract] Shares expected to be granted as percentage of target (as a percent) Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target Gain (loss) on fair value hedging relationships: Effect of Fair Value Hedges on Results of Operations [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding           Preferred Stock, Value, Issued Business Acquisition [Line Items] Business Acquisition [Line Items] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Inventories Inventory, Net [Abstract] Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Line Items] Issuances of notes receivable Payments to Acquire Receivables Diluted (in dollars per share) Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Gross Amounts Derivative Liability, Subject to Master Netting Arrangement, before Offset PEO Total Compensation Amount PEO Total Compensation Amount Hedging Relationship [Axis] Hedging Relationship [Axis] Accounts receivable, net of allowances of $8.1 and $7.9, respectively Accounts Receivable, after Allowance for Credit Loss, Current Amount of gain (loss) reclassified from accumulated OCI into income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Treasury stock (in shares) Treasury stock, beginning balance (in shares) Treasury stock, ending balance (in shares) Treasury Stock, Common, Shares Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Litigation Case [Axis] Litigation Case [Axis] Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Weighted average exercise price of options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Fair value, per option (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Net income attributable to Edwards Lifesciences Corporation Net Income (Loss) Net Income (Loss) Less: cash acquired Cash Acquired from Acquisition Due in 1 year or less Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract]  ESPP Employee Stock [Member] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Probability of Milestone Achievement Measurement Input, Probability Of Milestone Achievement [Member] Measurement Input, Probability Of Milestone Achievement [Member] Affected Line on Consolidated Condensed Statements of Operations Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Schedule of Computation of Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of sales Cost of sales Cost of sales Cost of Goods and Services Sold Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Executive Category: Executive Category [Axis] Foreign currency contracts Foreign Exchange Contract [Member] Fair Value Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract] Level 1 Fair Value, Inputs, Level 1 [Member] Name Measure Name Name Forgone Recovery, Individual Name Intellectual property agreement accrual Increase (Decrease) In Legal Settlement Accrual Increase (Decrease) In Legal Settlement Accrual Goodwill Goodwill Goodwill Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Investment Type [Axis] Investment Type [Axis] Maximum additional required investment Equity Securities, FV-NI, Maximum Additional Required Equity Securities, FV-NI, Maximum Additional Required Measurement Basis [Axis] Measurement Basis [Axis] Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Investments [Domain] Investments [Domain] Medical Technology Company Medical Technology Company [Member] Medical Technology Company ACCUMULATED OTHER COMPREHENSIVE LOSS Comprehensive Income (Loss) Note [Text Block] Local Phone Number Local Phone Number Fair Value Measurement [Domain] Fair Value Measurement [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Option to acquire investment amount Option To Acquire Investment, Amount Option To Acquire Investment, Amount Selling, general, and administrative expenses Selling, General and Administrative Expenses [Member] Derivative notional amount Derivative liability, fair value Derivative, Notional Amount Unrealized gain (loss) on available-for-sale investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Measurement Frequency [Axis] Measurement Frequency [Axis] Operating lease liabilities Operating Lease, Liability, Noncurrent Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Amounts reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, before Tax, Attributable to Parent Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Tax benefit from employee share-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract] Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Rest of World Rest of World Segment [Member] Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World). Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Income Statement Location [Axis] Income Statement Location [Axis] Changes to noncontrolling interest Noncontrolling Interest, Period Increase (Decrease) Total stock-based compensation expense, net of tax Share-Based Payment Arrangement, Expense, after Tax Foreign currency forward exchange contracts Foreign Exchange Forward [Member] Transcatheter Mitral and Tricuspid Therapies Transcatheter Mitral And Tricuspid Therapies [Member] Transcatheter Mitral And Tricuspid Therapies [Member] Europe Europe [Member] Taxes payable Accrued Income Taxes, Current Accrued and other liabilities Payables and Accruals [Abstract] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Product and Service [Domain] Product and Service [Domain] Schedule of Accrued and Other Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Cash Collateral Received Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset Inventories Increase (Decrease) in Inventories Research and development expenses Research and Development Expense [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Notes payable fair value disclosure Notes Payable, Fair Value Disclosure Anti-dilutive securities excluded from the computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Restricted stock units granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Document Quarterly Report Document Quarterly Report Capital expenditures accruals Capital Expenditures Incurred but Not yet Paid Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Right-of-use assets obtained in exchange for new lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Trading Arrangement: Trading Arrangement [Axis] Contingent consideration liability measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Derivatives designated as hedging instruments Derivatives, Fair Value [Line Items] Available-for-sale Debt Securities, Available-for-Sale [Abstract] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Daveen Chopra [Member] Daveen Chopra Derivative liabilities Offsetting Derivative Liabilities [Abstract] Operating lease liabilities Operating Lease, Liability, Current Prepaid expenses Prepaid Expense, Current Unrealized Loss on Available-for-sale Investments Loss on available-for-sale investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Proceeds from available-for-sale investments (Note 4) Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Entity Shell Company Entity Shell Company Noncontrolling interest, gross Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Long-term investments (Note 4) Long-Term Investments Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] New Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities Offsetting Liabilities [Table Text Block] Income taxes Increase (Decrease) in Income Taxes Payable Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral [Abstract] Counterparty Name [Domain] Counterparty Name [Domain] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Less: Noncontrolling interest Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net Investee drew additional amount Equity Securities, FV-NI, Investee, Additional Amount Drawn Equity Securities, FV-NI, Investee, Additional Amount Drawn Fair value, 12 months or greater Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Common stock, shares issued (in shares) Common Stock, Shares, Issued Gross profit Gross Profit Schedule of Investments in Debt Securities Unrealized Gain (Loss) on Investments [Table Text Block] Gross Unrealized Losses Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss Schedule of Weighted-Average Assumptions for Options Granted Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Treasury stock, at cost, 41.2 and 38.0 shares, respectively Treasury Stock, Common, Value Security Exchange Name Security Exchange Name Assets Assets, Fair Value Disclosure Gross unrealized losses, total Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Selling, general, and administrative expenses Selling, General and Administrative Expense Noncontrolling interest, option adjustment Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment Accumulated other comprehensive loss (Note 12) Accumulated Other Comprehensive Income (Loss), Net of Tax Employee Stock Option Employee Stock Option [Member] Foreign Currency Translation Adjustments Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] Value of Shares as % of Contract Value Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement. Financial Instruments Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Corporate items Costs and Expenses Unrecognized compensation cost, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Other Proceeds from (Payments for) Other Financing Activities Maximum Maximum [Member] Comprehensive income attributable to Edwards Lifesciences Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total remaining unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Number of lawsuits that if settled could have a material adverse impact on net income or cash flows Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Tabular List, Table Tabular List [Table Text Block] Cross currency swap contracts Cross currency swap contracts Currency Swap [Member] Entity Address, Address Line One Entity Address, Address Line One Purchases of treasury stock Treasury Stock, Value, Acquired, Cost Method Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Gross Unrealized Gains Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain Fair value of derivatives Derivative Liability, Current STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Other Other Noncash Income (Expense) Purchases of available-for-sale investments (Note 4) Payments to Acquire Debt Securities, Available-for-Sale Business Acquisition [Axis] Business Acquisition [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Financial instruments Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] New Markets Tax Credit New Markets Tax Credit [Member] New Markets Tax Credit Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Derivative [Table] Derivative [Table] Restricted cash included in other assets Restricted Cash, Noncurrent Proceeds from held-to-maturity investments (Note 4) Proceeds from Sale and Maturity of Held-to-Maturity Securities Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Final settlement per share price (in dollars per share) Accelerated Share Repurchases, Final Price Paid Per Share Income Statement [Abstract] Income Statement [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Related Party [Domain] Related Party, Type [Domain] BUSINESS COMBINATION Business Combination Disclosure [Text Block] Derivatives Fair value of derivative liabilities Net Amounts Presented in the Consolidated Balance Sheet Derivative Liability Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Instruments not due at a single maturity date Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value Operating segments Operating Segments [Member] Common stock issued under stock plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other current assets Other Assets, Current Class of Stock [Line Items] Class of Stock [Line Items] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Diluted: Earnings Per Share, Diluted [Abstract] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Carrying value of equity method investments Equity Method Investments Inventories (Note 2) Total inventories Inventory, Net Europe Europe Segment [Member] Represents the Europe reportable segment of the entity. Statistical Measurement [Axis] Statistical Measurement [Axis] Market Based Restricted Stock Units Market Based Restricted Stock Units [Member] Market Based Restricted Stock Units Instruments not due at a single maturity date Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date Balance Sheet Location [Domain] Balance Sheet Location [Domain] Financial Instrument [Axis] Financial Instrument [Axis] Entity Interactive Data Current Entity Interactive Data Current Total purchase price Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Investments taken period Equity Method Investments, Investment Period Equity Method Investments, Investment Period Adjustments to reconcile net income to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Total Shareholder Return Amount Total Shareholder Return Amount United States United States Segment [Member] Represents the United States reportable segment of the entity. Purchases of treasury stock Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Due after 1 year through 5 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Surgical Structural Heart Surgical Heart Valve Therapy [Member] This element represents the surgical heart valve therapy product line. Due in 1 year or less Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Non-cash investing and financing transactions: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Total Edwards Lifesciences Corporation Stockholders' Equity Parent [Member] Segments [Domain] Segments [Domain] Investments held for deferred compensation plans Deferred Compensation Plan Assets Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Financial Instruments Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets Assets, Current [Abstract] Japan Japan Segment [Member] Represents the Japan reportable segment of the entity. Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Anti-dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Operating cash flows from operating leases Operating Lease, Payments Common stock, shares outstanding (in shares) Common stock, beginning balance (in shares) Common stock, ending balance (in shares) Common Stock, Shares, Outstanding Basic: Earnings Per Share, Basic [Abstract] Maximum additional option to acquire investment Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment Accounts and other receivables, net Increase (Decrease) in Accounts and Other Receivables PEO PEO [Member] Held-to-maturity Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract] Schedule of Accelerated Share Repurchases Accelerated Share Repurchases [Table Text Block] Other receivables Other Receivables Amounts included in the measurement of lease liabilities: Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract] Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement [Member] Transcatheter Aortic Valve Replacement [Member] Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing) Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income (Loss) [Line Items] Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Gross Amounts Derivative Asset, Subject to Master Netting Arrangement, before Offset Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Litigation settlement Estimated Litigation Liability, Current Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Carrying value of non-marketable equity securities Equity Securities, FV-NI, Current Taxes payable Taxes Payable Net of tax Net income attributable to Edwards Lifesciences Corporation Net Income (Loss) Available to Common Stockholders, Basic Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Due after 1 year through 5 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Enterprise-Wide Information Revenues from External Customers and Long-Lived Assets [Line Items] Debt Instrument [Axis] Debt Instrument [Axis] Intellectual property agreement and litigation expense (Note 3) Intellectual property litigation expense Litigation Settlement, Expense Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective income tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Measurement Input Type [Domain] Measurement Input Type [Domain] Uncertain tax positions Liability for Uncertainty in Income Taxes, Noncurrent Prepaid royalty asset Prepaid Royalties Total liabilities Liabilities Expected volatility (as a percent) Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Allocation of stock-based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Fair value, total Debt Securities, Available-for-Sale, Unrealized Loss Position Gain (loss) on cash flow hedging relationships: Effect of Cash Flow Hedges on Results of Operations [Abstract] Measurement Frequency [Domain] Measurement Frequency [Domain] Due after 5 years through 10 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Amortized Cost All Executive Categories All Executive Categories [Member] Net Amount Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Unrealized Pension Credits Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Intellectual property agreement term Intellectual Property Agreement Term Intellectual Property Agreement Term Intellectual property agreement and litigation expense Intellectual Property Litigation Expense Represents the net amount of judgment or settlement awarded to (against) the entity and legal, forensic, accounting, investigative fees and other expenses related to intellectual property litigation. Income tax benefit Share-Based Payment Arrangement, Expense, Tax Benefit Earnings per share: Earnings Per Share [Abstract] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Hedged items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Decrease in unrecognized tax benefits is reasonably possible Decrease in Unrecognized Tax Benefits is Reasonably Possible Common stock, $1.00 par value, 1,050.0 shares authorized, 649.1 and 646.3 shares issued, and 607.9 and 608.3 shares outstanding, respectively Common Stock, Value, Issued Fair value, less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Deferred income tax benefit (expense) Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Accrued professional services Accrued Professional Fees, Current Non-cash operating lease cost Operating Lease, Right-of-Use Asset, Periodic Reduction INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE Legal Matters and Contingencies [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Limited Liability Company Limited Liability Company [Member] Total investments in unconsolidated entities Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Contingent consideration liability Business Combination, Contingent Consideration, Liability Equity Securities Equity Securities [Member] All Individuals All Individuals [Member] Cash paid during the year for: Supplemental Cash Flow Information [Abstract] Long-term prepaid royalties (Note 3) Increase (Decrease) in Prepaid Royalties Litigation Case [Domain] Litigation Case [Domain] Other income, net Other income, net Other income, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Purchases of held-to-maturity investments (Note 4) Payments to Acquire Held-to-Maturity Securities Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Japan JAPAN Contingent consideration liabilities (Note 7) Business Combination, Contingent Consideration, Liability, Noncurrent Current Fiscal Year End Date Current Fiscal Year End Date Amount Paid Stock Repurchase Program, Authorized Amount Derivatives designated as hedging instruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Fair Value Fair Value Debt Securities, Held-to-Maturity, Fair Value Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Liability for income taxes associated with uncertain tax positions Unrecognized Tax Benefits PEO Name PEO Name Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Due after 1 year through 5 years Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Due after 5 years through 10 years Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value U.S. government and agency securities U.S. government and agency securities United States government and agency securities US Treasury and Government [Member] Restricted cash included in other current assets Restricted Cash, Current Medical Device Company Investee Medical Device Company [Member] Medical Device Company Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Asset-backed securities Asset-Backed Securities [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Medtronic Inc Medtronic Inc [Member] Medtronic Inc Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Other liability Other Liabilities, Fair Value Disclosure Other accrued liabilities Other Accrued Liabilities, Current Corporate items Corporate, Non-Segment [Member] Accelerated Share Repurchases, Date [Axis] Accelerated Share Repurchases, Date [Axis] Secured promissory note Equity Securities, FV-NI Promissory Note Outstanding Equity Securities, FV-NI Promissory Note Outstanding Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Depreciation and amortization Depreciation, Depletion and Amortization Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Due in 1 year or less Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Business Combination and Asset Acquisition [Abstract] Total Edwards Lifesciences Corporation stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Net amounts that would favorably affect effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Unrealized Gain on Hedges Gain on hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Income before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest INVESTMENTS IN VARIABLE INTEREST ENTITIES Variable Interest Entity Disclosure [Text Block] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Rolling Maturity [Abstract] Decrease in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount Derivatives not designated as hedging instruments Not Designated as Hedging Instrument [Member] Other comprehensive gain (loss) before reclassifications OCI, before Reclassifications, before Tax, Attributable to Parent Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Net investment hedges Net Investment Hedging [Member] Entity Emerging Growth Company Entity Emerging Growth Company January 2022 Stock Repurchase Program Shares Sold in February 2022 January 2022 Stock Repurchase Program Shares Sold In February 2022 [Member] January 2022 Stock Repurchase Program Shares Sold In February 2022 Other intangible assets, net (Note 6) Intangible Assets, Net (Excluding Goodwill) Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income Derivative Instruments, Gain (Loss) [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] In-process research and development Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Document Fiscal Period Focus Document Fiscal Period Focus Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Stock compensation plan Share-Based Payment Arrangement [Member] Title Trading Arrangement, Individual Title Stock-based compensation (Note 9) Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] Unrealized pension credits (costs) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] City Area Code City Area Code Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] EARNINGS PER SHARE Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Equity securities Investments, All Other Investments [Abstract] Investment percentage (in percent) Equity Method Investment, Ownership Percentage Schedule of Changes in Fair Value of Contingent Consideration Obligation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total stockholders' equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Accrued marketing expenses Accrued Marketing Costs, Current Minimum Minimum [Member] Weighted-average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Property, plant, and equipment, net Property, Plant and Equipment, Net Due after 5 years through 10 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Fair Value BASIS OF PRESENTATION Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Exercise Price Award Exercise Price Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Fair Value Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract] Cash flow gain to be reclassified in the next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Liabilities Liabilities, Fair Value Disclosure Foreign currency Gain (Loss), Foreign Currency Transaction, before Tax Available-for-Sale Available-for-Sale Securities, Debt Maturities [Abstract] Liabilities Derivative Liability [Abstract] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Net income Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Deferred income taxes Deferred Income Tax Assets, Net Property, payroll, and other taxes Accrual for Property Payroll and Other Taxes Other than Income Taxes Current Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Other Payments for (Proceeds from) Other Investing Activities Percentage of interest acquired Business Acquisition, Percentage of Voting Interests Acquired Retained Earnings Retained Earnings [Member] Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and equity Liabilities and Equity Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other assets (Note 5) Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Average risk-free interest rate (as a percent) Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Unrealized gain (loss) on hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Basic (in dollars per share) Basic earnings per share (in dollars per share) Earnings Per Share, Basic Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Unallocated amounts: Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Net income attributable to Edwards Lifesciences Corporation Net Income (Loss) Available to Common Stockholders, Diluted Arrangement Duration Trading Arrangement Duration Initial Delivery of Shares Settled January 2022 Initial Delivery Of Shares Settled January 2022 [Member] Initial Delivery Of Shares Settled January 2022 Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income Schedule of Segment Reporting Information, by Segment [Table Text Block] Instruments not due at a single maturity date Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost Share information Share Information [Abstract] Due in 1 year or less Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year Income taxes Income Taxes Paid Consolidation Consolidation, Policy [Policy Text Block] OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Supplemental Balance Sheet Disclosures [Text Block] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Finished products inventories held on consignment Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Accrued rebates Accrued Rebates Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates. Termination Date Trading Arrangement Termination Date Common stock, shares authorized (in shares) Common Stock, Shares Authorized Due after 1 year through 5 years Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years Collections of notes receivable Proceeds from Collection of Notes Receivable Fair Value Fair Value Available-for-sale investments: Debt Securities, Available-for-Sale Fair value of financial instruments measured on a recurring basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Legal and insurance Accrued Litigation And Insurance Reserves Accrued Litigation And Insurance Reserves Derivative Instrument [Axis] Derivative Instrument [Axis] Liability Class [Axis] Liability Class [Axis] All Trading Arrangements All Trading Arrangements [Member] Measurement Input Type [Axis] Measurement Input Type [Axis] All Adjustments to Compensation All Adjustments to Compensation [Member] Derivative Financial Instruments Derivative [Line Items] Award Timing Disclosures [Line Items] Maximum secured promissory note Equity Securities, FV-NI, Maximum Secured Promissory Note Equity Securities, FV-NI, Maximum Secured Promissory Note Compensation Amount Outstanding Recovery Compensation Amount Changes due to currency rate movements and expenses expected to occur, maximum term Maximum Length of Time, Foreign Currency Cash Flow Hedge Comprehensive loss attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Cash Collateral Received Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset Loss (gain) on investments, net Gain (Loss) on Investments Other comprehensive loss, net of tax (Note 12): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Derivatives Fair value of derivative assets Net Amounts Presented in the Consolidated Balance Sheet Derivative Asset Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Schedule of Investments in Unconsolidated Affiliates Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Financing receivable Financing Receivable, before Allowance for Credit Loss Municipal securities Municipal securities Municipal securities Municipal Bonds [Member] Insider Trading Arrangements [Line Items] AOCI Attributable to Parent, Net of Tax AOCI Attributable to Parent, Net of Tax [Roll Forward] Research and development accruals Research And Development Accruals Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials. Accrued realignment reserves Restructuring Reserve, Current Related Party [Axis] Related Party, Type [Axis] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Common stock issued under stock plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Dilutive effect of stock plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Adjustment to Compensation, Amount Adjustment to Compensation Amount Cost of sales Cost of sales Cost of Sales [Member] Change in fair value of contingent consideration liabilities (Note 7) Change in fair value of contingent consideration liabilities (Note 7) Change in fair value of contingent consideration liabilities Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Noncontrolling interest (Note 6) Equity, Attributable to Noncontrolling Interest Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Adoption Date Trading Arrangement Adoption Date Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] February 2023 Stock Repurchase Program Shares Sold in March 2023 February 2023 Stock Repurchase Program Shares Sold In March 2023 [Member] February 2023 Stock Repurchase Program Shares Sold In March 2023 Performance period (years) Share-based Compensation Arrangement by Share-based Payment Award, Performance Period Share-based Compensation Arrangement by Share-based Payment Award, Performance Period Treasury Stock Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Amount Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Liabilities Liabilities, Fair Value Disclosure [Abstract] Amount of Gain or (Loss) Recognized in Income on Derivative Derivative, Gain (Loss) on Derivative, Net Total stock-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Provision for income taxes Provision for income taxes Income Tax Expense (Benefit) Loans receivables, maximum lending amount Loans Receivables, Maximum Lending Capacity Loans Receivables, Maximum Lending Capacity Finished products Inventory, Finished Goods, Net of Reserves Derivatives designated as hedging instruments Derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Employee compensation and withholdings Employee-related Liabilities, Current FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Name Trading Arrangement, Individual Name Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Payments for legal settlements Payments for Legal Settlements Gross unrealized losses, 12 months or greater Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Equity [Abstract] Equity [Abstract] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Reclassification of realized investment losses to earnings Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Fair value of net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Net sales Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Critical Care Critical Care [Member] This element represents the critical care product line. Amendment Flag Amendment Flag Fair value hedges Fair Value Hedging [Member] Gross Amounts Offset in the Consolidated Balance Sheet Derivative Liability, Subject to Master Netting Arrangement, Asset Offset Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Deferred income taxes Increase (Decrease) in Deferred Income Taxes Gross unrealized losses, less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Repayments of pre-existing notes Repayments of Notes Payable Total purchase price, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Interest income, net Interest expense (income), net Interest Income (Expense), Net Equity method investments Equity Method Investment, Financial Statement, Reported Amounts [Abstract] Assets Assets, Fair Value Disclosure [Abstract] Due after 5 years through 10 years Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Fair Value Bank time deposits Bank Time Deposits [Member] Purchases of treasury stock (in shares) Shares Received (in shares) Treasury Stock, Shares, Acquired Contingent consideration liabilities Obligations, Fair Value Disclosure Net Amount Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Long-term debt Long-Term Debt, Excluding Current Maturities Contingent Consideration Contingent Consideration Liability [Member] Contingent Consideration Liability Diluted (in shares) Dilutive weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Assets Derivative Asset [Abstract] Variable Interest Entities [Abstract] Investments in Variable Interest Entities Accelerated Share Repurchases, Date [Domain] Accelerated Share Repurchases, Date [Domain] Derivative assets Offsetting Derivative Assets [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in capital Additional Paid in Capital, Common Stock Interest income, net Interest Income [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Accrued and other liabilities (Note 2) Total accrued and other liabilities Accrued And Other Liabilities, Current Accrued And Other Liabilities, Current Other liability Other Liabilities [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition United States UNITED STATES Fair Value on a Recurring Basis Fair Value, Recurring [Member] Reconciling items Segment Reconciling Items [Member] Other liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Schedule of Supplemental Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Short-term investments (Note 4) Short-Term Investments Other income, net Other income, net Other Nonoperating Income (Expense) [Member] Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Cash flow hedges Cash Flow Hedging [Member] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Net increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Rest of World Rest of World [Member] Represents the geographic areas of the world other than the United States, Europe and Japan. Total before tax Segment operating income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets Offsetting Assets [Table Text Block] Work in process Inventory, Work in Process, Net of Reserves Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Gross Amounts Offset in the Consolidated Balance Sheet Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Basic (in shares) Weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Offsetting Assets [Line Items] Offsetting Assets [Line Items] Initial delivery, price per share (in dollars per share) Accelerated Share Repurchases, Initial Price Paid Per Share Operating income, net Consolidated operating income Operating Income (Loss) Segment Net Sales Net Sales Reconciliation Revenues [Abstract] Consolidated Entities [Domain] Consolidated Entities [Domain] Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Increase in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount Statement [Line Items] Statement [Line Items] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Payment for acquisition options (Note 5) Payment for option to acquire company Other Payments to Acquire Businesses Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Initial Delivery of Shares Settled February2023 Initial Delivery Of Shares Settled February 2023 [Member] Initial Delivery Of Shares Settled February 2023 Investment option to acquire Equity Securities, FV-NI, Option To Acquire Investment Equity Securities, FV-NI, Option To Acquire Investment Segment Operating Income Pre-tax Income Reconciliation Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Convertible Promissory Note Convertible Promissory Note [Member] Convertible Promissory Note Stockholders' equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Noncontrolling Interest Noncontrolling Interest [Member] EX-101.PRE 9 ew-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 10 ew-20230630_g1.jpg begin 644 ew-20230630_g1.jpg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–+_;KFROK19CNLF4 W4-Q]GE$)P" MS(R\X#-\Z?MF_M+_ /!P;^QO\(]2_P""@?BC0/@-J_@+PVJ:GXO^!VDV]\^I M:5HQ<>9C56(6XNH8V!ED11$"KNDN?%"PCB^(.MP ,OA+PB\VV]O)9)'DD ,=M,5 />O@!\9/# M/[17P(\%?M!>"K>XBT;QUX2TWQ#I,5X@65+:]M8[F)7 Z,$E4$>N:^=?&_[5 M_P"U#HG_ 6N\(_L9Z/INC'X0ZE^SU?^,=:NIM/8WJ:C!JAM699@V%11)9KL MVD'SW)YV[?J'P!X%\*_"[P)HGPS\":1'I^A^'=(MM,T:PASLMK2WB6*&)<\X M5$51]*@N/ACX#N_B?9_&:X\-PMXGL-!N=%M-7WL)(["XG@GF@P#M*M+;0MD@ MD%." 6! /S[_ &F_C3_P70=$BOWA!D-K$4$9(BWO(IW?1W[.W[;_P 0OVU_^"=7@C]L']E; MX36DGBCXB:-$=(T'Q+J+1Z?I%Z9GM[F2[F0"22UMY(IV_=J))EC55"-("NK_ M ,%!/B%XUO/A+=_LJ_ +R;GXI_%C2;S1?#$9:[_ /94_9O^'O['_P"S?X*_9A^%4$B:!X'\.VVDZ?)/CS9Q$@#S MR8X,DC[Y'(P"SM@"@#XM\$_M8_\ !4[]DO\ X*<_"7]C7]M_Q#\./B?X(^/> MGZXWA7Q1X!\+7&D7F@7^EVHNIXY8'GE#VX1XUW,S,1(&WCRV1_T2K\M/VO/& MW_!0?]@?_@K)\$_VK?CGXQ\"_%7X2_%?Q79?"73K72_!3Z7?> YM5G5D:UWW M%PY,TD*/-,96\Y;01%(]L!'ZET %%%% !1110!X/_P %%-:_;O\ !G[-NN_$ MC_@GP_@[4/'/AS3YK^'PCXQ\-W%]'X@2,!C:P/!=P-!.5#^7D.KOM0A-V]># M_P""*O[>GB+_ (*._L):#^TIX]\9>'K_ ,5W%[)M_AG5K-XGO]9TX#Y8[I[>YE,).56>XE9E*K&J@'VW^R_P#' M/]N_XV_%WXO?$2X\<^ -4^"/@W7KO1_AQ-HW@.\35_%US:0!;UQ*=0>(00WR MSV:21Q,;A[>1E$:A2_@7_!0#]L;_ (+'_P#!/#_@F7<_MW?%7XL? O4?%&GP MZ,=5^'ME\']4BALYKZY@@>#[<^NEI#$9CEO(7<4(P.M?H[\,/AGX%^#'PYT+ MX2?#'PW;Z/X=\-:3!INB:7:KB.UM84$<<8SR<*HY)))Y)))-? '_ ==_P#* M$?XE_P#8=\._^GBUH ]LT>\_X*JZ!K_PR\>:G\8?A/XV\$^(M5LX?'6D:+\( M]2TO5-+L[J!MEW;3'6;N.41SM#Y@>)0(][YP#CQ'X:?MG?\ !3/XS?\ !7;X MV_\ !-[PU\:OA!H.A?"CPQI>NV/B:^^$6H7]WJ$5];6DRP21IKD"1LANB#(" M0PCSL7=\OWY\'_\ DDOA;_L7+'_T0E?G'^QE_P K2?[8G_9(O"7_ *0:50!V MO[6'_!2_]MO_ ()1>./#'BS_ (*#?#SP)X]^!7B;6XM&N_BY\*=&O])O?"UU M+GRWU'2KJZO1)$P#?/#/_"WR[_+BD_0#1M8TGQ#I%KX@T'4H+VQOK9+BRO+6 M4/%/$ZADD1APRLI!!'!!S7PS_P ',6J>!]-_X(E?&]/'4D CNM/TJ#3(YB-T ME\=7LS $'4L' ;CHJ,>@->S?\$B]#\=>&O\ @EO^SWH7Q)CN(]9M?@]X?2[A MNP1+"OV"+RXW!Y#+'L4@\@J0>: /HFBBB@ HHHH *\'_ ."BFM?MW^#/V;== M^)'_ 3X?P=J'CGPYI\U_#X1\8^&[B^C\0)& QM8'@NX&@G*A_+R'5WVH0F[ M>OO%% 'R7_P15_;T\1?\%'?V$M!_:4\>^,O#U_XKN+VYL/%^B^'=#ET^/0-1 MA?#V3Q2W$[D[#%('9AN25&VKG K?LO\ QS_;O^-OQ=^+WQ$N/'/@#5/@CX-U MZ[T?X<3:-X#O$U?Q=WD91&H4O\2?M<_!'X MM?\ !/?_ (+1:%\)_P!BWXHQ^#/!O[?%K?6'C/3K>)M_AG5K-XGO]9TX#Y8[ MI[>YE,).56>XE9E*K&J_KW\,/AGX%^#'PYT+X2?#'PW;Z/X=\-:3!INB:7:K MB.UM84$<<8SR<*HY)))Y)))- 'YQ?\% /VQO^"Q__!/#_@F7<_MW?%7XL? O M4?%&GPZ,=5^'ME\']4BALYKZY@@>#[<^NEI#$9CEO(7<4(P.M?16CWG_ 55 MT#7_ (9>/-3^,/PG\;>"?$6JVI:7JFEV=U VR[MICK-W'*(YVA M\P/$H$>]\X!QXG_P==_\H1_B7_V'?#O_ *>+6OOKX/\ _))?"W_8N6/_ *(2 M@#X#^&G[9W_!3/XS?\%=OC;_ ,$WO#7QJ^$&@Z%\*/#&EZ[8^)K[X1:A?W>H M17UM:3+!)&FN0)&R&Z(,@)#"/.Q=WRZO[6'_ 4O_;;_ ."47CCPQXL_X*#? M#SP)X]^!7B;6XM&N_BY\*=&O])O?"UU+GRWU'2KJZO1)$P#?/#/_ M\N_RX MI.*_8R_Y6D_VQ/\ LD7A+_T@TJO3_P#@YBU3P/IO_!$KXWIXZD@$=UI^E0:9 M',1NDOCJ]F8 @ZE@X#<=%1CT!H ^YM&UC2?$.D6OB#0=2@O;&^MDN+*\M90\ M4\3J&21&'#*RD$$<$'-6:^=O^"1>A^.O#7_!+?\ 9[T+XDQW$>LVOP>\/I=P MW8(EA7[!%Y<;@\AECV*0>05(/-?1- !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !7A7_!0K_@GY\%/^"CWP#;X(_&"?4=+N=/U2'6/"'B[0IA%J7AS5H, MF"]MG((#+DJRGAE8C@[67W6B@#\O/VW/^"HW_!3[_@F8GA;X3?M'? 'P;K7A MC7+NTTA_VN-.6\?0]),C+";W5M!A0R6TRY$K1K>+#)SY3<&-/J+]C7]A?1?V M,/V6_%2_LJ?$32_&7Q+^)5S<^*M=^+/C,>?%XJUZ\!D74;@6AYM 9-T<$+!0 MAP'W.\K?36J:5IFN:;<:-K>FP7EG=PM#=6EU"LD4T;##(ZL"&4@D$$8(-O@S\!XIK'X+^!+;PMILP;&@Z'+);:7"6;$OV%/^"_'@GXB^+OBKH7_ 4!^ S:[XSU M%9]5U"^^%MW<2QV\>X6UA"TDI,5I KN(X5X#22R-NEEED?\ 2>B@#XY\;?LO M?\%6]4_8,N/@GX;_ &X?"I^-/BC6+J;QA\4;W0KB&UL+*1F5+;2+6W*_8RL" M01"3.Y6\Z8?O9!(OE_P^_89_X+L>%O">A_!:'_@H3\%_"_@.R6WT^ZM? 7PI MDL[^UTL,JS)9RR,RPSF+>%E(W!R'SN^:OT6HH 2-!&@C4DA0 -S$G\2>32T4 M4 %%%% 'A7_!0K_@GY\%/^"CWP#;X(_&"?4=+N=/U2'6/"'B[0IA%J7AS5H, MF"]MG((#+DJRGAE8C@[67XQ_;<_X*C?\%/O^"9B>%OA-^T=\ ?!NM>&-?%XJUZ\!D74;@6AYM 9-T<$+!0AP'W.\K?.?PH M_8+_ .#@'X-VFL_\(I_P42^!X6UA"TDI,5I KN(X5X#22R-NEEED?WVT^!O_ 54\&?L M:6_AWPG^U[X!U_X^3^*VU77_ !5XQ\)SGP]=6AD91IUO:6S(]E$MNMNN] S% MTFU_94_:)_:0\(? 9M?ACXAC\2Z!X)^'-K> M/97?B"*&2&WU&ZN[TB1TMUFE>&V2- LI61Y)=B*/IBBB@ HHHH **** "OA? M]NS_ ()W?M=?M4_\%"/@+^V;X#\:_#O1=)^ .IZA^FN-=6]\I9_- MECA"VI,<*JH59=C$L2X^4?=%% $&F2:E+IMO+K-I!;WC0(;N"UN&FBCE*C%]-U_4+"\U M?Q)XA>ZFF06MRLZPQ6\,>WYGCC)D:7@;EV?Q%I&E0V4DN@ZA.]G>-%"B"4&6%7@#L"2F)-@Q\SU\5_#W_ ()U?\%# M_A7_ ,%/_B[_ ,%*/!WQ#^#+W'Q8T#3]&N/!^J0ZM,FF6MG!:PQ%+F-8S)(1 M:JS,8P"7;"KQ7Z$44 ?$?QB_X)5_%C]OGXL>%?&G_!3/]H31_%'@/P3JZ:MX M?^!_P^\-2Z=H-SJ" A+G5+BYN)I]2*AF CVP1@$C:0\BO]MQQQPQK%$@55 " MJHP !T %+10 4444 %%%% !1110!\+_MV?\ !.[]KK]JG_@H1\!?VS? ?C7X M=Z+I/P!U/4+G2?#^JSWTUQKJWOE+/YLL<(6U)CA55"K+L8EB7'RC[ATR34I= M-MY=9M(+>\:!#=P6MPTT4B@#Y!_X+1_L&?'K M_@IG^Q_J?[''PF\8^$O"^FZ_J%A>:OXD\0O=33(+6Y6=88K>&/;\SQQDR-+P M-R[.0P^BO@9H_P 6?"WP;T;PO\5;/P\_B+2-*ALI)=!U"=[.\:*%$$H,L*O M'8$E,2;!CYGKM** /SW^'O\ P3J_X*'_ K_ ."G_P 7?^"E'@[XA_!E[CXL M:!I^C7'@_5(=6F33+6S@M88BES&L9DD(M59F,8!+MA5XKK/C%_P2K^+'[?/Q M8\*^-/\ @IG^T)H_BCP'X)U=-6\/_ _X?>&I=.T&YU! 0ESJEQ17^W** $CCCAC6*) JJ %51@ #H *6BB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\_OV'?V]?^"AWQR_8G\< M>//$OPD\,:[\7G^/OB'P'\/-+,$VGZ/;PVDYC^TZE(A=UM[7R;YI&3]Y*+9( ME_>R GA?%/[<7_!7/_@F_P#M00NS>;?ZA>S7UY.2Y)W27-Q-(1G W[5 4!1\O?&?X867_ 43_;6^ M'ELL"W'PI_9M\:OXGU;52-T6O>.8(G@LK&V;^)-.$L\UQ*"5%P\5N,O%<+& M=#^V#XF_X*3?$KXC2?!/_@GQ/X \&VFBZ9#=^*_B9\2=-N;Z-[J8L8M-T^TA M*B218T66>:4E$6XA5 SE]GFO_!*'_@H/^UK\9_C[\8/^"?'_ 4*^'OAO3/C M'\%GL+FY\0>"1*-)\1Z5>)N@NXDD):-MIC8_=#"8#9&R.H^S/B7\2? WP>\! M:M\3_B5XC@TG0M$LVNM2U"YSMBC7T"@L[$D*J*"SLRJH+$ _/'_!/W]F?Q9H MWQ5^+/[?_P ;O"LNB>/_ ([ZM82Q^'+L#SO#?AO3[<6VE:?-@D+=-%NN+D*< M+-/Y?S"$,P!]1T444 %%%% !1110 4444 %?G]^P[^WK_P %#OCE^Q/XX\>> M)?A)X8UWXO/\??$/@/X>:68)M/T>WAM)S']IU*1"[K;VODWS2,G[R46R1+^] MD!/Z U@_#KX8^ _A-HEWX<^'?AN'2[*_U[4M:O((79O-O]0O9KZ\G)#K M/Q3\-]#NM-O/"^N73[;:-XYG(E@;)/.]F2*1MRL@63[!_:XMO^"A'CO68?AQ M^Q)XD\"^ [>#3EO-8^(7CS19=6\V9W=8["RLH98QN CWS3S-M598EC21BYB\ MZ^,_PPLO^"B?[:WP\ME@6X^%/[-OC5_$^K:J1NBU[QS!$\%E8VS?Q)IPEGFN M)02HN'BMQEXKA8_I?XR:%\7/$OPYU+0_@9\1='\)^)KF!DTW7]=\,OJ]O9L0 M1O-JES;>8PX(S)MR.58<4 ?+O_!'G]MO]JK]JC0/BW\&_P!M7P+H%A\2/@?\ M29_"&OZ_X/CD72->VQK)'?\ @E]^VII?AW5O&WP]U:'QG!\2_#6G_9U\8V^M2R3R7MV,*&N-Y0;L M# !BQB!6;](Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@#Q'_@H!\+_ -LKXT_L\ZA\+?V(_C3X<^'GBC6I/L]]XPUZ MRN)Y;&Q*GS/L@@*F.X;A1*3F-2S)A]CI\K?#_P#88_X+M>%/"&B?!:U_X*%? M!?PMX%LDM]/N;?P)\*9+2_M-,#!9ELY9&98IS'OVRD%@Y#YW?-7Z+T4 ?$?[ M?'['_P#P51_:%_:*\-^._P!FK]J+X4>%/ G@D1W7AOPKXO\ "-WJKSZJ$7_B M97?SA)9H6WBW!!6+/FX\W:Z=A^QM\ ?^"I_ACXTR^/\ ]O?]M/P;XU\.6.A3 M6^A>$OA_X/;2(6OY9(\W=V[$O-LB61$CW; 9BY7,->LKB>6 MQL2I\S[(("ICN&X42DYC4LR8?8Z>W44 ?G1\/_V&/^"[7A3PAHGP6M?^"A7P M7\+>!;)+?3[FW\"?"F2TO[33 P69;.61F6*//@S?\ PLDT.*WO_"7C[3]3M]4M[U6;?<0WMKY@E#*4^61 M.",9.^OH:B@#QC]F7]E"Y^#_ ,1O'?[1?Q1\76GB7XG?$R6Q'B?6M/TPV=E9 MV-C$T=EIME TDCQV\(DE7=*9YU+9DC8CA%&,XX^M>1?\-J_M,_]%+_ /*-9?\ QFNJ M_P""BW_);=+_ .Q5@_\ 2FYKP*@#U/\ X;5_:9_Z*7_Y1K+_ .,UZ[^Q=^T+ M\8/BS\4;_P .?$#Q?_:%E!H$MS%#_9]O%ME$\"ALQQJ3P[#&<<_2OD^O??\ M@G3_ ,EMU3_L59__ $IMJ /L^BBB@ ILTT5M"]Q/(%2-2SL>@ &2:=10!YK\ M+?VR_P!DKXW?$C4_@Y\'_P!I7P/XF\7:+;-<:OX7T3Q/;7&HV42LJM)+;HYD MC4,Z EE !=0>HKI/BS\9_A-\!_!\_P 0OC5\1]&\*Z#:@FZUG7]02UM8 22 M\LA"H 3DD"ORM_X*^?L3_M*_%G_ (*@:C^V'_P3X\1G1?CE\$?@;X9\3^'M M,MK=!'XMBDU?7X+S3KC&#,\EO!'&@8[753"/Z#\$_P#!2+X/?\%2?^"+ M7QG^-G@BS&EZ[9_"'Q/I?Q"\#WK9NO#VK)I%R)K:56 +1MRT0KJZ* M?:WPR^*OPV^-'@^U^(/PE\*]/T3P[X&\(Z*(A=:UJ4MB)$@C,K)'$B M0PS322NRI'%!(QS@*>$\.?\ !3[5O#'[;NG?\$_?VHOV<;CP-X]\6^%;G7?A ME=:1XLAU?2?%<=NDCSVD=RT5L]O=*(I#YSTGPS\8I/"\IL?&D$UMX0AL;$(EJD;*'O&DE!D>6, M*I>=B %4*/L/]M?X=?%7XO\ ['7Q4^%'P,\0G2?&?B7X=ZSI?A74A<>3]GU" M>REB@;S!S%^\9?W@Y3[PY% '*W?_ 5!_P"">FG^+KCP7J'[8/@6WN;74VTV MYO;C6T33XKU6VM:M?-BU$X;Y3%YN\-\N,\5[!X ^('@GXJ>#K#XA?#CQ19:W MH>JP^=IFK:=.);>ZCW%?,C<<.I(.&&01R"0_X( MX?\ !0GX3V7P5^(W@GPQ!X*UOP+\1-*2VT;Q*L<0@9UDE B$MS_K'CFV^:\Q M:)YM^:^QO%OQ0^#W_!$__@G-X4T/Q/9:IXATOP@VG^$?!VCZ*BFZU:ZN;DPV M%J'F940D,N^61@%".WS'"L ?5U>4_#G]N']DWXO_ +1'B+]E#X6?'+1O$/C_ M ,):3_:7B70-':2X_LZW\U(OWLZ*85D#R(#%O\P9R5 !->;^!_\ @H;XGT[] MNG1?^"?W[2W[/\?@SQ?XN\$7'B?P7K'A_P 6#6]*U2"W/CF\<84R?LQZ TA ^\?M\(R?P 'X4 ?HK17RK M\6O^"CGC_3?AOX_^.?[,O[*-Y\3O OPQO=2M/$NN1^,+?3)M2ETUF74AI,#Q M2?;A;/'-$S2/;AY8)$B,N 2[P]_P5@^!_P 8_A#\#?B)^S'I9\6:I^T3=7EO M\-]$UC4ETJ-9+&WGGU#[=/LF^SBV^SRQ.(HYW:7:L:NI+@ ^J**\C_9Q_:*^ M)'Q;^(/CWX4_%KX!S^!M;\!W&GI*ZZ^FHV6L17<+RI=6^2!7?&=B;B"['LJY)["CXO?$_PU\%?A;X@^+?C"1ETSPYI$^H M7@CQO=8T+;%SU9B JCN6 K^?7]J7]J7XK_M<_%>]^*GQ4UN26261ETS3$E)M MM+MLY6WA4\*H&,GJQRS$DDU\YQ!Q!3R2G%*/-4ELNB7=_P!:G[)X1^$>,\3, M95J5*OL<+1LIS2O*4GJH03TO;5MW44UH[G[3Z%_P5<_X)[>(M<7P]I_[36D1 MW#/L$E]87EK!GWFFA2(#W+8KWW1M:T?Q%I5OKOA_5K:_L;N)9;6\LYUEBF0C M(='4D,I'0@XK^92OL+_@D=^WIXR_9M^.6D?!SQ5K\UQX!\7:G'97-A<2%H], MNYF"17<63B,;RJR8X*$L02BU\_E7&U2OBHTL7!)2=KQOIZIMZ>=]#]WMGIMG-J.HW<5O;V\323SSR!$C11EF9CP "23P *\)B_X*B_\ !/NY,US9 M?M5^%KG3+:5X[KQ+:7$DVBP,C;7\S4T0V:!3P2TH (.3P:^-/^"R7Q<\0?M4 M?\%0/V:?^"(]MKUYIW@GXC+/XS^,,-E3Q:4[H0RP2G3+L2J#\Q M:'IMY_234;GX6?!#X9XU :+X7\(^']/CMUC\J.UL-/M5 C2,* $CC VJ % MP.E !\-/BW\+_C-H<_BCX2?$#2/$NF6]Z]I)J>AWZ75OYRJK,BRQDHY =<[2 M1SCJ#715\3_LT?'K]@']E']G;XR>-OV /&>A?%SPMI?B+5/'=]X#^#>N:3=2 M:%'+:P27D,0>\CA6/S89KA4W(5$XCCC;8H:+]CK_ (+"^-?VSKCX1>+_ (?? M\$_/B+;?#;XFZ5?SZI\4YK^U;2?#=S:I,[03=)'CS$L9N"L)X+/6=(QK&\C*A /I.BO _ M!/[9_BW2O%GQ:\*_M0_ P_#Z'X1>"--\5ZIXBL/$7]KZ7JNFW0U1I)K206\$ MI\D:7,'62&.3+#";=K/S7@7]OSXQ^+-)^$7Q-O?V1C%\/_C1J.GQ>&_$FE^. MH;VZT>VO;9[FUGU2U%LJ0>8BJH%O/@7P)LM< M\-ZO#?6=P <'9- S(^#Z$UNU^,'_ 1B\47OP^_X*,?MS?'?]BWX<:[XI_9F MM]227PWH7@<6J6.L>(4=#<'2/M4\%HP4?;"2DBIY36P!(,(/U=^QK_P6N\8? MMR^'?A#\2O@A_P $Z_B;?>!OB3X@U'2?$7C6*]M'L_"$EO=7$,;7"Y#S*T<, M, 'WC17R?'_P4H\??%7X<^,/CU^QQ^R7J'Q2^'O@K5;_ M $^?78/%D&GW?B22P=H[U]#M6AD%_''(DD2M++;":2)EB\P;6:A\5O\ @HC8 M?M%_\$I/$'[<'[ VBW'B_3]8\"ZS<03OJ\6EW?ATPV%T9IIEDW?O[:>(*T*$ MECAD9EPQ .Q^)G_!6W_@GG\&_%]EX0^*?[1=OH0U._N[#2_$.H^'=330;V\M M2RW-K#K'V;^SYIXG1HWA2X,BR*4*[QMKU;]FW]I+X)_M>?!+0?VC?V=/'47B M7P7XG@EFT/6X;.>W%RL(%U#_@AY\+ MM5_:._X)\CQ[X,^'WP\L?%'AV&*_T?5;C5[JU>6<7<%I>R0I;S1C?("\@#[7[;+ M8"\6.-%$\JL \<,:A0S#I MX:TQ;1I_$D.IOJ<)LH6^UL\8&PNQ.4;+9Y)YKV6@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /C#_@ MHM_R6W2_^Q5@_P#2FYKP*ON3]HO]D/\ X7]XVM?&/_"PO[)^S:4EE]F_LGS] MVV65]^[S4Q_K,8QVZ\\<#_P[2_ZK5_Y;G_W30!\LU[[_ ,$Z?^2VZI_V*L__ M *4VU=3_ ,.TO^JU?^6Y_P#=-=]^SI^R'_PH'QM=>,?^%A?VM]ITI[+[-_9/ MD;=TL3[]WFOG_5XQCOUXY /:**** "BBB@#Y:\'>-O!]Q_P6C^('@NW\46$F MKQ_LU>%'DTU+M#.@37M?9LH#D86:%B,<"5#T89^$_P#@NG^PM\=/V&==^)/_ M 54_P""=.B>9I'Q \$:IX>_::^&ELC?9=5L+NUEA.O1Q)TFA:7S97495@9B M"CW6[]8++]GC]G_3?$B>,=.^!G@Z#5X[O[5'JL/AFT6Y6?=N\T2B/<'W<[LY MSSFNLOK&RU.RFTW4K.*XM[B)HKBWGC#I*C##*RGA@02"#P0: /RG_P""T%U' M\&_@Q^QA^W!\1_@TOC_X3_"3Q';?\+9\.S:-'J,4>F:GH\=F+Z2VE4I((3NV M[ACS9(AE2P(]Q_9=^.W_ 1/_:!_: \#M_P3[^!GP:\;>-T6746\1^"?AU9V MMUX,TT6\F^]N+H6:R63NYCMD@)2:1[C[NQ)63[AG\/Z#F76B_!+X/^%O!UG>W'GWM MIX5\/VVGQ7$O_/1UMT0.W)^8@GF@#\[?^"-'QN^$GPZ_;U_;7_9_\;_$#3-- M\<^(OVIM2OM!\(W%P/[2U"TEMS(MS%;C,CPA(W=I0-B* 69003]X_MF_'#5? MV9?V0?BG^T?H>E0WU[X ^'>M>(K2RN0?+N)+*QFN5C;!!PQC .".O6NSM/A] MX"L/&=W\1[#P1I$'B&_M4MK[7H=-B6]N($QMBDG"[W08&%)(&!Q5_5](TGQ! MI5SH.O:7;WUC>P/!>65Y LL4\3@JT;HP(92"00000<&@#X6_;)^'?_!%_P#X M+'?L23?'+XU_$+P'>>&;?PY)=:;\4(]6M[35O"68RY#3%A) \;'Y[.;*EUVO M&3BOD+X%?MM_M=?L&?\ !NW\!?&?QTA\K4O%?Q4T[PII7CKQUHK7I\&^%;F] MN)+37KBVFYD,%O;J;99/E >U)W !'_6OQ;^R+^R?X_\ 'D7Q3\=_LP_#S6_$ M\$HD@\1ZOX*L+F_C<=&6XDB,@(]0V:[#QAX+\'?$+PS=^"O'WA/3-*[#5?B+K'C&76K?5]6D@*Q6EK<(39M.SLJ"QT]4599D185>15;W/X$ M^)O#L_\ P=$_''1(==M&O%_9FT.(VJW"F3>E[;R,NW.T$ U4L_V?O@ M-IWB@>.-/^"7AENS=+K$/ANU6Z$Y8L9?-$>_>222VO)>Z[\4? 5G.WBO3+J^GO(;Q M+R:W\,VMY=6!#%@8998V>+!)(VDQJK[=X"S(P ;:N1WVC/04 ?$? M_!'SXA?MT>!_VD/CQ_P3^_:]^--O\8]/^#9T(^%OC&+$0WMY%?02S?V;?D%M M]U$@C1?,)=W62,C[^K#^'7PP^&OP?\+0^!OA+\/-#\+:);,S6^C^'=)A ML;6(LAK\5OV]/^"1WQS_9N\9:AXJ^#?A# M4_%W@&XF::PN=+@:YN],C))\FYB0%R$''G %" "Q4G;7YYQME6*KU(8NE%R2 M7*[=-6T_35W[']@?1DX[R/*L)B>'\=5C2J5*GM:;DTE-N,8RA=Z254C ]]Q%&A> /'GBC7% M\,>&?!.KZCJ3/L73K'399IRW]T1HI;/MBOTQ_P""3?\ P2;\=?#KQU8?M/\ M[3^@?V9>:9^^\*>%+@AIXYR,"[N0,B,H"2D9^R6K/TLHHHK] MW/\ *H**** /RO\ ^"XO[/GQG_9\_;X_9]_X+B?!'X>:KXPL?@Z&T#XLZ!H- ML9[^'PW*UT)+V")>9!'%J%^K_P!TO$QP@D9/T-^$?[6G[,OQW^#-O^T-\)/C MOX6UOP3<6:W1\26NLQ"VMT*Y(G9F'V=UY#))M=""& ((KT.O*_$/["O[$?BW MQ>;S7UO4/A[ILUXTF<[S,\!+*,H<$KE" >*]]_X M)*^$]7_:%_X-KO"GPD^$'BBU77O$7P0\0>'=+O8;I<6>IS+?6R!V!^1DE=2< M\C%??VO_ Y^'OBOPO'X(\4>!-&U+18A&(M(O]+BFM4"?< B=2@V]N..U1^! M_A=\,_AC!<6OPV^'>A>'HKMU>ZCT/2(;19F4$*7$2KN(!.">F30!^?W_ 0F M_;"^!7@__@CWI7P]_:"\4:9X-U_X!:;J?AKXO^%O$TR6UUH;VEQ.?W\$A#;9 M8"C XPSET&65A7SQ^QE^PQ^SCH'_ 1%_9[_ &)_^"H<6L>"YOBY\3K[4_ . MI-J_]EZAX+UB>._OM,:.:0$07$EO$P"2*1YMWY;*7.*_6_Q'^S5^SGXQ^(UK M\8?%WP!\$ZKXML2ALO%.I>%;.?4;?9C9LN7C,J;<#&&&,<5M>/?AE\-_BIHX M\/?$_P"'VA^)-/#%A8Z]I,-Y""5*D[)59G0D=Z /S._9/\ B7^UK^QE M\8/VD_V!OVX?BZW[2'PH^&/P"D\;VGCC4[-?[733W6X4^'M4DW-YMQ-!'^^*7[,_P =/BGI7AZ' MX%>)-2&K1V-MJ#/*]]HUR29(X[>-)977Y6B\L-.THWE/UH\"_ SX)_"[P5<_ M#;X9_![PMX=\.7OF_;- T+P];6EE/YB[9-\$2+&VY>&R#D<'-4? _P"S-^S? M\,O&5S\1OAM^S]X(\/>(;V(QWFO:'X4L[2]G0G)5YXHU=@3U!)% ';U^27[ M&G_ KXQ?\'&/[=GACQGI?A;Q1'-I?A5K&PU6VM[U7>UL8(+DHD@8%HI"(WP, MJQP<&OUHO["QU6QFTO5+**YMKF)HKBWGC#QRQL"&1E/#*02"#P0:XW1_V9_V M'_V?O!%C?64Z3V=[9^%+.*6"52"KHZQ@JP(!!!!!% &MKMEX/\ MAW\,-1M;"STW0]$TK1[AO*ACCMK6SA6-F8X&$C0#)/0#DU^?'_!M)&/B)_P; MZ?#_ ,!>"?%T%MK'V+Q=I;W4$P9],O)M:U-XBX7E&"S12@==K*1U%?HQXI\) M^%O'&A3^%O&OAK3]8TRZV_:=.U2S2X@FVL'7='("K89589'!4'J*SO WPD^% M7PP:Y?X:?#+P]X=:]""\.A:+!:&<)NV;_*1=VW)=0BLYM.@DU&YU".^82,/] M&9+DA9Q\C&)B"1@GC?\ @FK\'-:_9M_X-_?VD/B%\1K:7PYHGQ)/Q$\;>%=/ MUE#:M8:)>:>8+$,DF/+$J6ZS(IP2MRG&6Q7Z9>.?V:_V<_B?XRLOB+\2O@#X M*\0^(-,V_P!FZ[KGA6SN[RTVG*^7-+&SQX)R-I&*W?&OP^\ _$G2H]"^(O@C M1]?L8K@3Q6>M:9%=1)*%91($E5@& 9ANQG#$=S0!\._\$L/%_A67_@W8\!:^ MGB*R-CI_P$OHK^[^TKY=N\-M&F%_ M):_#._\ M*6A\PQ>1XCEDFW!>FQ%9FST )-?K_9?LY?L]:;H]]X=T[X$>#+? M3]3,1U*Q@\+VB0W?EL6C\U!'MDV,25W [221BM+PM\(OA1X&TB]T#P3\,/#V MCV&IJ5U*RTK18+>&[!4J1(D:!9/E)'S \$B@#S+_ ()Z_M!?!3]H']E'P/JG MP1^)ND>*K/2?!NC6FIWVA78N;>VNOL$+-;/*F4$Z KYD.?,CW+O5=RY]NK-\ M(^#/!_P_\/6WA'P%X4TW1-)LU*VFEZ18QVUO "2Q"1Q@*N22>!U)K2H **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ IES665PJHH&2Q)X YS17"1 M0Q(7EEE<*J*!DL2> .+PQ$Y34=1B)5M58 M'[H[B 'M_'U/&!7TO"_"^8<4Y@L/AU:"UG-[17ZM]%U\DFU\QQ5Q5EW"F7/$ M8AWF](06\G^B75]/-M)_=G@CQ[X-^)/AZ/Q7X#\1VNJZ=*[HEW:2;E+*<,I[ M@@]C['O6O7Y6_LL_M3>,OV9O&7]I::7O=#O74:SHS28691QYB9X651T;OT/' M3]-?AK\2O!OQ;\&V?CSP'K"7NG7J91UX:-OXHW7JKJ>"IZ5Z7&?!6,X4Q5U> M="7PS_\ ;9=I?@UJNJ7F<$\;X+BW"6=H8B/Q0_\ ;H]X_BGH^C>[1117Q!]T M%-FFBMH7N)Y J1J6=CT R33J* /-?A;^V7^R5\;OB1J?P<^#_[2O@?Q-XNT M6V:XU?POHGB>VN-1LHE95:26W1S)&H9T!+* "Z@]172?%GXS_";X#^#Y_B%\ M:OB/HWA70;4$W6LZ_J"6MK "27ED(5 ":=<8P9GDMX(XT#':ZJ M83@.KQ_0?@G_ (*1?![_ (*D_P#!%KXS_&SP19C2]=L_A#XGTOXA>![ULW7A M[5DTBY$UM*K %HVY:.0@;T/(5U=% /M;X9?%7X;?&CP?:_$'X2^.=+\2:%?* M&LM8T:\2XMKA2H8-'(A*NI5@002"#6_7@\_[1_@W]F7]EOX4"^T"]UG7/%>G MZ)X=\#>$=%$0NM:U*6Q$B01F5DCB1(89II)794CB@D8YP%/">'/^"GVK>&/V MW=._X)^_M1?LXW'@;Q[XM\*W.N_#*ZTCQ9#J^D^*X[=)'GM([EHK9[>Z412' MRY8U4A"=_*;P#ZSK+\9>-?"7P\\-W7C'QSXBM-)TJQ3?>:A?3".&!YXKX"_X),_MS_ML_M3_ +6O[1VD_&WX!6]GI/AGXQ2>%Y38^-()K;PA#8V( M1+5(V4/>-)*#(\L852\[$ *H4?HC0!YI\!_VS?V2OVI)[JW_ &;/VD_!/CYK M'B]_X0_Q);ZB+9*BX7KTKT'P3_ ,%]_%GQ MH_8>OOV[/V>O^";'Q(\6>%_#KZM<^-!+XAT[3UT33K"6022A[A@U[<>3&TS0 M6L#O\ @I+K>C?MX^'?^">O M[3O[.\_@?QCXY\)7/B'P#J^A^)!K>DZK#;>:US;23?9[=[:YC2)G*F-HR,8D MRR!@#ZGHKYE7]O\ \>?%W5_B%!^Q-^S._P 4=,^%WB"XT#Q+K-WXQAT6'4=8 MMD5[K3M*WPS?:YH2ZQN\QMH/,.Q96VN5Y.7_ (+2_ /Q!_P3;US_ (*5?!_X M2^-O&'A_PJ+J'QAX1LHK*TU?PW>6P'VFWOXKJYC$9A+(7\HS/LD5T1U.: /L M:BO@'XR_\%S]6^!O[/7P]_;3\:?L">/X_@AXKT_0I_$WQ'_MRQ3^P6U..%E: M.P=A=7=O'),(OM#) LC -$'1XV?KOBY_P5XUSX#?'3X<>'_C'^Q#XZ\-_"7X MJ^.+7PAX0^+VJZM8H)=5NPWV3S]*#F[M+>8HQ5Y_+D"*6>)2-M 'VA17CGQ: M_:KU;0OC/_PS-\ _A>OCOX@V_AM/$&LZ=3/!-?MS?"WXM_%CX)7.@_"77WBFB=O1^A[5^8=S;7-E,[)6D^DWU3Z2?P[/W?A_&_$[@7%9TO[5P+0''+].@S7%?L1?L(:C\2]1B^)WQFT:>T\/6DY^QZ3E26C4?[L>G-W?V>GO?#X/A?P)BUB*>=8V\%'6G'5.7]Z77E[+[77W? MB?1117X&?T$%%%% 'RUX.\;>#[C_ (+1_$#P7;^*+"35X_V:O"CR::EVAG0) MKVOLV4!R,+-"Q&.!*AZ,,_"?_!=/]A;XZ?L,Z[\2?^"JG_!.G1/,TCX@>"-4 M\/?M-?#2V1OLNJV%W:RPG7HXDZ30M+YLKJ,JP,Q!1[K=^L%E^SQ^S_IOB1/& M.G? SP=!J\=W]JCU6'PS:+:)1'N#[N=V-O&Z++J+>(_!/PZL[6Z\&::+>3?>W%T+-9 M+)WV4P- 5V&(QD;2 MFWY=N,8XQBL'X6? WX*? O3+K1?@E\'_ MX.L[VX\^]M/"OA^VT^*XE_P"> MCK;H@=N3\Q!/- 'YV_\ !&CXW?"3X=?MZ_MK_L_^-_B!IFF^.?$7[4VI7V@^ M$;BX']I:A:2VYD6YBMQF1X0D;NTH&Q% +,H()_3>]O;/3K.74-0NXH+>")I) MYYI J1HHRS,QX !))Z5F6GP^\!6'C.[^(]AX(TB#Q#?VJ6U]KT.FQ+>W$"8 MVQ23A=[H,#"DD# XJ7Q7X.\(^/-#E\,^.?"VFZUIL[*TVGZM8QW,$A5@REHY M 5." 1D<$ T ?E__ ,&E_C;P?J?_ 3^^*(++[/:>'/B8MW*;E- ML)<7SJ'.?E)21& /4.I[BOU+L/V9?V;M*2XCTS]GSP/;+=VY@NE@\)V:":(D M$QOB/YE)53M/&5'I1!^S-^S?:Z;<:-;?L^^"([.[>-[NTC\*68BF:/=L9U$> M&*[FP2.-QQU- 'XK^+/'WB7X!_\ !*#_ ()K?\%$]'T*\\1^ ?@9K]K+\3(- M%C^T/8V5U";*2[9%XS"4FC&<8EF121NR/U.^"7_!4?\ 8X_:V^)_AOX;_LD:EO_ +1TO3M%@@MKK>FQO,B1 KY0!3N!R.#Q M4/PM^"?P:^!VCS^'O@I\)/#'@_3[JX-Q1A*3(N5"F)F(\Q<^'^"_A=<>"/^"._P#P4D_:GN)1IO@;XW_$+QQK MWPQ6Y_=0ZAH\DDD-KJ$*MC$=W(Y$7'SHD3+E74G]@OB9^SA^SS\:=8T_Q%\8 M_@-X,\6:AI/_ ""[[Q-X7M+^:SYW?NGGC9H^>?E(YK8\8?#7X<_$/1X/#WC_ M , :)KFGVLJRVUCK&E0W,,3A2H94D4JI"LP! R 2.] 'Y-?\%8_$GAVY_P"# M0[P[+;ZY9NM_\(/AC!8LMPI^T2K=:*S1IS\S!8Y"5'($;9^Z:]-_X.*/&O@Z MW_91_9?UR?Q3IRV=Q^U7X#O;>Z:\3RY;9([MWF5LX9 A#%AP 0<\U]^S_LT_ MLY76D6^@7/P \$R6%G-+-:63^%;,PP22!!(Z(8]JLXCC#$#+>6N<[1@O?V:? MV?PI9NEM&TC2,D:F/"*7=W(& 6=CU)- 'Y<_ MM4?%/]DW]B;_ (+Q>.O%G_!3[X1>&+_X4_'WX<>'O^%=?$+QIX0AU73=%U+2 MHY+>:R+RQ2?9Q)YKO(R\#?;L^%;>OV]_P3Y\7?\ !/KXD^*O&_CG_@G9\!?A M_IWA95L[/6?B;X \(6NF6GB/45,S/9QRP6\9OA:H8V:4,T:M=[%)=90GNOC/ MX&_!3XC^ X/A7\0_@_X6U[PQ;+&MMX5&C4*O"X7@<"M MGPKX3\+>!?#MGX0\$^&M/T?2=/A$-AI>E6:6]O;1CHD<<8"HH] * -"BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " &BBB@#__9 end GRAPHIC 11 ew-20230630_g10.jpg begin 644 ew-20230630_g10.jpg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end GRAPHIC 12 ew-20230630_g11.jpg begin 644 ew-20230630_g11.jpg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end GRAPHIC 13 ew-20230630_g12.jpg begin 644 ew-20230630_g12.jpg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end GRAPHIC 14 ew-20230630_g2.jpg begin 644 ew-20230630_g2.jpg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end GRAPHIC 15 ew-20230630_g3.jpg begin 644 ew-20230630_g3.jpg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end GRAPHIC 16 ew-20230630_g4.jpg begin 644 ew-20230630_g4.jpg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end GRAPHIC 17 ew-20230630_g5.jpg begin 644 ew-20230630_g5.jpg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end GRAPHIC 18 ew-20230630_g6.jpg begin 644 ew-20230630_g6.jpg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end GRAPHIC 19 ew-20230630_g7.jpg begin 644 ew-20230630_g7.jpg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end GRAPHIC 20 ew-20230630_g8.jpg begin 644 ew-20230630_g8.jpg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ݮ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end GRAPHIC 21 ew-20230630_g9.jpg begin 644 ew-20230630_g9.jpg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end XML 22 R1.htm IDEA: XBRL DOCUMENT v3.23.2
COVER - shares
 6 Months Ended
Jun. 30, 2023
Jul. 25, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Document Transition Report false  
Entity File Number 1-15525  
Entity Registrant Name EDWARDS LIFESCIENCES CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 36-4316614  
Entity Address, Address Line One One Edwards Way  
Entity Address, City or Town Irvine  
Entity Address, State or Province CA  
Zip Code 92614  
City Area Code 949  
Local Phone Number 250-2500  
Title of 12(b) Security Common Stock, par value $1.00 per share  
Trading Symbol EW  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   607,916,300
Entity Central Index Key 0001099800  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Amendment Flag false  
XML 23 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 1,042.6 $ 769.0
Short-term investments (Note 4) 466.7 446.3
Accounts receivable, net of allowances of $8.1 and $7.9, respectively 754.4 643.0
Other receivables 62.5 56.1
Inventories (Note 2) 980.2 875.5
Prepaid expenses 123.2 110.0
Other current assets 217.4 195.9
Total current assets 3,647.0 3,095.8
Long-term investments (Note 4) 856.2 1,239.0
Property, plant, and equipment, net 1,662.2 1,632.8
Operating lease right-of-use assets 84.9 92.3
Goodwill 1,299.5 1,164.3
Other intangible assets, net (Note 6) 431.4 285.2
Deferred income taxes 610.7 484.0
Other assets (Note 5) 412.1 299.1
Total assets 9,004.0 8,292.5
Current liabilities    
Accounts payable 193.0 201.9
Accrued and other liabilities (Note 2) 939.9 795.0
Operating lease liabilities 24.3 25.5
Total current liabilities 1,157.2 1,022.4
Long-term debt 596.7 596.3
Contingent consideration liabilities (Note 7) 0.0 26.2
Taxes payable 81.2 143.4
Operating lease liabilities 63.5 69.5
Uncertain tax positions 303.7 267.5
Litigation settlement accrual (Note 2) 112.5 143.0
Other liabilities 242.7 217.5
Total liabilities 2,557.5 2,485.8
Commitments and contingencies (Note 11)
Stockholders' equity    
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding           0.0 0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 649.1 and 646.3 shares issued, and 607.9 and 608.3 shares outstanding, respectively 649.1 646.3
Additional paid-in capital 2,145.5 1,969.3
Retained earnings 8,237.6 7,590.0
Accumulated other comprehensive loss (Note 12) (255.5) (254.9)
Treasury stock, at cost, 41.2 and 38.0 shares, respectively (4,401.0) (4,144.0)
Total Edwards Lifesciences Corporation stockholders' equity 6,375.7 5,806.7
Noncontrolling interest (Note 6) 70.8 0.0
Total stockholders' equity 6,446.5 5,806.7
Total liabilities and equity $ 9,004.0 $ 8,292.5
XML 24 R3.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 8.1 $ 7.9
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 50,000,000.0 50,000,000.0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 1.00 $ 1.00
Common stock, shares authorized (in shares) 1,050,000,000 1,050,000,000
Common stock, shares issued (in shares) 649,100,000 646,300,000
Common stock, shares outstanding (in shares) 607,900,000 608,300,000
Treasury stock (in shares) 41,200,000 38,000,000.0
XML 25 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Net sales $ 1,530.2 $ 1,373.9 $ 2,989.8 $ 2,715.1
Cost of sales 343.0 269.4 672.5 568.7
Gross profit 1,187.2 1,104.5 2,317.3 2,146.4
Selling, general, and administrative expenses 468.7 409.0 905.0 779.3
Research and development expenses 270.3 250.8 531.5 479.4
Intellectual property agreement and litigation expense (Note 3) 147.9 6.1 191.4 13.2
Change in fair value of contingent consideration liabilities (Note 7) (26.9) (20.9) (26.2) (23.8)
Operating income, net 327.2 459.5 715.6 898.3
Interest income, net (9.1) (0.9) (17.7) (1.5)
Other income, net (2.2) (4.3) (3.8) (1.0)
Income before provision for income taxes 338.5 464.7 737.1 900.8
Provision for income taxes 33.0 58.3 91.1 120.8
Net income 305.5 406.4 646.0 780.0
Net loss attributable to noncontrolling interest (Note 6) (1.6) 0.0 (1.6) 0.0
Net income attributable to Edwards Lifesciences Corporation $ 307.1 $ 406.4 $ 647.6 $ 780.0
Earnings per share:        
Basic (in dollars per share) $ 0.51 $ 0.65 $ 1.07 $ 1.26
Diluted (in dollars per share) $ 0.50 $ 0.65 $ 1.06 $ 1.24
Weighted-average number of common shares outstanding:        
Basic (in shares) 606.9 620.9 607.2 621.5
Diluted (in shares) 610.3 626.7 610.6 628.1
XML 26 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net income $ 305.5 $ 406.4 $ 646.0 $ 780.0
Other comprehensive loss, net of tax (Note 12):        
Foreign currency translation adjustments (11.5) (43.2) (7.7) (53.2)
Unrealized gain (loss) on hedges 5.3 31.3 (11.9) 44.7
Unrealized pension credits (costs) 0.2 (0.1) 0.1 (0.1)
Unrealized gain (loss) on available-for-sale investments 2.1 (30.9) 11.1 (68.0)
Reclassification of realized investment losses to earnings 3.8 5.1 7.8 9.9
Other comprehensive loss (0.1) (37.8) (0.6) (66.7)
Comprehensive income 305.4 368.6 645.4 713.3
Comprehensive loss attributable to noncontrolling interest (1.6) 0.0 (1.6) 0.0
Comprehensive income attributable to Edwards Lifesciences Corporation $ 307.0 $ 368.6 $ 647.0 $ 713.3
XML 27 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities    
Net income $ 646.0 $ 780.0
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 71.3 68.8
Non-cash operating lease cost 13.7 13.9
Stock-based compensation (Note 9) 76.3 68.6
Change in fair value of contingent consideration liabilities (Note 7) (26.2) (23.8)
Loss (gain) on investments, net (3.5) 38.2
Deferred income taxes (134.7) (102.4)
Other 2.8 4.2
Changes in operating assets and liabilities:    
Accounts and other receivables, net (124.3) (77.7)
Inventories (113.7) (85.8)
Accounts payable and accrued liabilities 76.2 (81.7)
Income taxes 31.0 49.7
Prepaid expenses and other current assets (43.4) 25.7
Intellectual property agreement accrual (14.5) (19.7)
Long-term prepaid royalties (Note 3) (114.0) 0.0
Other 4.7 (32.5)
Net cash provided by operating activities 347.7 625.5
Cash flows from investing activities    
Capital expenditures (109.4) (115.8)
Purchases of held-to-maturity investments (Note 4) (15.5) (180.7)
Proceeds from held-to-maturity investments (Note 4) 83.5 277.5
Purchases of available-for-sale investments (Note 4) (6.8) (114.3)
Proceeds from available-for-sale investments (Note 4) 314.5 584.1
Business combination, net of cash (Note 6) (141.2) 0.0
Payment for acquisition options (Note 5) (15.0) (55.5)
Issuances of notes receivable (22.5) (45.5)
Collections of notes receivable 0.0 18.0
Other (16.9) (8.7)
Net cash provided by investing activities 70.7 359.1
Cash flows from financing activities    
Purchases of treasury stock (256.8) (760.7)
Proceeds from stock plans 102.7 86.5
Other (0.4) (2.0)
Net cash used in financing activities (154.5) (676.2)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash 11.0 27.1
Net increase in cash, cash equivalents, and restricted cash 274.9 335.5
Cash, cash equivalents, and restricted cash at beginning of period 772.6 867.4
Cash, cash equivalents, and restricted cash at end of period $ 1,047.5 $ 1,202.9
XML 28 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Edwards Lifesciences Corporation Stockholders' Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Common stock, beginning balance (in shares) at Dec. 31, 2021     642.0          
Beginning balance at Dec. 31, 2021 $ 5,835.9   $ 642.0 $ (2,416.9) $ 1,700.4 $ 6,068.1 $ (157.7)  
Treasury stock, beginning balance (in shares) at Dec. 31, 2021       17.9        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 373.6         373.6    
Other comprehensive loss, net of tax (28.9)           (28.9)  
Common stock issued under stock plans (in shares)     0.9          
Common stock issued under stock plans 37.5   $ 0.9   36.6      
Stock-based compensation expense 32.4       32.4      
Purchases of treasury stock (in shares)       3.6        
Purchases of treasury stock (405.6)     $ (405.6)        
Common stock, ending balance (in shares) at Mar. 31, 2022     642.9          
Ending balance at Mar. 31, 2022 5,844.9   $ 642.9 $ (2,822.5) 1,769.4 6,441.7 (186.6)  
Treasury stock, ending balance (in shares) at Mar. 31, 2022       21.5        
Common stock, beginning balance (in shares) at Dec. 31, 2021     642.0          
Beginning balance at Dec. 31, 2021 5,835.9   $ 642.0 $ (2,416.9) 1,700.4 6,068.1 (157.7)  
Treasury stock, beginning balance (in shares) at Dec. 31, 2021       17.9        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 780.0              
Common stock, ending balance (in shares) at Jun. 30, 2022     645.0          
Ending balance at Jun. 30, 2022 5,943.6   $ 645.0 $ (3,177.6) 1,852.5 6,848.1 (224.4)  
Treasury stock, ending balance (in shares) at Jun. 30, 2022       25.2        
Common stock, beginning balance (in shares) at Mar. 31, 2022     642.9          
Beginning balance at Mar. 31, 2022 5,844.9   $ 642.9 $ (2,822.5) 1,769.4 6,441.7 (186.6)  
Treasury stock, beginning balance (in shares) at Mar. 31, 2022       21.5        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 406.4         406.4    
Other comprehensive loss, net of tax (37.8)           (37.8)  
Common stock issued under stock plans (in shares)     2.1          
Common stock issued under stock plans 49.0   $ 2.1   46.9      
Stock-based compensation expense 36.2       36.2      
Purchases of treasury stock (in shares)       3.7        
Purchases of treasury stock (355.1)     $ (355.1)        
Common stock, ending balance (in shares) at Jun. 30, 2022     645.0          
Ending balance at Jun. 30, 2022 $ 5,943.6   $ 645.0 $ (3,177.6) 1,852.5 6,848.1 (224.4)  
Treasury stock, ending balance (in shares) at Jun. 30, 2022       25.2        
Common stock, beginning balance (in shares) at Dec. 31, 2022 608.3   646.3          
Beginning balance at Dec. 31, 2022 $ 5,806.7 $ 5,806.7 $ 646.3 $ (4,144.0) 1,969.3 7,590.0 (254.9) $ 0.0
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 38.0     38.0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 340.5 340.5       340.5    
Other comprehensive loss, net of tax (0.5) (0.5)         (0.5)  
Common stock issued under stock plans (in shares)     0.8          
Common stock issued under stock plans 41.9 41.9 $ 0.8   41.1      
Stock-based compensation expense 38.9 38.9     38.9      
Purchases of treasury stock (in shares)       3.1        
Purchases of treasury stock (249.5) (249.5)   $ (249.5)        
Changes to noncontrolling interest 84.0             84.0
Common stock, ending balance (in shares) at Mar. 31, 2023     647.1          
Ending balance at Mar. 31, 2023 $ 6,062.0 5,978.0 $ 647.1 $ (4,393.5) 2,049.3 7,930.5 (255.4) 84.0
Treasury stock, ending balance (in shares) at Mar. 31, 2023       41.1        
Common stock, beginning balance (in shares) at Dec. 31, 2022 608.3   646.3          
Beginning balance at Dec. 31, 2022 $ 5,806.7 5,806.7 $ 646.3 $ (4,144.0) 1,969.3 7,590.0 (254.9) 0.0
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 38.0     38.0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 646.0              
Common stock, ending balance (in shares) at Jun. 30, 2023 607.9   649.1          
Ending balance at Jun. 30, 2023 $ 6,446.5 6,375.7 $ 649.1 $ (4,401.0) 2,145.5 8,237.6 (255.5) 70.8
Treasury stock, ending balance (in shares) at Jun. 30, 2023 41.2     41.2        
Common stock, beginning balance (in shares) at Mar. 31, 2023     647.1          
Beginning balance at Mar. 31, 2023 $ 6,062.0 5,978.0 $ 647.1 $ (4,393.5) 2,049.3 7,930.5 (255.4) 84.0
Treasury stock, beginning balance (in shares) at Mar. 31, 2023       41.1        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 305.5 307.1       307.1   (1.6)
Other comprehensive loss, net of tax (0.1) (0.1)         (0.1)  
Common stock issued under stock plans (in shares)     2.0          
Common stock issued under stock plans 60.8 60.8 $ 2.0   58.8      
Stock-based compensation expense 37.4 37.4     37.4      
Purchases of treasury stock (in shares)       0.1        
Purchases of treasury stock (7.5) (7.5)   $ (7.5)        
Changes to noncontrolling interest $ (11.6)             (11.6)
Common stock, ending balance (in shares) at Jun. 30, 2023 607.9   649.1          
Ending balance at Jun. 30, 2023 $ 6,446.5 $ 6,375.7 $ 649.1 $ (4,401.0) $ 2,145.5 $ 8,237.6 $ (255.5) $ 70.8
Treasury stock, ending balance (in shares) at Jun. 30, 2023 41.2     41.2        
XML 29 R8.htm IDEA: XBRL DOCUMENT v3.23.2
BASIS OF PRESENTATION
 6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
BASIS OF PRESENTATION BASIS OF PRESENTATION
The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.

The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.

In the opinion of management, the interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.

There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.

New Accounting Standards Not Yet Adopted

In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.
XML 30 R9.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
 6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
Composition of Certain Financial Statement Captions
(in millions)

Components of selected captions in the consolidated condensed balance sheets consisted of the following:
June 30, 2023December 31, 2022
Inventories
Raw materials$181.2 $156.4 
Work in process223.0 177.4 
Finished products576.0 541.7 
$980.2 $875.5 

At June 30, 2023 and December 31, 2022, $149.7 million and $128.6 million, respectively, of the Company's finished products inventories were held on consignment.
June 30, 2023December 31, 2022
Accrued and other liabilities 
Employee compensation and withholdings$312.7 $268.7 
Taxes payable106.6 50.6 
Property, payroll, and other taxes56.1 45.6 
Research and development accruals70.7 66.9 
Accrued rebates130.1 116.1 
Fair value of derivatives17.8 20.7 
Accrued marketing expenses16.9 17.0 
Legal and insurance30.4 28.1 
Litigation settlement (a)
69.2 53.3 
Accrued relocation costs23.3 25.2 
Accrued professional services10.2 6.6 
Accrued realignment reserves14.4 15.6 
Other accrued liabilities81.5 80.6 
$939.9 $795.0 
_______________________________________
(a)     As of June 30, 2023, $69.2 million was accrued in "Accrued and Other Liabilities" and $112.5 million was accrued in "Litigation Settlement Accrual" on the consolidated condensed balance sheet related to a settlement agreement with Abbott Laboratories and its direct and indirect subsidiaries.

Supplemental Cash Flow Information
(in millions)
Six Months Ended
June 30,
20232022
Cash paid during the year for:
Income taxes$193.5 $173.0 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$14.3 $14.5 
Non-cash investing and financing transactions:  
Right-of-use assets obtained in exchange for new lease liabilities$6.0 $10.6 
Capital expenditures accruals$26.9 $24.6 

Cash, Cash Equivalents, and Restricted Cash
(in millions)
June 30, 2023December 31, 2022
Cash and cash equivalents$1,042.6 $769.0 
Restricted cash included in other current assets1.4 0.5 
Restricted cash included in other assets3.5 3.1 
Total cash, cash equivalents, and restricted cash$1,047.5 $772.6 

Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.
XML 31 R10.htm IDEA: XBRL DOCUMENT v3.23.2
INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE
 6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSEOn April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and will pay annual royalty payments that are tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million pre-tax charge in "Intellectual Property Agreement and Litigation Expense" in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in "Intellectual Property Agreement and Litigation Expense" in April 2023 related to products currently in development.
XML 32 R11.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS
 6 Months Ended
Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
INVESTMENTS INVESTMENTS
Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):
 June 30, 2023December 31, 2022
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$28.1 $— $— $28.1 $96.0 $— $— $96.0 
Available-for-sale
U.S. government and agency securities103.4 — (5.0)98.4 137.7 — (6.1)131.6 
Asset-backed securities262.5 — (10.0)252.5 380.6 — (14.0)366.6 
Corporate debt securities864.9 — (34.0)830.9 1,028.1 — (47.8)980.3 
Municipal securities2.8 — (0.2)2.6 2.7 — (0.2)2.5 
Total$1,233.6 $— $(49.2)$1,184.4 $1,549.1 $— $(68.1)$1,481.0 
The cost and fair value of investments in debt securities, by contractual maturity, as of June 30, 2023, were as follows:
Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$26.3 $26.3 $450.9 $440.4 
Due after 1 year through 5 years1.8 1.8 472.0 446.7 
Due after 5 years through 10 years— — 4.6 4.4 
Instruments not due at a single maturity date (a)
— — 306.1 292.9 
$28.1 $28.1 $1,233.6 $1,184.4 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.
Actual maturities may differ from the contractual maturities due to call or prepayment rights.
The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2023 and December 31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):

June 30, 2023
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$10.9 $(0.1)$86.2 $(4.9)$97.1 $(5.0)
Asset-backed securities50.9 (0.8)199.9 (9.2)250.8 (10.0)
Corporate debt securities23.3 (0.1)793.3 (33.9)816.6 (34.0)
Municipal securities— — 2.6 (0.2)2.6 (0.2)
$85.1 $(1.0)$1,082.0 $(48.2)$1,167.1 $(49.2)
December 31, 2022
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$61.6 $(1.5)$69.5 $(4.6)$131.1 $(6.1)
Asset-backed securities103.3 (1.3)254.6 (12.7)357.9 (14.0)
Corporate debt securities189.0 (5.3)784.8 (42.5)973.8 (47.8)
Municipal securities— — 2.5 (0.2)2.5 (0.2)
$353.9 $(8.1)$1,111.4 $(60.0)$1,465.3 $(68.1)

The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of June 30, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.

Investments in Unconsolidated Entities

The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "Long-term Investments" on the consolidated condensed balance sheets, and are as follows:
 June 30,
2023		December 31,
2022
 (in millions)
Equity method investments  
Carrying value of equity method investments$23.5 $21.4 
Equity securities  
Carrying value of non-marketable equity securities86.9 86.9 
Total investments in unconsolidated entities$110.4 $108.3 

During the six months ended June 30, 2023, the Company made $1.7 million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. As of June 30, 2023, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $3.1 million due to impairments and observable price changes.
During the three and six months ended June 30, 2023, the gross realized gains or losses from sales of available-for-sale investments were not material.
XML 33 R12.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS IN VARIABLE INTEREST ENTITIES
 6 Months Ended
Jun. 30, 2023
Variable Interest Entities [Abstract]  
INVESTMENTS IN VARIABLE INTEREST ENTITIES INVESTMENTS IN VARIABLE INTEREST ENTITIES The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to
consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.

Consolidated VIEs

In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. See Note 6 for additional information.

Unconsolidated VIEs

Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.

In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option to acquire the medical device company, of which $15.0 million has been paid as of June 30, 2023. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. The option and the note are included in "Other Assets" on the consolidated condensed balance sheet.
In January 2023, the Company loaned a privately-held medical device company (the "Investee") $10.0 million under a $45.0 million secured promissory note agreement. In April 2023, the Investee drew an additional $7.5 million under the promissory note. Previously, in 2021, the Company invested $39.3 million, included in "Long-term Investments," in the Investee's preferred equity securities and paid $13.1 million, included in "Other Assets," for an option to acquire the Investee. Per the agreement, the Company may be required to invest up to an additional $6.5 million in the Investee's preferred equity securities and up to an additional $14.4 million for the option to acquire the Investee.

In August 2022, the Company entered into an option agreement with a medical device company. Under the option agreement, Edwards paid $47.1 million for an option to acquire the medical device company. The $47.1 million option is included in "Other Assets" on the consolidated condensed balance sheet.

In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $32.5 million has been advanced as of June 30, 2023. In addition, in 2019 the Company paid $35.0 million for an option to acquire the medical device company. The $35.0 million option and the $32.5 million note receivable are included in "Other Assets" on the consolidated condensed balance sheet.

In May 2022, the Company entered into an option agreement with a medical technology company. Under the option agreement, Edwards paid $60.0 million for an option to acquire the medical technology company, of which $10.0 million was paid in 2021. The $60.0 million option is included in "Other Assets" on the consolidated condensed balance sheet.

In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 4.
XML 34 R13.htm IDEA: XBRL DOCUMENT v3.23.2
BUSINESS COMBINATION
 6 Months Ended
Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
BUSINESS COMBINATION BUSINESS COMBINATIONOn February 28, 2023, the Company acquired 61% of the then outstanding shares of a medical technology company in an all cash transaction. The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated condensed financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company.
The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination. Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):

Assets$8.1 
Goodwill133.2 
In-process research and development136.6 
Liabilities assumed(1.7)
Deferred tax liabilities(28.0)
Fair value of net assets acquired248.2 
Less: Noncontrolling interest (a)
(72.4)
Total purchase price
175.8 
Less: cash acquired(6.8)
Total purchase price, net of cash acquired (b)
$169.0 
_______________________________________
(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.
(b)     Includes $22.5 million paid in a previous year under option agreements and $5.3 million for the settlement of a pre-existing note.

Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s Rest of World segment and is not deductible for tax purposes.

Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.
XML 35 R14.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS
 6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.
Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.
Level 3—Unobservable inputs that are not corroborated by market data.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. As of June 30, 2023, the fair value of the notes payable, based on Level 2 inputs, was $580.5 million.
Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
June 30, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$635.0 $— $— $635.0 
Available-for-sale investments:
Corporate debt securities
— 830.9 — 830.9 
Asset-backed securities
— 252.5 — 252.5 
United States government and agency securities— 98.4 — 98.4 
Municipal securities
— 2.6 — 2.6 
Investments held for deferred compensation plans125.3 — — 125.3 
Derivatives— 63.9 — 63.9 
$760.3 $1,248.3 $— $2,008.6 
Liabilities    
Derivatives$— $17.8 $— $17.8 
Other liability— — 14.0 14.0 
$— $17.8 $14.0 $31.8 
December 31, 2022    
Assets    
Cash equivalents$280.4 $— $— $280.4 
Available-for-sale investments:
Corporate debt securities
— 980.3 — 980.3 
Asset-backed securities
— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities
— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$429.6 $1,509.4 $— $1,939.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other liability— — 14.0 14.0 
$— $27.2 $40.2 $67.4 

Cash Equivalents and Available-for-sale Investments

Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond and money market mutual funds. The fair values of these investments are based on quoted market prices.
Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. As of June 30, 2023 the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was reduced to zero.

The following tables summarize the changes in fair value of the contingent consideration and the other liability (in millions):
 Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)— (26.2)
Balance at June 30, 2023$— $14.0 $14.0 
Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(23.8)— (23.8)
Balance at June 30, 2022$38.2 $14.0 $52.2 
XML 36 R15.htm IDEA: XBRL DOCUMENT v3.23.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 6 Months Ended
Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 June 30, 2023December 31, 2022
 (in millions)
Foreign currency forward exchange contracts$1,763.7 $1,678.4 
Cross currency swap contracts300.0 300.0 

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (b) its net
investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions).

All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):
  Fair Value
Derivatives designated as hedging instrumentsBalance Sheet
Location		June 30, 2023December 31, 2022
Assets   
Foreign currency contractsOther current assets$32.2 $24.9 
Cross currency swap contractsOther assets$31.7 $40.6 
Liabilities   
Foreign currency contractsAccrued and other liabilities$17.8 $20.7 
Foreign currency contractsOther liabilities$— $6.5 

The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):
    Gross Amounts
Not Offset in
the Consolidated
Balance Sheet		 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		 
  Net Amounts
Presented in the
Consolidated
Balance Sheet
June 30, 2023Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative assets      
Foreign currency contracts$32.2 $— $32.2 $(8.6)$— $23.6 
Cross currency swap contracts$31.7 $— $31.7 $— $— $31.7 
Derivative liabilities      
Foreign currency contracts$17.8 $— $17.8 $(8.6)$— $9.2 
December 31, 2022      
Derivative assets      
Foreign currency contracts$24.9 $— $24.9 $(12.0)$— $12.9 
Cross currency swap contracts$40.6 $— $40.6 $— $— $40.6 
Derivative liabilities   
Foreign currency contracts$27.2 $— $27.2 $(12.0)$— $15.2 
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
 Three Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Three Months Ended
June 30,
 
2023202220232022
Cash flow hedges
Foreign currency contracts$23.2 $57.9 Cost of sales$13.9 $16.3 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
 Six Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Six Months Ended
June 30,
 
2023202220232022
Cash flow hedges
Foreign currency contracts$26.9 $82.6 Cost of sales$43.7 $23.6 

 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
Effectiveness Testing)
 Three Months Ended
June 30,		 Location of Gain or
(Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)		Three Months Ended
June 30,
 
2023202220232022
Net investment hedges
Cross currency swap contracts$(6.5)$19.4 Interest income, net$1.8 $2.0 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
 Six Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Six Months Ended
June 30,
 
2023202220232022
Net investment hedges
Cross currency swap contracts$(9.0)$23.3 Interest income, net$3.5 $3.6 

The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Three Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Fair value hedges
Foreign currency contractsOther income, net$11.3 $— 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Six Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Fair value hedges
Foreign currency contractsOther income, net$11.3 $— 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Three Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$9.9 $26.6 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Six Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$4.5 $42.1 
The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):
 Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Three Months Ended
June 30, 2023		Six Months Ended
June 30, 2023
 Cost of salesOther income, netCost of salesOther income, net
Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded$(343.0)$2.2 $(672.5)$3.8 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
$— $(10.1)$— $(8.9)
Derivatives designated as hedging instruments
$— $10.1 $— $8.9 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
$— $1.2 $— $2.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
$13.9 $— $43.7 $— 
 Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Three Months Ended
June 30, 2022		Six Months Ended
June 30, 2022
 Cost of salesCost of sales
Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded$(269.4)$(568.7)
The effects of fair value and cash flow hedging:
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
$16.3 $23.6 

The Company expects that during the next twelve months it will reclassify to earnings a $9.0 million gain currently recorded in "Accumulated Other Comprehensive Loss."
XML 37 R16.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION
 6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and six months ended June 30, 2023 and 2022 was as follows (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Cost of sales$6.2 $6.9 $13.2 $13.1 
Selling, general, and administrative expenses22.5 21.1 44.8 39.8 
Research and development expenses8.7 8.2 18.3 15.7 
Total stock-based compensation expense37.4 36.2 76.3 68.6 
Income tax benefit(6.8)(5.9)(11.5)(10.3)
Total stock-based compensation expense, net of tax$30.6 $30.3 $64.8 $58.3 

At June 30, 2023, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $275.0 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 34 months.

During the six months ended June 30, 2023, the Company granted 1.9 million stock options at a weighted-average
exercise price per share of $88.72, and 0.8 million restricted stock units at a weighted-average grant-date fair value per share of $88.06. During the six months ended June 30, 2023, the Company also granted 0.1 million market-based restricted stock units at a weighted-average grant-date fair value per share of $110.10. The market-based restricted stock units granted during the six months ended June 30, 2023 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a three-year performance period and may range from 0% to 175% of the target number of shares granted.
Fair Value Disclosures

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the six months ended June 30, 2023 and 2022 included a risk-free interest rate of 3.6% and 2.8%, respectively, and an expected volatility rate of 32.6% and 33.8%, respectively.

The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
 Option Awards
Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Risk-free interest rate3.4 %3.0 %3.4 %3.0 %
Expected dividend yieldNoneNoneNoneNone
Expected volatility32.8 %31.4 %32.8 %31.4 %
Expected term (years)5.15.05.15.0
Fair value, per option$31.03 $35.07 $31.01 $35.08 
The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
 ESPP
Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Risk-free interest rate4.7 %1.1 %4.6 %0.3 %
Expected dividend yieldNoneNoneNoneNone
Expected volatility34.8 %31.5 %31.5 %32.1 %
Expected term (years)0.60.60.60.6
Fair value, per share$22.02 $23.63 $19.03 $28.63 
XML 38 R17.htm IDEA: XBRL DOCUMENT v3.23.2
ACCELERATED SHARE REPURCHASE
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
ACCELERATED SHARE REPURCHASE ACCELERATED SHARE REPURCHASE
During 2023 and 2022, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreement, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share
January 2022$250.0 1.9 $104.87 80 %February 20222.3 $110.31 
February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 

The ASR agreements were each accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "Additional Paid-in Capital" and subsequently, upon settlement, was transferred to "Treasury Stock" on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.
XML 39 R18.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES
 6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
The Company is reviewing and investigating whether business activities in Japan and other markets violate certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the outcome of the review and investigation or the potential impact on its financial statements.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.
The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.
XML 40 R19.htm IDEA: XBRL DOCUMENT v3.23.2
ACCUMULATED OTHER COMPREHENSIVE LOSS
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE LOSS ACCUMULATED OTHER COMPREHENSIVE LOSS
The following tables summarize the activity for each component of "Accumulated Other Comprehensive Loss" (in millions):
 Foreign
Currency
Translation
Adjustments		Unrealized Gain on Hedges
Unrealized Loss on Available-for-sale Investments		Unrealized
Pension
Credits		Total
Accumulated
Other
Comprehensive
Loss
December 31, 2022$(218.8)$23.8 $(65.6)$5.7 $(254.9)
Other comprehensive gain (loss) before reclassifications4.9 6.7 9.0 (0.1)20.5 
Amounts reclassified from accumulated other comprehensive loss(1.7)(29.8)4.0 — (27.5)
Deferred income tax benefit 0.6 5.9 — — 6.5 
March 31, 2023$(215.0)$6.6 $(52.6)$5.6 $(255.4)
Other comprehensive (loss) gain before reclassifications(11.3)33.5 2.1 0.2 24.5 
Amounts reclassified from accumulated other comprehensive loss(1.8)(25.2)3.8 — (23.2)
Deferred income tax benefit (expense)1.6 (3.0)— — (1.4)
June 30, 2023$(226.5)$11.9 $(46.7)$5.8 $(255.5)

 Foreign
Currency
Translation
Adjustments		Unrealized Gain on Hedges
Unrealized Loss on Available-for-sale Investments		Unrealized
Pension
Costs		Total
Accumulated
Other
Comprehensive
Loss
December 31, 2021$(172.5)$29.7 $(6.9)$(8.0)$(157.7)
Other comprehensive (loss) gain before reclassifications(7.4)24.7 (47.6)— (30.3)
Amounts reclassified from accumulated other comprehensive loss(1.6)(7.3)4.8 — (4.1)
Deferred income tax (expense) benefit(1.0)(4.0)10.5 — 5.5 
March 31, 2022$(182.5)$43.1 $(39.2)$(8.0)$(186.6)
Other comprehensive (loss) gain before reclassifications(36.5)57.9 (20.9)(0.1)0.4 
Amounts reclassified from accumulated other comprehensive loss(2.0)(16.3)5.1 — (13.2)
Deferred income tax expense(4.7)(10.3)(10.0)— (25.0)
June 30, 2022$(225.7)$74.4 $(65.0)$(8.1)$(224.4)
The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,		 
 Affected Line on Consolidated Condensed
Statements of Operations
Details about Accumulated Other
Comprehensive Loss Components
2023202220232022
Foreign currency translation adjustments$1.8 $2.0 $3.5 $3.6 Other income, net
(0.4)(0.5)(0.8)(0.9)Provision for income taxes
$1.4 $1.5 $2.7 $2.7 Net of tax
Gain on hedges$13.9 $16.3 $43.7 $23.6 Cost of sales
11.3 — 11.3 — Other income, net
25.2 16.3 55.0 23.6 Total before tax
(4.8)(4.3)(11.9)(6.4)Provision for income taxes
$20.4 $12.0 $43.1 $17.2 Net of tax
Loss on available-for-sale investments$(3.8)$(5.1)$(7.8)$(9.9)Interest income, net
0.9 1.2 1.9 2.4 Provision for income taxes
$(2.9)$(3.9)$(5.9)$(7.5)Net of tax
XML 41 R20.htm IDEA: XBRL DOCUMENT v3.23.2
EARNINGS PER SHARE
 6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Basic:    
Net income attributable to Edwards Lifesciences Corporation$307.1 $406.4 $647.6 $780.0 
Weighted-average shares outstanding606.9 620.9 607.2 621.5 
Basic earnings per share$0.51 $0.65 $1.07 $1.26 
Diluted:    
Net income attributable to Edwards Lifesciences Corporation$307.1 $406.4 $647.6 $780.0 
Weighted-average shares outstanding606.9 620.9 607.2 621.5 
Dilutive effect of stock plans3.4 5.8 3.4 6.6 
Dilutive weighted-average shares outstanding610.3 626.7 610.6 628.1 
Diluted earnings per share$0.50 $0.65 $1.06 $1.24 
Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 6.7 million and 3.6 million common shares for the three months ended June 30, 2023 and 2022, respectively, and 5.9 million and 2.6 million shares for the six months ended June 30, 2023 and 2022, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive.
XML 42 R21.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAXES
 6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The Company's effective income tax rates were 9.7% and 12.5% for the three months ended June 30, 2023 and 2022, respectively, and 12.4% and 13.4% for the six months ended June 30, 2023 and 2022, respectively. The decrease in the effective rate between the six months ended June 30, 2023 and 2022 is primarily due to an increase in the benefit from the federal research and development credit and the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation. In addition, the effective rates for the six months ended June 30, 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. The effective rates include a tax benefit from employee share-based compensation of $9.3 million and $19.8 million for the three months ended June 30, 2023 and 2022, respectively, and $12.3 million and $33.2 million for the six months ended June 30, 2023 and 2022, respectively.

In the normal course of business, the Internal Revenue Service (“IRS”) and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.

As of June 30, 2023 and December 31, 2022, the gross liability recorded for income taxes associated with uncertain tax positions was $520.0 million and $475.3 million, respectively. The Company estimates that these liabilities would be reduced by $205.1 million and $182.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $314.9 million and $293.2 million, respectively, if not required, would favorably affect the Company's effective tax rate.

The Company executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively “Surgical/TAVR”) intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all of the APAs which cover transactions with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. The execution of some or all of these APA renewals depends on many variables outside of the Company's control.

The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters. The IRS began its examination of the 2018 through 2020 tax years during the first quarter of 2022.

The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010 and on.

During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015-2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed an increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $220 million and reflects a significant departure from the transfer pricing methods the Company had previously agreed upon with the IRS for these types of transactions. The Company disagreed with the NOPA and submitted a formal protest on the matter during the fourth quarter of 2021. During the second quarter of 2022, the Company received the IRS's rebuttal to the Company's protest and was notified that the case had been transferred to the IRS Independent Office of Appeals ("Appeals"). The opening conference was held with Appeals during March 2023 and discussions with Appeals continued throughout the second quarter of 2023. While Appeals still maintains
jurisdiction over the matter as of June 30, 2023, the Company and Appeals have now concluded that a satisfactory resolution of this matter at the administrative level is not possible.

The Company now plans to vigorously contest the proposed adjustments through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate based on prior experience and interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOPA received or as a result of the Appeals proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018-2023 tax years. While no payment of any amount related to the NOPA has yet been required, the Company made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any potential deficiency that may be ultimately sustained.

Surgical/TAVR intercompany royalty transactions covering tax years 2018-2023 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of June 30, 2023. The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.
XML 43 R22.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT INFORMATION
 6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.

Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Segment Net Sales    
United States$895.3 $800.8 $1,744.4 $1,550.3 
Europe336.0 309.8 671.4 609.9 
Japan109.7 145.1 214.0 286.0 
Rest of World182.2 145.9 347.8 288.2 
Total segment net sales$1,523.2 $1,401.6 $2,977.6 $2,734.4 
Segment Operating Income    
United States$592.4 $549.5 $1,155.8 $1,061.0 
Europe177.7 164.5 359.4 331.1 
Japan63.4 95.9 126.8 195.4 
Rest of World80.1 54.6 150.6 114.3 
Total segment operating income$913.6 $864.5 $1,792.6 $1,701.8 
The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Net Sales Reconciliation    
Segment net sales$1,523.2 $1,401.6 $2,977.6 $2,734.4 
Foreign currency7.0 (27.7)12.2 (19.3)
Consolidated net sales$1,530.2 $1,373.9 $2,989.8 $2,715.1 
Pre-tax Income Reconciliation    
Segment operating income$913.6 $864.5 $1,792.6 $1,701.8 
Unallocated amounts:    
Corporate items(492.4)(450.4)(961.3)(869.8)
Intellectual property agreement and litigation expense(147.9)(6.1)(191.4)(13.2)
Change in fair value of contingent consideration liabilities26.9 20.9 26.2 23.8 
Foreign currency27.0 30.6 49.5 55.7 
Consolidated operating income327.2 459.5 715.6 898.3 
Non-operating income11.3 5.2 21.5 2.5 
Consolidated pre-tax income$338.5 $464.7 $737.1 $900.8 
Enterprise-wide Information
(in millions)

The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Net Sales by Geographic Region    
United States$895.3 $800.8 $1,744.4 $1,550.3 
Europe336.2 302.8 667.3 613.9 
Japan117.9 122.9 232.0 258.4 
Rest of World180.8 147.4 346.1 292.5 
$1,530.2 $1,373.9 $2,989.8 $2,715.1 
Net Sales by Major Product Group    
Transcatheter Aortic Valve Replacement$991.6 $906.9 $1,939.5 $1,788.2 
Transcatheter Mitral and Tricuspid Therapies47.6 27.9 89.2 54.9 
Surgical Structural Heart256.3 228.5 504.5 449.3 
Critical Care234.7 210.6 456.6 422.7 
$1,530.2 $1,373.9 $2,989.8 $2,715.1 
XML 44 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Pay vs Performance Disclosure        
Net Income (Loss) $ 307.1 $ 406.4 $ 647.6 $ 780.0
XML 45 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Insider Trading Arrangements - Daveen Chopra [Member]
 3 Months Ended 6 Months Ended
Jun. 30, 2023
shares
Jun. 30, 2023
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   On May 30, 2023, Daveen Chopra, Corporate Vice President of TMTT, entered into a 10b5-1 trading plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the potential sale of 20,500 shares of the Company’s stock commencing September 6, 2023. The Plan terminates on the earlier of March 6, 2024 or the date all shares are sold.
Name Daveen Chopra  
Title Corporate Vice President of TMTT  
Rule 10b5-1 Arrangement Adopted true  
Non-Rule 10b5-1 Arrangement Adopted false  
Adoption Date May 30, 2023  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Arrangement Duration 182 days  
Aggregate Available 20,500 20,500
XML 46 R25.htm IDEA: XBRL DOCUMENT v3.23.2
BASIS OF PRESENTATION (Policies)
 6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.
Consolidation The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.
New Accounting Standards Not Yet Adopted
New Accounting Standards Not Yet Adopted

In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.
XML 47 R26.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)
 6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Components of selected captions in the consolidated condensed balance sheets consisted of the following:
June 30, 2023December 31, 2022
Inventories
Raw materials$181.2 $156.4 
Work in process223.0 177.4 
Finished products576.0 541.7 
$980.2 $875.5 
Schedule of Accrued and Other Liabilities
June 30, 2023December 31, 2022
Accrued and other liabilities 
Employee compensation and withholdings$312.7 $268.7 
Taxes payable106.6 50.6 
Property, payroll, and other taxes56.1 45.6 
Research and development accruals70.7 66.9 
Accrued rebates130.1 116.1 
Fair value of derivatives17.8 20.7 
Accrued marketing expenses16.9 17.0 
Legal and insurance30.4 28.1 
Litigation settlement (a)
69.2 53.3 
Accrued relocation costs23.3 25.2 
Accrued professional services10.2 6.6 
Accrued realignment reserves14.4 15.6 
Other accrued liabilities81.5 80.6 
$939.9 $795.0 
_______________________________________
(a)     As of June 30, 2023, $69.2 million was accrued in "Accrued and Other Liabilities" and $112.5 million was accrued in "Litigation Settlement Accrual" on the consolidated condensed balance sheet related to a settlement agreement with Abbott Laboratories and its direct and indirect subsidiaries.
Schedule of Supplemental Cash Flow Information
Supplemental Cash Flow Information
(in millions)
Six Months Ended
June 30,
20232022
Cash paid during the year for:
Income taxes$193.5 $173.0 
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$14.3 $14.5 
Non-cash investing and financing transactions:  
Right-of-use assets obtained in exchange for new lease liabilities$6.0 $10.6 
Capital expenditures accruals$26.9 $24.6 
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents, and Restricted Cash
(in millions)
June 30, 2023December 31, 2022
Cash and cash equivalents$1,042.6 $769.0 
Restricted cash included in other current assets1.4 0.5 
Restricted cash included in other assets3.5 3.1 
Total cash, cash equivalents, and restricted cash$1,047.5 $772.6 
Schedule of Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
(in millions)
June 30, 2023December 31, 2022
Cash and cash equivalents$1,042.6 $769.0 
Restricted cash included in other current assets1.4 0.5 
Restricted cash included in other assets3.5 3.1 
Total cash, cash equivalents, and restricted cash$1,047.5 $772.6 
XML 48 R27.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS (Tables)
 6 Months Ended
Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
Schedule of Investments in Debt Securities
Investments in debt securities at the end of each period were as follows (in millions):
 June 30, 2023December 31, 2022
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$28.1 $— $— $28.1 $96.0 $— $— $96.0 
Available-for-sale
U.S. government and agency securities103.4 — (5.0)98.4 137.7 — (6.1)131.6 
Asset-backed securities262.5 — (10.0)252.5 380.6 — (14.0)366.6 
Corporate debt securities864.9 — (34.0)830.9 1,028.1 — (47.8)980.3 
Municipal securities2.8 — (0.2)2.6 2.7 — (0.2)2.5 
Total$1,233.6 $— $(49.2)$1,184.4 $1,549.1 $— $(68.1)$1,481.0 
Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity
The cost and fair value of investments in debt securities, by contractual maturity, as of June 30, 2023, were as follows:
Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$26.3 $26.3 $450.9 $440.4 
Due after 1 year through 5 years1.8 1.8 472.0 446.7 
Due after 5 years through 10 years— — 4.6 4.4 
Instruments not due at a single maturity date (a)
— — 306.1 292.9 
$28.1 $28.1 $1,233.6 $1,184.4 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.
Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position
The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2023 and December 31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):

June 30, 2023
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$10.9 $(0.1)$86.2 $(4.9)$97.1 $(5.0)
Asset-backed securities50.9 (0.8)199.9 (9.2)250.8 (10.0)
Corporate debt securities23.3 (0.1)793.3 (33.9)816.6 (34.0)
Municipal securities— — 2.6 (0.2)2.6 (0.2)
$85.1 $(1.0)$1,082.0 $(48.2)$1,167.1 $(49.2)
December 31, 2022
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$61.6 $(1.5)$69.5 $(4.6)$131.1 $(6.1)
Asset-backed securities103.3 (1.3)254.6 (12.7)357.9 (14.0)
Corporate debt securities189.0 (5.3)784.8 (42.5)973.8 (47.8)
Municipal securities— — 2.5 (0.2)2.5 (0.2)
$353.9 $(8.1)$1,111.4 $(60.0)$1,465.3 $(68.1)
Schedule of Investments in Unconsolidated Affiliates These investments are recorded in "Long-term Investments" on the consolidated condensed balance sheets, and are as follows:
 June 30,
2023		December 31,
2022
 (in millions)
Equity method investments  
Carrying value of equity method investments$23.5 $21.4 
Equity securities  
Carrying value of non-marketable equity securities86.9 86.9 
Total investments in unconsolidated entities$110.4 $108.3 
XML 49 R28.htm IDEA: XBRL DOCUMENT v3.23.2
BUSINESS COMBINATION (Tables)
 6 Months Ended
Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Summary of Fair Values of Assets Acquired and Liabilities Assumed The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):
Assets$8.1 
Goodwill133.2 
In-process research and development136.6 
Liabilities assumed(1.7)
Deferred tax liabilities(28.0)
Fair value of net assets acquired248.2 
Less: Noncontrolling interest (a)
(72.4)
Total purchase price
175.8 
Less: cash acquired(6.8)
Total purchase price, net of cash acquired (b)
$169.0 
_______________________________________
(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.
(b)     Includes $22.5 million paid in a previous year under option agreements and $5.3 million for the settlement of a pre-existing note.
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS (Tables)
 6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
June 30, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$635.0 $— $— $635.0 
Available-for-sale investments:
Corporate debt securities
— 830.9 — 830.9 
Asset-backed securities
— 252.5 — 252.5 
United States government and agency securities— 98.4 — 98.4 
Municipal securities
— 2.6 — 2.6 
Investments held for deferred compensation plans125.3 — — 125.3 
Derivatives— 63.9 — 63.9 
$760.3 $1,248.3 $— $2,008.6 
Liabilities    
Derivatives$— $17.8 $— $17.8 
Other liability— — 14.0 14.0 
$— $17.8 $14.0 $31.8 
December 31, 2022    
Assets    
Cash equivalents$280.4 $— $— $280.4 
Available-for-sale investments:
Corporate debt securities
— 980.3 — 980.3 
Asset-backed securities
— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities
— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$429.6 $1,509.4 $— $1,939.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other liability— — 14.0 14.0 
$— $27.2 $40.2 $67.4 
Schedule of Changes in Fair Value of Contingent Consideration Obligation The following tables summarize the changes in fair value of the contingent consideration and the other liability (in millions):
 Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)— (26.2)
Balance at June 30, 2023$— $14.0 $14.0 
Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(23.8)— (23.8)
Balance at June 30, 2022$38.2 $14.0 $52.2 
XML 51 R30.htm IDEA: XBRL DOCUMENT v3.23.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 6 Months Ended
Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk
The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
 June 30, 2023December 31, 2022
 (in millions)
Foreign currency forward exchange contracts$1,763.7 $1,678.4 
Cross currency swap contracts300.0 300.0 
Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets
The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):
  Fair Value
Derivatives designated as hedging instrumentsBalance Sheet
Location		June 30, 2023December 31, 2022
Assets   
Foreign currency contractsOther current assets$32.2 $24.9 
Cross currency swap contractsOther assets$31.7 $40.6 
Liabilities   
Foreign currency contractsAccrued and other liabilities$17.8 $20.7 
Foreign currency contractsOther liabilities$— $6.5 
Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets
The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):
    Gross Amounts
Not Offset in
the Consolidated
Balance Sheet		 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		 
  Net Amounts
Presented in the
Consolidated
Balance Sheet
June 30, 2023Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative assets      
Foreign currency contracts$32.2 $— $32.2 $(8.6)$— $23.6 
Cross currency swap contracts$31.7 $— $31.7 $— $— $31.7 
Derivative liabilities      
Foreign currency contracts$17.8 $— $17.8 $(8.6)$— $9.2 
December 31, 2022      
Derivative assets      
Foreign currency contracts$24.9 $— $24.9 $(12.0)$— $12.9 
Cross currency swap contracts$40.6 $— $40.6 $— $— $40.6 
Derivative liabilities   
Foreign currency contracts$27.2 $— $27.2 $(12.0)$— $15.2 
Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities
The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):
    Gross Amounts
Not Offset in
the Consolidated
Balance Sheet		 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		 
  Net Amounts
Presented in the
Consolidated
Balance Sheet
June 30, 2023Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative assets      
Foreign currency contracts$32.2 $— $32.2 $(8.6)$— $23.6 
Cross currency swap contracts$31.7 $— $31.7 $— $— $31.7 
Derivative liabilities      
Foreign currency contracts$17.8 $— $17.8 $(8.6)$— $9.2 
December 31, 2022      
Derivative assets      
Foreign currency contracts$24.9 $— $24.9 $(12.0)$— $12.9 
Cross currency swap contracts$40.6 $— $40.6 $— $— $40.6 
Derivative liabilities   
Foreign currency contracts$27.2 $— $27.2 $(12.0)$— $15.2 
Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
 Three Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Three Months Ended
June 30,
 
2023202220232022
Cash flow hedges
Foreign currency contracts$23.2 $57.9 Cost of sales$13.9 $16.3 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
 Six Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Six Months Ended
June 30,
 
2023202220232022
Cash flow hedges
Foreign currency contracts$26.9 $82.6 Cost of sales$43.7 $23.6 

 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
Effectiveness Testing)
 Three Months Ended
June 30,		 Location of Gain or
(Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)		Three Months Ended
June 30,
 
2023202220232022
Net investment hedges
Cross currency swap contracts$(6.5)$19.4 Interest income, net$1.8 $2.0 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		 Amount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
 Six Months Ended
June 30,		 Location of Gain or
(Loss) Reclassified from
Accumulated OCI
into Income		Six Months Ended
June 30,
 
2023202220232022
Net investment hedges
Cross currency swap contracts$(9.0)$23.3 Interest income, net$3.5 $3.6 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Three Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Fair value hedges
Foreign currency contractsOther income, net$11.3 $— 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Six Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Fair value hedges
Foreign currency contractsOther income, net$11.3 $— 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Three Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$9.9 $26.6 
  Amount of Gain or (Loss)
Recognized in Income on
Derivative
  Six Months Ended
June 30,
 Location of Gain or (Loss)
Recognized in Income on
Derivative
20232022
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$4.5 $42.1 
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):
 Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Three Months Ended
June 30, 2023		Six Months Ended
June 30, 2023
 Cost of salesOther income, netCost of salesOther income, net
Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded$(343.0)$2.2 $(672.5)$3.8 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
$— $(10.1)$— $(8.9)
Derivatives designated as hedging instruments
$— $10.1 $— $8.9 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
$— $1.2 $— $2.4 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
$13.9 $— $43.7 $— 
 Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Three Months Ended
June 30, 2022		Six Months Ended
June 30, 2022
 Cost of salesCost of sales
Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded$(269.4)$(568.7)
The effects of fair value and cash flow hedging:
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
$16.3 $23.6 
XML 52 R31.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION (Tables)
 6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and six months ended June 30, 2023 and 2022 was as follows (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Cost of sales$6.2 $6.9 $13.2 $13.1 
Selling, general, and administrative expenses22.5 21.1 44.8 39.8 
Research and development expenses8.7 8.2 18.3 15.7 
Total stock-based compensation expense37.4 36.2 76.3 68.6 
Income tax benefit(6.8)(5.9)(11.5)(10.3)
Total stock-based compensation expense, net of tax$30.6 $30.3 $64.8 $58.3 
Schedule of Weighted-Average Assumptions for Options Granted
The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
 Option Awards
Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Risk-free interest rate3.4 %3.0 %3.4 %3.0 %
Expected dividend yieldNoneNoneNoneNone
Expected volatility32.8 %31.4 %32.8 %31.4 %
Expected term (years)5.15.05.15.0
Fair value, per option$31.03 $35.07 $31.01 $35.08 
Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted
The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:
 ESPP
Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Risk-free interest rate4.7 %1.1 %4.6 %0.3 %
Expected dividend yieldNoneNoneNoneNone
Expected volatility34.8 %31.5 %31.5 %32.1 %
Expected term (years)0.60.60.60.6
Fair value, per share$22.02 $23.63 $19.03 $28.63 
XML 53 R32.htm IDEA: XBRL DOCUMENT v3.23.2
ACCELERATED SHARE REPURCHASE (Tables)
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Schedule of Accelerated Share Repurchases The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share
January 2022$250.0 1.9 $104.87 80 %February 20222.3 $110.31 
February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 
XML 54 R33.htm IDEA: XBRL DOCUMENT v3.23.2
ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss
The following tables summarize the activity for each component of "Accumulated Other Comprehensive Loss" (in millions):
 Foreign
Currency
Translation
Adjustments		Unrealized Gain on Hedges
Unrealized Loss on Available-for-sale Investments		Unrealized
Pension
Credits		Total
Accumulated
Other
Comprehensive
Loss
December 31, 2022$(218.8)$23.8 $(65.6)$5.7 $(254.9)
Other comprehensive gain (loss) before reclassifications4.9 6.7 9.0 (0.1)20.5 
Amounts reclassified from accumulated other comprehensive loss(1.7)(29.8)4.0 — (27.5)
Deferred income tax benefit 0.6 5.9 — — 6.5 
March 31, 2023$(215.0)$6.6 $(52.6)$5.6 $(255.4)
Other comprehensive (loss) gain before reclassifications(11.3)33.5 2.1 0.2 24.5 
Amounts reclassified from accumulated other comprehensive loss(1.8)(25.2)3.8 — (23.2)
Deferred income tax benefit (expense)1.6 (3.0)— — (1.4)
June 30, 2023$(226.5)$11.9 $(46.7)$5.8 $(255.5)

 Foreign
Currency
Translation
Adjustments		Unrealized Gain on Hedges
Unrealized Loss on Available-for-sale Investments		Unrealized
Pension
Costs		Total
Accumulated
Other
Comprehensive
Loss
December 31, 2021$(172.5)$29.7 $(6.9)$(8.0)$(157.7)
Other comprehensive (loss) gain before reclassifications(7.4)24.7 (47.6)— (30.3)
Amounts reclassified from accumulated other comprehensive loss(1.6)(7.3)4.8 — (4.1)
Deferred income tax (expense) benefit(1.0)(4.0)10.5 — 5.5 
March 31, 2022$(182.5)$43.1 $(39.2)$(8.0)$(186.6)
Other comprehensive (loss) gain before reclassifications(36.5)57.9 (20.9)(0.1)0.4 
Amounts reclassified from accumulated other comprehensive loss(2.0)(16.3)5.1 — (13.2)
Deferred income tax expense(4.7)(10.3)(10.0)— (25.0)
June 30, 2022$(225.7)$74.4 $(65.0)$(8.1)$(224.4)
Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss
The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,		 
 Affected Line on Consolidated Condensed
Statements of Operations
Details about Accumulated Other
Comprehensive Loss Components
2023202220232022
Foreign currency translation adjustments$1.8 $2.0 $3.5 $3.6 Other income, net
(0.4)(0.5)(0.8)(0.9)Provision for income taxes
$1.4 $1.5 $2.7 $2.7 Net of tax
Gain on hedges$13.9 $16.3 $43.7 $23.6 Cost of sales
11.3 — 11.3 — Other income, net
25.2 16.3 55.0 23.6 Total before tax
(4.8)(4.3)(11.9)(6.4)Provision for income taxes
$20.4 $12.0 $43.1 $17.2 Net of tax
Loss on available-for-sale investments$(3.8)$(5.1)$(7.8)$(9.9)Interest income, net
0.9 1.2 1.9 2.4 Provision for income taxes
$(2.9)$(3.9)$(5.9)$(7.5)Net of tax
XML 55 R34.htm IDEA: XBRL DOCUMENT v3.23.2
EARNINGS PER SHARE (Tables)
 6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Basic:    
Net income attributable to Edwards Lifesciences Corporation$307.1 $406.4 $647.6 $780.0 
Weighted-average shares outstanding606.9 620.9 607.2 621.5 
Basic earnings per share$0.51 $0.65 $1.07 $1.26 
Diluted:    
Net income attributable to Edwards Lifesciences Corporation$307.1 $406.4 $647.6 $780.0 
Weighted-average shares outstanding606.9 620.9 607.2 621.5 
Dilutive effect of stock plans3.4 5.8 3.4 6.6 
Dilutive weighted-average shares outstanding610.3 626.7 610.6 628.1 
Diluted earnings per share$0.50 $0.65 $1.06 $1.24 
XML 56 R35.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT INFORMATION (Tables)
 6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Segment Net Sales    
United States$895.3 $800.8 $1,744.4 $1,550.3 
Europe336.0 309.8 671.4 609.9 
Japan109.7 145.1 214.0 286.0 
Rest of World182.2 145.9 347.8 288.2 
Total segment net sales$1,523.2 $1,401.6 $2,977.6 $2,734.4 
Segment Operating Income    
United States$592.4 $549.5 $1,155.8 $1,061.0 
Europe177.7 164.5 359.4 331.1 
Japan63.4 95.9 126.8 195.4 
Rest of World80.1 54.6 150.6 114.3 
Total segment operating income$913.6 $864.5 $1,792.6 $1,701.8 
The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Net Sales Reconciliation    
Segment net sales$1,523.2 $1,401.6 $2,977.6 $2,734.4 
Foreign currency7.0 (27.7)12.2 (19.3)
Consolidated net sales$1,530.2 $1,373.9 $2,989.8 $2,715.1 
Pre-tax Income Reconciliation    
Segment operating income$913.6 $864.5 $1,792.6 $1,701.8 
Unallocated amounts:    
Corporate items(492.4)(450.4)(961.3)(869.8)
Intellectual property agreement and litigation expense(147.9)(6.1)(191.4)(13.2)
Change in fair value of contingent consideration liabilities26.9 20.9 26.2 23.8 
Foreign currency27.0 30.6 49.5 55.7 
Consolidated operating income327.2 459.5 715.6 898.3 
Non-operating income11.3 5.2 21.5 2.5 
Consolidated pre-tax income$338.5 $464.7 $737.1 $900.8 
Schedule of Enterprise-Wide Information
The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.
 Three Months Ended
June 30,		Six Months Ended
June 30,
 2023202220232022
Net Sales by Geographic Region    
United States$895.3 $800.8 $1,744.4 $1,550.3 
Europe336.2 302.8 667.3 613.9 
Japan117.9 122.9 232.0 258.4 
Rest of World180.8 147.4 346.1 292.5 
$1,530.2 $1,373.9 $2,989.8 $2,715.1 
Net Sales by Major Product Group    
Transcatheter Aortic Valve Replacement$991.6 $906.9 $1,939.5 $1,788.2 
Transcatheter Mitral and Tricuspid Therapies47.6 27.9 89.2 54.9 
Surgical Structural Heart256.3 228.5 504.5 449.3 
Critical Care234.7 210.6 456.6 422.7 
$1,530.2 $1,373.9 $2,989.8 $2,715.1 
XML 57 R36.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Inventory (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Inventories    
Raw materials $ 181.2 $ 156.4
Work in process 223.0 177.4
Finished products 576.0 541.7
Total inventories 980.2 875.5
Finished products inventories held on consignment $ 149.7 $ 128.6
XML 58 R37.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Accrued Liabilities and Long Term Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Accrued and other liabilities    
Employee compensation and withholdings $ 312.7 $ 268.7
Taxes payable 106.6 50.6
Property, payroll, and other taxes 56.1 45.6
Research and development accruals 70.7 66.9
Accrued rebates 130.1 116.1
Fair value of derivatives 17.8 20.7
Accrued marketing expenses 16.9 17.0
Legal and insurance 30.4 28.1
Litigation settlement 69.2 53.3
Accrued relocation costs 23.3 25.2
Accrued professional services 10.2 6.6
Accrued realignment reserves 14.4 15.6
Other accrued liabilities 81.5 80.6
Total accrued and other liabilities 939.9 795.0
Litigation settlement accrual $ 112.5 $ 143.0
XML 59 R38.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash paid during the year for:    
Income taxes $ 193.5 $ 173.0
Amounts included in the measurement of lease liabilities:    
Operating cash flows from operating leases 14.3 14.5
Non-cash investing and financing transactions:    
Right-of-use assets obtained in exchange for new lease liabilities 6.0 10.6
Capital expenditures accruals $ 26.9 $ 24.6
XML 60 R39.htm IDEA: XBRL DOCUMENT v3.23.2
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 1,042.6 $ 769.0    
Restricted cash included in other current assets 1.4 0.5    
Restricted cash included in other assets 3.5 3.1    
Total cash, cash equivalents, and restricted cash $ 1,047.5 $ 772.6 $ 1,202.9 $ 867.4
XML 61 R40.htm IDEA: XBRL DOCUMENT v3.23.2
INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE - Narrative (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 6 Months Ended
Apr. 12, 2023
Apr. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Loss Contingencies [Line Items]              
Intellectual property agreement term 15 years            
Intellectual property litigation expense       $ 147.9 $ 6.1 $ 191.4 $ 13.2
Medtronic Inc              
Loss Contingencies [Line Items]              
Payments for legal settlements $ 300.0            
Intellectual property litigation expense   $ 139.0 $ 37.0        
Prepaid royalty asset   $ 124.0          
XML 62 R41.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS - Investments in Debt Securities (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Held-to-maturity    
Fair Value $ 28.1  
Available-for-sale    
Amortized Cost 1,233.6 $ 1,549.1
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (49.2) (68.1)
Fair Value 1,184.4 1,481.0
Bank time deposits    
Held-to-maturity    
Amortized Cost 28.1 96.0
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 28.1 96.0
U.S. government and agency securities    
Available-for-sale    
Amortized Cost 103.4 137.7
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (5.0) (6.1)
Fair Value 98.4 131.6
Asset-backed securities    
Available-for-sale    
Amortized Cost 262.5 380.6
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (10.0) (14.0)
Fair Value 252.5 366.6
Corporate debt securities    
Available-for-sale    
Amortized Cost 864.9 1,028.1
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (34.0) (47.8)
Fair Value 830.9 980.3
Municipal securities    
Available-for-sale    
Amortized Cost 2.8 2.7
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (0.2) (0.2)
Fair Value $ 2.6 $ 2.5
XML 63 R42.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS - Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Amortized Cost    
Due in 1 year or less $ 26.3  
Due after 1 year through 5 years 1.8  
Due after 5 years through 10 years 0.0  
Instruments not due at a single maturity date 0.0  
Amortized Cost 28.1  
Fair Value    
Due in 1 year or less 26.3  
Due after 1 year through 5 years 1.8  
Due after 5 years through 10 years 0.0  
Instruments not due at a single maturity date 0.0  
Fair Value 28.1  
Amortized Cost    
Due in 1 year or less 450.9  
Due after 1 year through 5 years 472.0  
Due after 5 years through 10 years 4.6  
Instruments not due at a single maturity date 306.1  
Amortized Cost 1,233.6 $ 1,549.1
Fair Value    
Due in 1 year or less 440.4  
Due after 1 year through 5 years 446.7  
Due after 5 years through 10 years 4.4  
Instruments not due at a single maturity date 292.9  
Fair Value $ 1,184.4 $ 1,481.0
XML 64 R43.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS - Investments in Continuous Loss Position (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months $ 85.1 $ 353.9
Gross unrealized losses, less than 12 months (1.0) (8.1)
Fair value, 12 months or greater 1,082.0 1,111.4
Gross unrealized losses, 12 months or greater (48.2) (60.0)
Fair value, total 1,167.1 1,465.3
Gross unrealized losses, total (49.2) (68.1)
U.S. government and agency securities    
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months 10.9 61.6
Gross unrealized losses, less than 12 months (0.1) (1.5)
Fair value, 12 months or greater 86.2 69.5
Gross unrealized losses, 12 months or greater (4.9) (4.6)
Fair value, total 97.1 131.1
Gross unrealized losses, total (5.0) (6.1)
Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months 50.9 103.3
Gross unrealized losses, less than 12 months (0.8) (1.3)
Fair value, 12 months or greater 199.9 254.6
Gross unrealized losses, 12 months or greater (9.2) (12.7)
Fair value, total 250.8 357.9
Gross unrealized losses, total (10.0) (14.0)
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months 23.3 189.0
Gross unrealized losses, less than 12 months (0.1) (5.3)
Fair value, 12 months or greater 793.3 784.8
Gross unrealized losses, 12 months or greater (33.9) (42.5)
Fair value, total 816.6 973.8
Gross unrealized losses, total (34.0) (47.8)
Municipal securities    
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months 0.0 0.0
Gross unrealized losses, less than 12 months 0.0 0.0
Fair value, 12 months or greater 2.6 2.5
Gross unrealized losses, 12 months or greater (0.2) (0.2)
Fair value, total 2.6 2.5
Gross unrealized losses, total $ (0.2) $ (0.2)
XML 65 R44.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS - Investments in Unconsolidated Entities (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Equity method investments    
Carrying value of equity method investments $ 23.5 $ 21.4
Equity securities    
Carrying value of non-marketable equity securities 86.9 86.9
Total investments in unconsolidated entities $ 110.4 $ 108.3
XML 66 R45.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS - Narrative (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Debt and Equity Securities, FV-NI [Line Items]    
Carrying value of equity method investments $ 23.5 $ 21.4
Other income, net    
Debt and Equity Securities, FV-NI [Line Items]    
Increase in non-marketable equity securities due to observable price changes 8.8  
Decrease in non-marketable equity securities due to observable price changes $ 3.1  
Limited Liability Company    
Debt and Equity Securities, FV-NI [Line Items]    
Investments taken period 7 years  
Limited Liability Company | New Markets Tax Credit    
Debt and Equity Securities, FV-NI [Line Items]    
Carrying value of equity method investments $ 1.7  
Investment percentage (in percent) 39.00%  
XML 67 R46.htm IDEA: XBRL DOCUMENT v3.23.2
INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) - USD ($)
$ in Millions
 1 Months Ended 4 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2023
Mar. 31, 2023
Aug. 31, 2022
Jun. 30, 2022
May 31, 2022
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2021
Dec. 31, 2019
Jan. 31, 2023
Dec. 31, 2022
Variable Interest Entity [Line Items]                        
Payment for option to acquire company             $ 15.0 $ 55.5        
Carrying value of non-marketable equity securities           $ 86.9 86.9         $ 86.9
Investee                        
Variable Interest Entity [Line Items]                        
Secured promissory note                     $ 10.0  
Maximum secured promissory note                     $ 45.0  
Investee drew additional amount $ 7.5                      
Carrying value of non-marketable equity securities                 $ 39.3      
Investment option to acquire                 13.1      
Maximum additional option to acquire investment                 14.4      
Investee | Equity Securities                        
Variable Interest Entity [Line Items]                        
Maximum additional required investment                 6.5      
Investee | Variable Interest Entity, Not Primary Beneficiary                        
Variable Interest Entity [Line Items]                        
Loans receivables, maximum lending amount   $ 45.0   $ 47.5                
Payment for option to acquire company     $ 47.1     15.0       $ 35.0    
Financing receivable           32.5 32.5          
Option to acquire investment amount     $ 47.1     $ 35.0 $ 35.0          
Investee | Variable Interest Entity, Not Primary Beneficiary | Convertible Promissory Note                        
Variable Interest Entity [Line Items]                        
Financing receivable   $ 5.0                    
Medical Technology Company | Variable Interest Entity, Not Primary Beneficiary                        
Variable Interest Entity [Line Items]                        
Payment for option to acquire company         $ 60.0       $ 10.0      
Option to acquire investment amount         $ 60.0              
XML 68 R47.htm IDEA: XBRL DOCUMENT v3.23.2
BUSINESS COMBINATION - Narrative (Details)
Feb. 28, 2023
Medical Technology Company | Variable Interest Entity, Primary Beneficiary  
Business Acquisition [Line Items]  
Percentage of interest acquired 61.00%
XML 69 R48.htm IDEA: XBRL DOCUMENT v3.23.2
BUSINESS COMBINATION - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
 6 Months Ended
Feb. 28, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Business Acquisition [Line Items]        
Goodwill   $ 1,299.5   $ 1,164.3
Payment for option to acquire company   $ 15.0 $ 55.5  
Medical Technology Company | Variable Interest Entity, Primary Beneficiary        
Business Acquisition [Line Items]        
Assets $ 8.1      
Goodwill 133.2      
In-process research and development 136.6      
Liabilities assumed (1.7)      
Deferred tax liabilities (28.0)      
Fair value of net assets acquired 248.2      
Less: Noncontrolling interest (72.4)      
Total purchase price 175.8      
Less: cash acquired (6.8)      
Total purchase price, net of cash acquired 169.0      
Noncontrolling interest, gross 94.4      
Noncontrolling interest, option adjustment 22.0      
Payment for option to acquire company 22.5      
Repayments of pre-existing notes $ 5.3      
XML 70 R49.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS - Narrative (Details)
Jun. 30, 2023
USD ($)
Contingent Consideration  
Financial instruments  
Contingent consideration liability $ 0
Probability of Milestone Achievement | Contingent Consideration  
Financial instruments  
Contingent consideration liability measurement input 0
Level 2  
Financial instruments  
Notes payable fair value disclosure $ 580,500,000
XML 71 R50.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Assets    
Available-for-sale investments: $ 1,184.4 $ 1,481.0
Corporate debt securities    
Assets    
Available-for-sale investments: 830.9 980.3
Asset-backed securities    
Assets    
Available-for-sale investments: 252.5 366.6
United States government and agency securities    
Assets    
Available-for-sale investments: 98.4 131.6
Municipal securities    
Assets    
Available-for-sale investments: 2.6 2.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis    
Assets    
Cash equivalents 635.0 280.4
Investments held for deferred compensation plans 125.3 112.1
Derivatives 63.9 65.5
Assets 2,008.6 1,939.0
Liabilities    
Derivatives 17.8 27.2
Contingent consideration liabilities   26.2
Other liability 14.0 14.0
Liabilities 31.8 67.4
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Corporate debt securities    
Assets    
Available-for-sale investments: 830.9 980.3
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Asset-backed securities    
Assets    
Available-for-sale investments: 252.5 366.6
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | United States government and agency securities    
Assets    
Available-for-sale investments: 98.4 131.6
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Municipal securities    
Assets    
Available-for-sale investments: 2.6 2.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1    
Assets    
Cash equivalents 635.0 280.4
Investments held for deferred compensation plans 125.3 112.1
Derivatives 0.0 0.0
Assets 760.3 429.6
Liabilities    
Derivatives 0.0 0.0
Contingent consideration liabilities   0.0
Other liability 0.0 0.0
Liabilities 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Corporate debt securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Asset-backed securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | United States government and agency securities    
Assets    
Available-for-sale investments: 0.0 37.1
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Municipal securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2    
Assets    
Cash equivalents 0.0 0.0
Investments held for deferred compensation plans 0.0 0.0
Derivatives 63.9 65.5
Assets 1,248.3 1,509.4
Liabilities    
Derivatives 17.8 27.2
Contingent consideration liabilities   0.0
Other liability 0.0 0.0
Liabilities 17.8 27.2
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Corporate debt securities    
Assets    
Available-for-sale investments: 830.9 980.3
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Asset-backed securities    
Assets    
Available-for-sale investments: 252.5 366.6
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | United States government and agency securities    
Assets    
Available-for-sale investments: 98.4 94.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Municipal securities    
Assets    
Available-for-sale investments: 2.6 2.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3    
Assets    
Cash equivalents 0.0 0.0
Investments held for deferred compensation plans 0.0 0.0
Derivatives 0.0 0.0
Assets 0.0 0.0
Liabilities    
Derivatives 0.0 0.0
Contingent consideration liabilities   26.2
Other liability 14.0 14.0
Liabilities 14.0 40.2
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Corporate debt securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Asset-backed securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | United States government and agency securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Municipal securities    
Assets    
Available-for-sale investments: $ 0.0 $ 0.0
XML 72 R51.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS - Changes in Fair Value of Contingent Consideration Obligation (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ 40.2 $ 76.0
Changes in fair value (26.2) (23.8)
Ending balance 14.0 52.2
Contingent Consideration    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance 26.2 62.0
Changes in fair value (26.2) (23.8)
Ending balance 0.0 38.2
Other liability    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance 14.0 14.0
Changes in fair value 0.0 0.0
Ending balance $ 14.0 $ 14.0
XML 73 R52.htm IDEA: XBRL DOCUMENT v3.23.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) - Derivatives designated as hedging instruments - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Foreign currency forward exchange contracts    
Derivative Financial Instruments    
Derivative notional amount $ 1,763.7 $ 1,678.4
Cross currency swap contracts    
Derivative Financial Instruments    
Derivative notional amount $ 300.0 $ 300.0
XML 74 R53.htm IDEA: XBRL DOCUMENT v3.23.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)
€ in Millions, $ in Millions
 6 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2023
EUR (€)
Dec. 31, 2022
USD ($)
Derivative Financial Instruments      
Changes due to currency rate movements and expenses expected to occur, maximum term 13 months    
Cash flow gain to be reclassified in the next twelve months $ 9.0    
Derivatives designated as hedging instruments | Cross currency swap contracts      
Derivative Financial Instruments      
Derivative liability, fair value 300.0   $ 300.0
Net investment hedges | Derivatives designated as hedging instruments | Cross currency swap contracts      
Derivative Financial Instruments      
Derivative liability, fair value $ 300.0 € 257.2  
XML 75 R54.htm IDEA: XBRL DOCUMENT v3.23.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Assets    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other current assets, Other assets (Note 5) Other current assets, Other assets (Note 5)
Liabilities    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other liabilities, Accrued and other liabilities (Note 2) Other liabilities, Accrued and other liabilities (Note 2)
Foreign currency contracts    
Assets    
Fair value of derivative assets $ 32.2 $ 24.9
Liabilities    
Fair value of derivative liabilities 17.8 27.2
Cross currency swap contracts    
Assets    
Fair value of derivative assets 31.7 40.6
Derivatives designated as hedging instruments | Foreign currency contracts    
Assets    
Fair value of derivative assets 32.2 24.9
Derivatives designated as hedging instruments | Foreign currency contracts | Accrued and other liabilities    
Liabilities    
Fair value of derivative liabilities 17.8 20.7
Derivatives designated as hedging instruments | Foreign currency contracts | Other liabilities    
Liabilities    
Fair value of derivative liabilities 0.0 6.5
Derivatives designated as hedging instruments | Cross currency swap contracts    
Assets    
Fair value of derivative assets $ 31.7 $ 40.6
XML 76 R55.htm IDEA: XBRL DOCUMENT v3.23.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Foreign currency contracts    
Derivative assets    
Gross Amounts $ 32.2 $ 24.9
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 32.2 24.9
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments (8.6) (12.0)
Cash Collateral Received 0.0 0.0
Net Amount 23.6 12.9
Derivative liabilities    
Gross Amounts 17.8 27.2
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 17.8 27.2
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments (8.6) (12.0)
Cash Collateral Received 0.0 0.0
Net Amount 9.2 15.2
Cross currency swap contracts    
Derivative assets    
Gross Amounts 31.7 40.6
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 31.7 40.6
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments 0.0 0.0
Cash Collateral Received 0.0 0.0
Net Amount $ 31.7 $ 40.6
XML 77 R56.htm IDEA: XBRL DOCUMENT v3.23.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Foreign currency contracts | Derivatives not designated as hedging instruments        
Derivative Instruments, Gain (Loss)        
Amount of Gain or (Loss) Recognized in Income on Derivative $ 9.9 $ 26.6 $ 4.5 $ 42.1
Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments        
Derivative Instruments, Gain (Loss)        
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) 23.2 57.9 26.9 82.6
Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments | Cost of sales        
Derivative Instruments, Gain (Loss)        
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) 13.9 16.3 43.7 23.6
Net investment hedges | Cross currency swap contracts | Derivatives designated as hedging instruments        
Derivative Instruments, Gain (Loss)        
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) (6.5) 19.4 (9.0) 23.3
Net investment hedges | Cross currency swap contracts | Derivatives designated as hedging instruments | Interest income, net        
Derivative Instruments, Gain (Loss)        
Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing) 1.8 2.0 3.5 3.6
Fair value hedges | Foreign currency contracts | Derivatives designated as hedging instruments        
Derivative Instruments, Gain (Loss)        
Amount of Gain or (Loss) Recognized in Income on Derivative $ 11.3 $ 0.0 $ 11.3 $ 0.0
XML 78 R57.htm IDEA: XBRL DOCUMENT v3.23.2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedge Effects on Statement of Operations (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Derivative Instruments, Gain (Loss)        
Cost of sales $ (343.0) $ (269.4) $ (672.5) $ (568.7)
Other income, net 2.2 4.3 3.8 1.0
Foreign currency contracts | Cost of sales        
Gain (loss) on fair value hedging relationships:        
Hedged items 0.0   0.0  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 0.0   0.0  
Gain (loss) on cash flow hedging relationships:        
Amount of gain (loss) reclassified from accumulated OCI into income 13.9 $ 16.3 43.7 $ 23.6
Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments        
Gain (loss) on fair value hedging relationships:        
Derivatives designated as hedging instruments 0.0   0.0  
Foreign currency contracts | Other income, net        
Gain (loss) on fair value hedging relationships:        
Hedged items (10.1)   (8.9)  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 1.2   2.4  
Gain (loss) on cash flow hedging relationships:        
Amount of gain (loss) reclassified from accumulated OCI into income 0.0   0.0  
Foreign currency contracts | Other income, net | Derivatives designated as hedging instruments        
Gain (loss) on fair value hedging relationships:        
Derivatives designated as hedging instruments $ 10.1   $ 8.9  
XML 79 R58.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Allocation of stock-based compensation expense        
Total stock-based compensation expense $ 37.4 $ 36.2 $ 76.3 $ 68.6
Income tax benefit (6.8) (5.9) (11.5) (10.3)
Total stock-based compensation expense, net of tax 30.6 30.3 64.8 58.3
Cost of sales        
Allocation of stock-based compensation expense        
Total stock-based compensation expense 6.2 6.9 13.2 13.1
Selling, general, and administrative expenses        
Allocation of stock-based compensation expense        
Total stock-based compensation expense 22.5 21.1 44.8 39.8
Research and development expenses        
Allocation of stock-based compensation expense        
Total stock-based compensation expense $ 8.7 $ 8.2 $ 18.3 $ 15.7
XML 80 R59.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total remaining unrecognized compensation cost $ 275.0  
Unrecognized compensation cost, recognition period 34 months  
Options granted (in shares) 1.9  
Weighted average exercise price of options granted (in dollars per share) $ 88.72  
Performance period (years) 3 years  
Restricted Stock Units (RSUs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Restricted stock units granted (in shares) 0.8  
Weighted average grant date fair value (in dollars per share) $ 88.06  
Market Based Restricted Stock Units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Restricted stock units granted (in shares) 0.1  
Weighted average grant date fair value (in dollars per share) $ 110.10  
Average risk-free interest rate (as a percent) 3.60% 2.80%
Expected volatility (as a percent) 32.60% 33.80%
Market Based Restricted Stock Units | Minimum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares expected to be granted as percentage of target (as a percent) 0.00%  
Market Based Restricted Stock Units | Maximum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares expected to be granted as percentage of target (as a percent) 175.00%  
XML 81 R60.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION - Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) - $ / shares
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
 Option Awards        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Risk-free interest rate 3.40% 3.00% 3.40% 3.00%
Expected dividend yield 0.00% 0.00% 0.00% 0.00%
Expected volatility 32.80% 31.40% 32.80% 31.40%
Expected term (years) 5 years 1 month 6 days 5 years 5 years 1 month 6 days 5 years
Fair value, per option (in dollars per share) $ 31.03 $ 35.07 $ 31.01 $ 35.08
 ESPP        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Risk-free interest rate 4.70% 1.10% 4.60% 0.30%
Expected dividend yield 0.00% 0.00% 0.00% 0.00%
Expected volatility 34.80% 31.50% 31.50% 32.10%
Expected term (years) 7 months 6 days 7 months 6 days 7 months 6 days 7 months 6 days
Fair value, per option (in dollars per share) $ 22.02 $ 23.63 $ 19.03 $ 28.63
XML 82 R61.htm IDEA: XBRL DOCUMENT v3.23.2
ACCELERATED SHARE REPURCHASE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 1 Months Ended
Mar. 31, 2023
Feb. 28, 2023
Feb. 28, 2022
Jan. 31, 2022
Initial Delivery of Shares Settled January 2022        
Class of Stock [Line Items]        
Amount Paid       $ 250.0
Shares Received (in shares)       1.9
Initial delivery, price per share (in dollars per share)       $ 104.87
Value of Shares as % of Contract Value       80.00%
Initial Delivery of Shares Settled February2023        
Class of Stock [Line Items]        
Amount Paid   $ 200.0    
Shares Received (in shares)   2.0    
Initial delivery, price per share (in dollars per share)   $ 80.44    
Value of Shares as % of Contract Value   80.00%    
January 2022 Stock Repurchase Program Shares Sold in February 2022        
Class of Stock [Line Items]        
Shares Received (in shares)     2.3  
Final settlement per share price (in dollars per share)     $ 110.31  
February 2023 Stock Repurchase Program Shares Sold in March 2023        
Class of Stock [Line Items]        
Shares Received (in shares) 2.5      
Final settlement per share price (in dollars per share) $ 79.28      
XML 83 R62.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES (Details)
 6 Months Ended
Jun. 30, 2023
lawsuit
Commitments and Contingencies Disclosure [Abstract]  
Number of lawsuits that if settled could have a material adverse impact on net income or cash flows 1
XML 84 R63.htm IDEA: XBRL DOCUMENT v3.23.2
ACCUMULATED OTHER COMPREHENSIVE LOSS - Activity for Each Component of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
AOCI Attributable to Parent, Net of Tax        
Beginning balance   $ 5,806.7    
Other comprehensive gain (loss) before reclassifications $ 24.5 20.5 $ 0.4 $ (30.3)
Amounts reclassified from accumulated other comprehensive loss (23.2) (27.5) (13.2) (4.1)
Deferred income tax benefit (expense) (1.4) 6.5 (25.0) 5.5
Ending balance 6,375.7      
Accumulated Other Comprehensive Loss        
AOCI Attributable to Parent, Net of Tax        
Beginning balance (255.4) (254.9) (186.6) (157.7)
Ending balance (255.5) (255.4) (224.4) (186.6)
Foreign Currency Translation Adjustments        
AOCI Attributable to Parent, Net of Tax        
Beginning balance (215.0) (218.8) (182.5) (172.5)
Other comprehensive gain (loss) before reclassifications (11.3) 4.9 (36.5) (7.4)
Amounts reclassified from accumulated other comprehensive loss (1.8) (1.7) (2.0) (1.6)
Deferred income tax benefit (expense) 1.6 0.6 (4.7) (1.0)
Ending balance (226.5) (215.0) (225.7) (182.5)
Unrealized Gain on Hedges        
AOCI Attributable to Parent, Net of Tax        
Beginning balance 6.6 23.8 43.1 29.7
Other comprehensive gain (loss) before reclassifications 33.5 6.7 57.9 24.7
Amounts reclassified from accumulated other comprehensive loss (25.2) (29.8) (16.3) (7.3)
Deferred income tax benefit (expense) (3.0) 5.9 (10.3) (4.0)
Ending balance 11.9 6.6 74.4 43.1
Unrealized Loss on Available-for-sale Investments        
AOCI Attributable to Parent, Net of Tax        
Beginning balance (52.6) (65.6) (39.2) (6.9)
Other comprehensive gain (loss) before reclassifications 2.1 9.0 (20.9) (47.6)
Amounts reclassified from accumulated other comprehensive loss 3.8 4.0 5.1 4.8
Deferred income tax benefit (expense) 0.0 0.0 (10.0) 10.5
Ending balance (46.7) (52.6) (65.0) (39.2)
Unrealized Pension Credits        
AOCI Attributable to Parent, Net of Tax        
Beginning balance 5.6 5.7 (8.0) (8.0)
Other comprehensive gain (loss) before reclassifications 0.2 (0.1) (0.1) 0.0
Amounts reclassified from accumulated other comprehensive loss 0.0 0.0 0.0 0.0
Deferred income tax benefit (expense) 0.0 0.0 0.0 0.0
Ending balance $ 5.8 $ 5.6 $ (8.1) $ (8.0)
XML 85 R64.htm IDEA: XBRL DOCUMENT v3.23.2
ACCUMULATED OTHER COMPREHENSIVE LOSS - Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Affected Line on Consolidated Condensed Statements of Operations        
Other income, net $ 2.2 $ 4.3 $ 3.8 $ 1.0
Provision for income taxes (33.0) (58.3) (91.1) (120.8)
Net of tax 307.1 406.4 647.6 780.0
Interest expense (income), net 9.1 0.9 17.7 1.5
Cost of sales (343.0) (269.4) (672.5) (568.7)
Amount Reclassified from Accumulated Other Comprehensive Loss | Foreign currency translation adjustments        
Affected Line on Consolidated Condensed Statements of Operations        
Other income, net 1.8 2.0 3.5 3.6
Provision for income taxes (0.4) (0.5) (0.8) (0.9)
Net of tax 1.4 1.5 2.7 2.7
Amount Reclassified from Accumulated Other Comprehensive Loss | Gain on hedges        
Affected Line on Consolidated Condensed Statements of Operations        
Other income, net 11.3 0.0 11.3 0.0
Provision for income taxes (4.8) (4.3) (11.9) (6.4)
Net of tax 20.4 12.0 43.1 17.2
Cost of sales 13.9 16.3 43.7 23.6
Total before tax 25.2 16.3 55.0 23.6
Amount Reclassified from Accumulated Other Comprehensive Loss | Loss on available-for-sale investments        
Affected Line on Consolidated Condensed Statements of Operations        
Provision for income taxes 0.9 1.2 1.9 2.4
Net of tax (2.9) (3.9) (5.9) (7.5)
Interest expense (income), net $ (3.8) $ (5.1) $ (7.8) $ (9.9)
XML 86 R65.htm IDEA: XBRL DOCUMENT v3.23.2
EARNINGS PER SHARE - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Basic:        
Net income attributable to Edwards Lifesciences Corporation $ 307.1 $ 406.4 $ 647.6 $ 780.0
Weighted-average shares outstanding (in shares) 606.9 620.9 607.2 621.5
Basic earnings per share (in dollars per share) $ 0.51 $ 0.65 $ 1.07 $ 1.26
Diluted:        
Net income attributable to Edwards Lifesciences Corporation $ 307.1 $ 406.4 $ 647.6 $ 780.0
Weighted-average shares outstanding (in shares) 606.9 620.9 607.2 621.5
Dilutive effect of stock plans (in shares) 3.4 5.8 3.4 6.6
Dilutive weighted-average shares outstanding (in shares) 610.3 626.7 610.6 628.1
Diluted earnings per share (in dollars per share) $ 0.50 $ 0.65 $ 1.06 $ 1.24
XML 87 R66.htm IDEA: XBRL DOCUMENT v3.23.2
EARNINGS PER SHARE - Narrative (Details) - shares
shares in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Stock compensation plan        
Anti-dilutive securities        
Anti-dilutive securities excluded from the computation of earnings per share (in shares) 6.7 3.6 5.9 2.6
XML 88 R67.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAXES (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2021
Dec. 31, 2022
Income Tax Disclosure [Abstract]            
Effective income tax rate (as a percent) 9.70% 12.50% 12.40% 13.40%    
Tax benefit from employee share-based compensation $ 9.3 $ 19.8 $ 12.3 $ 33.2    
Liability for income taxes associated with uncertain tax positions 520.0   520.0     $ 475.3
Decrease in unrecognized tax benefits is reasonably possible 205.1   205.1     182.1
Net amounts that would favorably affect effective tax rate $ 314.9   $ 314.9     $ 293.2
Additional federal tax         $ 220.0  
XML 89 R68.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT INFORMATION - Information about Reportable Segments (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment Net Sales        
Net sales $ 1,530.2 $ 1,373.9 $ 2,989.8 $ 2,715.1
Operating segments        
Segment Net Sales        
Net sales 1,523.2 1,401.6 2,977.6 2,734.4
Segment Operating Income        
Segment operating income 913.6 864.5 1,792.6 1,701.8
United States | Operating segments        
Segment Net Sales        
Net sales 895.3 800.8 1,744.4 1,550.3
Segment Operating Income        
Segment operating income 592.4 549.5 1,155.8 1,061.0
Europe | Operating segments        
Segment Net Sales        
Net sales 336.0 309.8 671.4 609.9
Segment Operating Income        
Segment operating income 177.7 164.5 359.4 331.1
Japan | Operating segments        
Segment Net Sales        
Net sales 109.7 145.1 214.0 286.0
Segment Operating Income        
Segment operating income 63.4 95.9 126.8 195.4
Rest of World | Operating segments        
Segment Net Sales        
Net sales 182.2 145.9 347.8 288.2
Segment Operating Income        
Segment operating income $ 80.1 $ 54.6 $ 150.6 $ 114.3
XML 90 R69.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT INFORMATION - Reconciliations of Segment Net Sales to Consolidated Net Sales and Segment Pre-Tax Income to Consolidated Pre-Tax Income (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Net Sales Reconciliation        
Net sales $ 1,530.2 $ 1,373.9 $ 2,989.8 $ 2,715.1
Pre-tax Income Reconciliation        
Consolidated operating income 327.2 459.5 715.6 898.3
Unallocated amounts:        
Change in fair value of contingent consideration liabilities 26.9 20.9 26.2 23.8
Income before provision for income taxes 338.5 464.7 737.1 900.8
Operating segments        
Net Sales Reconciliation        
Net sales 1,523.2 1,401.6 2,977.6 2,734.4
Pre-tax Income Reconciliation        
Consolidated operating income 913.6 864.5 1,792.6 1,701.8
Reconciling items        
Net Sales Reconciliation        
Net sales 7.0 (27.7) 12.2 (19.3)
Unallocated amounts:        
Intellectual property agreement and litigation expense (147.9) (6.1) (191.4) (13.2)
Foreign currency 27.0 30.6 49.5 55.7
Non-operating income 11.3 5.2 21.5 2.5
Corporate items        
Unallocated amounts:        
Corporate items $ (492.4) $ (450.4) $ (961.3) $ (869.8)
XML 91 R70.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT INFORMATION - Enterprise-Wide Information (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Enterprise-Wide Information        
Net sales $ 1,530.2 $ 1,373.9 $ 2,989.8 $ 2,715.1
Transcatheter Aortic Valve Replacement        
Enterprise-Wide Information        
Net sales 991.6 906.9 1,939.5 1,788.2
Transcatheter Mitral and Tricuspid Therapies        
Enterprise-Wide Information        
Net sales 47.6 27.9 89.2 54.9
Surgical Structural Heart        
Enterprise-Wide Information        
Net sales 256.3 228.5 504.5 449.3
Critical Care        
Enterprise-Wide Information        
Net sales 234.7 210.6 456.6 422.7
United States        
Enterprise-Wide Information        
Net sales 895.3 800.8 1,744.4 1,550.3
Europe        
Enterprise-Wide Information        
Net sales 336.2 302.8 667.3 613.9
Japan        
Enterprise-Wide Information        
Net sales 117.9 122.9 232.0 258.4
Rest of World        
Enterprise-Wide Information        
Net sales $ 180.8 $ 147.4 $ 346.1 $ 292.5
XML 92 ew-20230630_htm.xml IDEA: XBRL DOCUMENT 0001099800 2023-01-01 2023-06-30 0001099800 2023-07-25 0001099800 2023-06-30 0001099800 2022-12-31 0001099800 2023-04-01 2023-06-30 0001099800 2022-04-01 2022-06-30 0001099800 2022-01-01 2022-06-30 0001099800 2021-12-31 0001099800 2022-06-30 0001099800 us-gaap:CommonStockMember 2022-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2022-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001099800 us-gaap:RetainedEarningsMember 2022-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001099800 us-gaap:ParentMember 2022-12-31 0001099800 us-gaap:NoncontrollingInterestMember 2022-12-31 0001099800 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001099800 us-gaap:ParentMember 2023-01-01 2023-03-31 0001099800 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001099800 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001099800 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001099800 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001099800 us-gaap:CommonStockMember 2023-03-31 0001099800 us-gaap:TreasuryStockCommonMember 2023-03-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001099800 us-gaap:RetainedEarningsMember 2023-03-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001099800 us-gaap:ParentMember 2023-03-31 0001099800 us-gaap:NoncontrollingInterestMember 2023-03-31 0001099800 2023-03-31 0001099800 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001099800 us-gaap:ParentMember 2023-04-01 2023-06-30 0001099800 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001099800 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001099800 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001099800 us-gaap:CommonStockMember 2023-06-30 0001099800 us-gaap:TreasuryStockCommonMember 2023-06-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001099800 us-gaap:RetainedEarningsMember 2023-06-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001099800 us-gaap:ParentMember 2023-06-30 0001099800 us-gaap:NoncontrollingInterestMember 2023-06-30 0001099800 us-gaap:CommonStockMember 2021-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2021-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001099800 us-gaap:RetainedEarningsMember 2021-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001099800 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001099800 2022-01-01 2022-03-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001099800 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001099800 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001099800 us-gaap:CommonStockMember 2022-03-31 0001099800 us-gaap:TreasuryStockCommonMember 2022-03-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001099800 us-gaap:RetainedEarningsMember 2022-03-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001099800 2022-03-31 0001099800 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001099800 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001099800 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001099800 us-gaap:CommonStockMember 2022-06-30 0001099800 us-gaap:TreasuryStockCommonMember 2022-06-30 0001099800 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001099800 us-gaap:RetainedEarningsMember 2022-06-30 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001099800 2023-04-12 2023-04-12 0001099800 ew:MedtronicIncMember 2023-04-12 2023-04-12 0001099800 ew:MedtronicIncMember 2023-03-01 2023-03-31 0001099800 ew:MedtronicIncMember 2023-04-30 0001099800 ew:MedtronicIncMember 2023-04-01 2023-04-30 0001099800 us-gaap:BankTimeDepositsMember 2023-06-30 0001099800 us-gaap:BankTimeDepositsMember 2022-12-31 0001099800 us-gaap:USTreasuryAndGovernmentMember 2023-06-30 0001099800 us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:AssetBackedSecuritiesMember 2023-06-30 0001099800 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:CorporateDebtSecuritiesMember 2023-06-30 0001099800 us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:MunicipalBondsMember 2023-06-30 0001099800 us-gaap:MunicipalBondsMember 2022-12-31 0001099800 ew:NewMarketsTaxCreditMember us-gaap:LimitedLiabilityCompanyMember 2023-06-30 0001099800 us-gaap:LimitedLiabilityCompanyMember 2023-01-01 2023-06-30 0001099800 us-gaap:OtherNonoperatingIncomeExpenseMember 2023-06-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2023-03-01 2023-03-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2023-03-01 2023-06-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember ew:ConvertiblePromissoryNoteMember 2023-03-31 0001099800 ew:MedicalDeviceCompanyMember 2023-01-31 0001099800 ew:MedicalDeviceCompanyMember 2023-04-01 2023-04-30 0001099800 ew:MedicalDeviceCompanyMember 2021-12-31 0001099800 ew:MedicalDeviceCompanyMember us-gaap:EquitySecuritiesMember 2021-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2022-08-01 2022-08-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2022-08-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2022-06-01 2022-06-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2023-06-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2019-01-01 2019-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2022-05-01 2022-05-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2021-01-01 2021-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2022-05-31 0001099800 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2023-02-28 0001099800 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2023-02-28 2023-02-28 0001099800 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-06-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-06-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-06-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-06-30 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-06-30 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2022-12-31 0001099800 ew:ContingentConsiderationLiabilityMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2023-06-30 0001099800 ew:ContingentConsiderationLiabilityMember 2023-06-30 0001099800 ew:ContingentConsiderationLiabilityMember 2022-12-31 0001099800 us-gaap:OtherLiabilitiesMember 2022-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2023-01-01 2023-06-30 0001099800 us-gaap:OtherLiabilitiesMember 2023-01-01 2023-06-30 0001099800 us-gaap:OtherLiabilitiesMember 2023-06-30 0001099800 ew:ContingentConsiderationLiabilityMember 2021-12-31 0001099800 us-gaap:OtherLiabilitiesMember 2021-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2022-01-01 2022-06-30 0001099800 us-gaap:OtherLiabilitiesMember 2022-01-01 2022-06-30 0001099800 ew:ContingentConsiderationLiabilityMember 2022-06-30 0001099800 us-gaap:OtherLiabilitiesMember 2022-06-30 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 ew:AccruedAndOtherLiabilitiesCurrentMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001099800 ew:AccruedAndOtherLiabilitiesCurrentMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember 2023-06-30 0001099800 us-gaap:CurrencySwapMember 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember 2022-12-31 0001099800 us-gaap:CurrencySwapMember 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-04-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-04-01 2022-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-04-01 2023-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-04-01 2022-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-04-01 2023-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2022-04-01 2022-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-01-01 2023-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2022-01-01 2022-06-30 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-04-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-04-01 2022-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-04-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-04-01 2022-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-01-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-01-01 2022-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-04-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-04-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001099800 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001099800 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001099800 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001099800 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2023-04-01 2023-06-30 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-06-30 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2023-01-01 2023-06-30 0001099800 srt:MinimumMember ew:MarketBasedRestrictedStockUnitsMember 2023-01-01 2023-06-30 0001099800 srt:MaximumMember ew:MarketBasedRestrictedStockUnitsMember 2023-01-01 2023-06-30 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2022-01-01 2022-06-30 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2023-04-01 2023-06-30 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2022-04-01 2022-06-30 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2023-01-01 2023-06-30 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2022-01-01 2022-06-30 0001099800 us-gaap:EmployeeStockMember 2023-04-01 2023-06-30 0001099800 us-gaap:EmployeeStockMember 2022-04-01 2022-06-30 0001099800 us-gaap:EmployeeStockMember 2023-01-01 2023-06-30 0001099800 us-gaap:EmployeeStockMember 2022-01-01 2022-06-30 0001099800 ew:InitialDeliveryOfSharesSettledJanuary2022Member 2022-01-31 0001099800 ew:InitialDeliveryOfSharesSettledJanuary2022Member 2022-01-01 2022-01-31 0001099800 ew:January2022StockRepurchaseProgramSharesSoldInFebruary2022Member 2022-02-01 2022-02-28 0001099800 ew:InitialDeliveryOfSharesSettledFebruary2023Member 2023-02-28 0001099800 ew:InitialDeliveryOfSharesSettledFebruary2023Member 2023-02-01 2023-02-28 0001099800 ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member 2023-03-01 2023-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-03-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-06-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-03-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-03-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-03-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-03-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-03-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2022-04-01 2022-06-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-04-01 2022-06-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-04-01 2022-06-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-04-01 2022-06-30 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-06-30 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2022-04-01 2022-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-04-01 2023-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-04-01 2022-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-04-01 2023-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-04-01 2022-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-06-30 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-06-30 0001099800 us-gaap:StockCompensationPlanMember 2023-04-01 2023-06-30 0001099800 us-gaap:StockCompensationPlanMember 2022-04-01 2022-06-30 0001099800 us-gaap:StockCompensationPlanMember 2023-01-01 2023-06-30 0001099800 us-gaap:StockCompensationPlanMember 2022-01-01 2022-06-30 0001099800 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2022-04-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2023-01-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2022-01-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2022-04-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2023-01-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2022-01-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2022-04-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2023-01-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2022-01-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2022-04-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2023-01-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2022-01-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember 2023-04-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember 2022-04-01 2022-06-30 0001099800 us-gaap:OperatingSegmentsMember 2023-01-01 2023-06-30 0001099800 us-gaap:OperatingSegmentsMember 2022-01-01 2022-06-30 0001099800 us-gaap:MaterialReconcilingItemsMember 2023-04-01 2023-06-30 0001099800 us-gaap:MaterialReconcilingItemsMember 2022-04-01 2022-06-30 0001099800 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-06-30 0001099800 us-gaap:MaterialReconcilingItemsMember 2022-01-01 2022-06-30 0001099800 us-gaap:CorporateNonSegmentMember 2023-04-01 2023-06-30 0001099800 us-gaap:CorporateNonSegmentMember 2022-04-01 2022-06-30 0001099800 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-06-30 0001099800 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-06-30 0001099800 country:US 2023-04-01 2023-06-30 0001099800 country:US 2022-04-01 2022-06-30 0001099800 country:US 2023-01-01 2023-06-30 0001099800 country:US 2022-01-01 2022-06-30 0001099800 srt:EuropeMember 2023-04-01 2023-06-30 0001099800 srt:EuropeMember 2022-04-01 2022-06-30 0001099800 srt:EuropeMember 2023-01-01 2023-06-30 0001099800 srt:EuropeMember 2022-01-01 2022-06-30 0001099800 country:JP 2023-04-01 2023-06-30 0001099800 country:JP 2022-04-01 2022-06-30 0001099800 country:JP 2023-01-01 2023-06-30 0001099800 country:JP 2022-01-01 2022-06-30 0001099800 ew:RestOfWorldMember 2023-04-01 2023-06-30 0001099800 ew:RestOfWorldMember 2022-04-01 2022-06-30 0001099800 ew:RestOfWorldMember 2023-01-01 2023-06-30 0001099800 ew:RestOfWorldMember 2022-01-01 2022-06-30 0001099800 ew:TranscatheterAorticValveReplacementMember 2023-04-01 2023-06-30 0001099800 ew:TranscatheterAorticValveReplacementMember 2022-04-01 2022-06-30 0001099800 ew:TranscatheterAorticValveReplacementMember 2023-01-01 2023-06-30 0001099800 ew:TranscatheterAorticValveReplacementMember 2022-01-01 2022-06-30 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2023-04-01 2023-06-30 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2022-04-01 2022-06-30 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2023-01-01 2023-06-30 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2022-01-01 2022-06-30 0001099800 ew:SurgicalHeartValveTherapyMember 2023-04-01 2023-06-30 0001099800 ew:SurgicalHeartValveTherapyMember 2022-04-01 2022-06-30 0001099800 ew:SurgicalHeartValveTherapyMember 2023-01-01 2023-06-30 0001099800 ew:SurgicalHeartValveTherapyMember 2022-01-01 2022-06-30 0001099800 ew:CriticalCareMember 2023-04-01 2023-06-30 0001099800 ew:CriticalCareMember 2022-04-01 2022-06-30 0001099800 ew:CriticalCareMember 2023-01-01 2023-06-30 0001099800 ew:CriticalCareMember 2022-01-01 2022-06-30 0001099800 ew:DaveenChopraMember 2023-01-01 2023-06-30 0001099800 ew:DaveenChopraMember 2023-04-01 2023-06-30 0001099800 ew:DaveenChopraMember 2023-06-30 shares iso4217:USD iso4217:USD shares pure iso4217:EUR ew:lawsuit 0001099800 --12-31 2023 Q2 false http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20230630#AccruedAndOtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20230630#AccruedAndOtherLiabilitiesCurrent P182D 10-Q true 2023-06-30 false 1-15525 EDWARDS LIFESCIENCES CORPORATION DE 36-4316614 One Edwards Way Irvine CA 92614 949 250-2500 Common Stock, par value $1.00 per share EW NYSE Yes Yes Large Accelerated Filer false false false 607916300 1042600000 769000000.0 466700000 446300000 8100000 7900000 754400000 643000000.0 62500000 56100000 980200000 875500000 123200000 110000000.0 217400000 195900000 3647000000 3095800000 856200000 1239000000 1662200000 1632800000 84900000 92300000 1299500000 1164300000 431400000 285200000 610700000 484000000.0 412100000 299100000 9004000000 8292500000 193000000.0 201900000 939900000 795000000.0 24300000 25500000 1157200000 1022400000 596700000 596300000 0 26200000 81200000 143400000 63500000 69500000 303700000 267500000 112500000 143000000.0 242700000 217500000 2557500000 2485800000 0.01 0.01 50000000.0 50000000.0 0 0 0 0 1.00 1.00 1050000000 1050000000 649100000 646300000 607900000 608300000 649100000 646300000 2145500000 1969300000 8237600000 7590000000 -255500000 -254900000 41200000 38000000.0 4401000000 4144000000 6375700000 5806700000 70800000 0 6446500000 5806700000 9004000000 8292500000 1530200000 1373900000 2989800000 2715100000 343000000.0 269400000 672500000 568700000 1187200000 1104500000 2317300000 2146400000 468700000 409000000.0 905000000.0 779300000 270300000 250800000 531500000 479400000 147900000 6100000 191400000 13200000 -26900000 -20900000 -26200000 -23800000 327200000 459500000 715600000 898300000 9100000 900000 17700000 1500000 2200000 4300000 3800000 1000000.0 338500000 464700000 737100000 900800000 33000000.0 58300000 91100000 120800000 305500000 406400000 646000000.0 780000000.0 -1600000 0 -1600000 0 307100000 406400000 647600000 780000000.0 0.51 0.65 1.07 1.26 0.50 0.65 1.06 1.24 606900000 620900000 607200000 621500000 610300000 626700000 610600000 628100000 305500000 406400000 646000000.0 780000000.0 -11500000 -43200000 -7700000 -53200000 5300000 31300000 -11900000 44700000 -200000 100000 -100000 100000 2100000 -30900000 11100000 -68000000.0 -3800000 -5100000 -7800000 -9900000 -100000 -37800000 -600000 -66700000 305400000 368600000 645400000 713300000 -1600000 0 -1600000 0 307000000.0 368600000 647000000.0 713300000 646000000.0 780000000.0 71300000 68800000 13700000 13900000 76300000 68600000 -26200000 -23800000 3500000 -38200000 134700000 102400000 -2800000 -4200000 124300000 77700000 113700000 85800000 76200000 -81700000 31000000.0 49700000 43400000 -25700000 -14500000 -19700000 114000000.0 0 -4700000 32500000 347700000 625500000 109400000 115800000 15500000 180700000 83500000 277500000 6800000 114300000 314500000 584100000 141200000 0 15000000.0 55500000 22500000 45500000 0 18000000.0 16900000 8700000 70700000 359100000 256800000 760700000 102700000 86500000 -400000 -2000000.0 -154500000 -676200000 11000000.0 27100000 274900000 335500000 772600000 867400000 1047500000 1202900000 646300000 646300000 38000000.0 -4144000000 1969300000 7590000000 -254900000 5806700000 0 5806700000 340500000 340500000 340500000 -500000 -500000 -500000 800000 800000 41100000 41900000 41900000 38900000 38900000 38900000 3100000 249500000 249500000 249500000 84000000.0 84000000.0 647100000 647100000 41100000 -4393500000 2049300000 7930500000 -255400000 5978000000 84000000.0 6062000000 307100000 307100000 -1600000 305500000 -100000 -100000 -100000 2000000.0 2000000.0 58800000 60800000 60800000 37400000 37400000 37400000 100000 7500000 7500000 7500000 -11600000 -11600000 649100000 649100000 41200000 -4401000000 2145500000 8237600000 -255500000 6375700000 70800000 6446500000 642000000.0 642000000.0 17900000 -2416900000 1700400000 6068100000 -157700000 5835900000 373600000 373600000 -28900000 -28900000 900000 900000 36600000 37500000 32400000 32400000 3600000 405600000 405600000 642900000 642900000 21500000 -2822500000 1769400000 6441700000 -186600000 5844900000 406400000 406400000 -37800000 -37800000 2100000 2100000 46900000 49000000.0 36200000 36200000 3700000 355100000 355100000 645000000.0 645000000.0 25200000 -3177600000 1852500000 6848100000 -224400000 5943600000 BASIS OF PRESENTATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the interim consolidated condensed financial statements reflect all adjustments necessary for a fair statement of the results for the interim periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company's significant accounting policies from those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.</span></div> The accompanying interim consolidated condensed financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") and should be read in conjunction with the consolidated financial statements and notes included in Edwards Lifesciences' Annual Report on Form 10-K for the year ended December 31, 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") have been condensed or omitted. The consolidated condensed financial statements include the accounts of all wholly-owned subsidiaries and variable interest entities for which the Company is the primary beneficiary. The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial results.</span></div> OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2023 and December 31, 2022, $149.7 million and $128.6 million, respectively, of the Company's finished products inventories were held on consignment. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     As of June 30, 2023, $69.2 million was accrued in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accrued and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">" and $112.5 million was accrued in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation Settlement Accrual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet related to a settlement agreement with Abbott Laboratories and its direct and indirect subsidiaries.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated condensed balance sheets consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 181200000 156400000 223000000.0 177400000 576000000.0 541700000 980200000 875500000 149700000 128600000 <div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:75.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     As of June 30, 2023, $69.2 million was accrued in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accrued and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">" and $112.5 million was accrued in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation Settlement Accrual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet related to a settlement agreement with Abbott Laboratories and its direct and indirect subsidiaries.</span></div> 312700000 268700000 106600000 50600000 56100000 45600000 70700000 66900000 130100000 116100000 17800000 20700000 16900000 17000000.0 30400000 28100000 69200000 53300000 23300000 25200000 10200000 6600000 14400000 15600000 81500000 80600000 939900000 795000000.0 69200000 112500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 193500000 173000000.0 14300000 14500000 6000000.0 10600000 26900000 24600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div> 1042600000 769000000.0 1400000 500000 3500000 3100000 1047500000 772600000 INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSEOn April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and will pay annual royalty payments that are tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pre-tax charge in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Litigation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April 2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Litigation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">"</span> in April 2023 related to products currently in development. P15Y 300000000 300000000 37000000 124000000 139000000 INVESTMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of June 30, 2023, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 5 years through 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Consists of mortgage- and asset-backed securities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2023 and December 31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of June 30, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Unconsolidated Entities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets, and are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company made $1.7 million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. As of June 30, 2023, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $3.1 million due to impairments and observable price changes. </span></div>During the three and six months ended June 30, 2023, the gross realized gains or losses from sales of available-for-sale investments were not material. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:23.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.730%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 28100000 0 0 28100000 96000000.0 0 0 96000000.0 103400000 0 5000000.0 98400000 137700000 0 6100000 131600000 262500000 0 10000000.0 252500000 380600000 0 14000000.0 366600000 864900000 0 34000000.0 830900000 1028100000 0 47800000 980300000 2800000 0 200000 2600000 2700000 0 200000 2500000 1233600000 0 49200000 1184400000 1549100000 0 68100000 1481000000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of June 30, 2023, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 5 years through 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Consists of mortgage- and asset-backed securities.</span></div> 26300000 26300000 450900000 440400000 1800000 1800000 472000000.0 446700000 0 0 4600000 4400000 0 0 306100000 292900000 28100000 28100000 1233600000 1184400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2023 and December 31, 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.274%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 10900000 100000 86200000 4900000 97100000 5000000.0 50900000 800000 199900000 9200000 250800000 10000000.0 23300000 100000 793300000 33900000 816600000 34000000.0 0 0 2600000 200000 2600000 200000 85100000 1000000.0 1082000000 48200000 1167100000 49200000 61600000 1500000 69500000 4600000 131100000 6100000 103300000 1300000 254600000 12700000 357900000 14000000.0 189000000.0 5300000 784800000 42500000 973800000 47800000 0 0 2500000 200000 2500000 200000 353900000 8100000 1111400000 60000000.0 1465300000 68100000 These investments are recorded in "<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets, and are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 23500000 21400000 86900000 86900000 110400000 108300000 1700000 0.39 P7Y 8800000 3100000 INVESTMENTS IN VARIABLE INTEREST ENTITIES The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. See Note 6 for additional information. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unconsolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option to acquire the medical device company, of which $15.0 million has been paid as of June 30, 2023. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. The option and the note are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company loaned a privately-held medical device company (the "Investee") $10.0 million under a $45.0 million secured promissory note agreement. In April 2023, the Investee drew an additional $7.5 million under the promissory note. Previously, in 2021, the Company invested $39.3 million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in the Investee's preferred equity securities and paid $13.1 million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for an option to acquire the Investee. Per the agreement, the Company may be required to invest up to an additional $6.5 million in the Investee's preferred equity securities and up to an additional $14.4 million for the option to acquire the Investee.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into an option agreement with a medical device company. Under the option agreement, Edwards paid $47.1 million for an option to acquire the medical device company. The $47.1 million option is included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $32.5 million has been advanced as of June 30, 2023. In addition, in 2019 the Company paid $35.0 million for an option to acquire the medical device company. The $35.0 million option and the $32.5 million note receivable are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an option agreement with a medical technology company. Under the option agreement, Edwards paid $60.0 million for an option to acquire the medical technology company, of which $10.0 million was paid in 2021. The $60.0 million option is included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheet.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 4.</span></div> 45000000 15000000 5000000 10000000 45000000 7500000 39300000 13100000 6500000 14400000 47100000 47100000 47500000 32500000 35000000 35000000 32500000 60000000 10000000 60000000 BUSINESS COMBINATIONOn February 28, 2023, the Company acquired 61% of the then outstanding shares of a medical technology company in an all cash transaction. The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated condensed financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination. Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)     Includes $22.5 million paid in a previous year under option agreements and $5.3 million for the settlement of a pre-existing note.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s Rest of World segment and is not deductible for tax purposes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.</span></div> 0.61 The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)     Includes $22.5 million paid in a previous year under option agreements and $5.3 million for the settlement of a pre-existing note.</span></div> 8100000 133200000 136600000 1700000 28000000.0 248200000 72400000 175800000 6800000 169000000.0 94400000 22000000 22500000 5300000 FAIR VALUE MEASUREMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated condensed financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include notes payable. As of June 30, 2023, the fair value of the notes payable, based on Level 2 inputs, was $580.5 million.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">June 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service. </span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in trading securities related to its deferred compensation plans. The investments are in a variety of stock, bond and money market mutual funds. The fair values of these investments are based on quoted market prices.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. As of June 30, 2023 the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was reduced to zero.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of the contingent consideration and the other liability (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 580500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">June 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 635000000.0 0 0 635000000.0 0 830900000 0 830900000 0 252500000 0 252500000 0 98400000 0 98400000 0 2600000 0 2600000 125300000 0 0 125300000 0 63900000 0 63900000 760300000 1248300000 0 2008600000 0 17800000 0 17800000 0 0 14000000.0 14000000.0 0 17800000 14000000.0 31800000 280400000 0 0 280400000 0 980300000 0 980300000 0 366600000 0 366600000 37100000 94500000 0 131600000 0 2500000 0 2500000 112100000 0 0 112100000 0 65500000 0 65500000 429600000 1509400000 0 1939000000 0 27200000 0 27200000 0 0 26200000 26200000 0 0 14000000.0 14000000.0 0 27200000 40200000 67400000 0 0 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in fair value of the contingent consideration and the other liability (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 26200000 14000000.0 40200000 -26200000 0 -26200000 0 14000000.0 14000000.0 62000000.0 14000000.0 76000000.0 -23800000 0 -23800000 38200000 14000000.0 52200000 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (a) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within the next 13 months (designated as cash flow hedges), (b) its net </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment in certain foreign subsidiaries (designated as net investment hedges) and (c) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with revaluation of certain assets and liabilities denominated in currencies other than their functional currencies (resulting principally from intercompany and local currency transactions). </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated condensed balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-815"><span style="-sec-ix-hidden:f-816">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-821"><span style="-sec-ix-hidden:f-822">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">June 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Location of Gain or<br/>(Loss) Reclassified from<br/>Accumulated OCI<br/>into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Location of Gain or<br/>(Loss) Reclassified from<br/>Accumulated OCI<br/>into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.891%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from <br/>Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Location of Gain or<br/>(Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.998%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from<br/> Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Location of Gain or<br/>(Loss) Reclassified from<br/>Accumulated OCI<br/>into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company will receive semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:74.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.796%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during the next twelve months it will reclassify to earnings a $9.0 million gain currently recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.319%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,763.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 1763700000 1678400000 300000000.0 300000000.0 P13M <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.436%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet<br/>Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-815"><span style="-sec-ix-hidden:f-816">Assets</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-821"><span style="-sec-ix-hidden:f-822">Liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 32200000 24900000 31700000 40600000 17800000 20700000 0 6500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">June 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated condensed balance sheets (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts <br/>Not Offset in<br/>the Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">June 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 32200000 0 32200000 8600000 0 23600000 31700000 0 31700000 0 0 31700000 17800000 0 17800000 8600000 0 9200000 24900000 0 24900000 12000000.0 0 12900000 40600000 0 40600000 0 0 40600000 27200000 0 27200000 12000000.0 0 15200000 The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated condensed statements of operations and consolidated condensed statements of comprehensive income (in millions):<div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Location of Gain or<br/>(Loss) Reclassified from<br/>Accumulated OCI<br/>into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.919%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Reclassified from<br/>Accumulated OCI<br/>into Income<br/>(Effective Portion)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Location of Gain or<br/>(Loss) Reclassified from<br/>Accumulated OCI<br/>into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.487%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.891%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative <br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from <br/>Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Location of Gain or<br/>(Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.998%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.767%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from<br/> Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Location of Gain or<br/>(Loss) Reclassified from<br/>Accumulated OCI<br/>into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:43.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss)<br/>Recognized in Income on<br/>Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 23200000 57900000 13900000 16300000 26900000 82600000 43700000 23600000 -6500000 19400000 1800000 2000000.0 -9000000.0 23300000 3500000 3600000 257200000 300000000 11300000 0 11300000 0 9900000 26600000 4500000 42100000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated condensed statements of operations (in millions):</span></div><div style="margin-bottom:8pt;margin-top:13pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2023</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:74.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.796%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30, 2022</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items presented in the consolidated condensed statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> 343000000.0 2200000 672500000 3800000 0 -10100000 0 -8900000 0 10100000 0 8900000 0 1200000 0 2400000 13900000 0 43700000 0 269400000 568700000 16300000 23600000 9000000 STOCK-BASED COMPENSATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and six months ended June 30, 2023 and 2022 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.8 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2023, the total remaining compensation cost related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan ("ESPP") subscription awards amounted to $275.0 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 34 months. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the Company granted 1.9 million stock options at a weighted-average</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exercise price per share of $88.72, and 0.8 million restricted stock units at a weighted-average grant-date fair value per share of $88.06. During the six months ended June 30, 2023, the Company also granted 0.1 million market-based restricted stock units at a weighted-average grant-date fair value per share of $110.10. The market-based restricted stock units granted during the six months ended June 30, 2023 vest based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total shareholder return relative to a selected industry peer group over a three-year performance period and may range from 0% to 175% of the target number of shares granted.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Disclosures</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the six months ended June 30, 2023 and 2022 included a risk-free interest rate of 3.6% and 2.8%, respectively, and an expected volatility rate of 32.6% and 33.8%, respectively.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.07 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.02 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to awards issued under the Company's incentive compensation plans for the three and six months ended June 30, 2023 and 2022 was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.8 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 6200000 6900000 13200000 13100000 22500000 21100000 44800000 39800000 8700000 8200000 18300000 15700000 37400000 36200000 76300000 68600000 6800000 5900000 11500000 10300000 30600000 30300000 64800000 58300000 275000000 P34M 1900000 88.72 800000 88.06 100000 110.10 P3Y 0 1.75 0.036 0.028 0.326 0.338 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values of stock options granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Option Awards</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.07 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.034 0.030 0.034 0.030 0 0 0 0 0.328 0.314 0.328 0.314 P5Y1M6D P5Y P5Y1M6D P5Y 31.03 35.07 31.01 35.08 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes the weighted-average grant-date fair values for ESPP subscriptions granted during the periods indicated and the related weighted-average assumptions used in the Black-Scholes option pricing model:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">ESPP</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.02 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.047 0.011 0.046 0.003 0 0 0 0 0.348 0.315 0.315 0.321 P0Y7M6D P0Y7M6D P0Y7M6D P0Y7M6D 22.02 23.63 19.03 28.63 ACCELERATED SHARE REPURCHASE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023 and 2022, the Company entered into accelerated share repurchase ("ASR") agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreement, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreements were each accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date, and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and subsequently, upon settlement, was transferred to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated condensed balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.</span></div> The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 250000000.0 1900000 104.87 0.80 2300000 110.31 200000000.0 2000000.0 80.44 0.80 2500000 79.28 COMMITMENTS AND CONTINGENCIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is reviewing and investigating whether business activities in Japan and other markets violate certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the outcome of the review and investigation or the potential impact on its financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.</span></div>The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved. 1 ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Credits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) gain before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) gain before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) gain before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.387%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on hedges</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Credits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) gain before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Loss on Available-for-sale Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) gain before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) gain before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div> -218800000 23800000 -65600000 5700000 -254900000 4900000 6700000 9000000.0 -100000 20500000 1700000 29800000 -4000000.0 0 27500000 -600000 -5900000 0 0 -6500000 -215000000.0 6600000 -52600000 5600000 -255400000 -11300000 33500000 2100000 200000 24500000 1800000 25200000 -3800000 0 23200000 -1600000 3000000.0 0 0 1400000 -226500000 11900000 -46700000 5800000 -255500000 -172500000 29700000 -6900000 -8000000.0 -157700000 -7400000 24700000 -47600000 0 -30300000 1600000 7300000 -4800000 0 4100000 1000000.0 4000000.0 -10500000 0 -5500000 -182500000 43100000 -39200000 -8000000.0 -186600000 -36500000 57900000 -20900000 -100000 400000 2000000.0 16300000 -5100000 0 13200000 4700000 10300000 10000000.0 0 25000000.0 -225700000 74400000 -65000000.0 -8100000 -224400000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.387%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated Condensed<br/>Statements of Operations</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Comprehensive Loss Components</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on hedges</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on available-for-sale investments</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 1800000 2000000.0 3500000 3600000 400000 500000 800000 900000 1400000 1500000 2700000 2700000 -13900000 -16300000 -43700000 -23600000 11300000 0 11300000 0 25200000 16300000 55000000.0 23600000 4800000 4300000 11900000 6400000 20400000 12000000.0 43100000 17200000 -3800000 -5100000 -7800000 -9900000 -900000 -1200000 -1900000 -2400000 -2900000 -3900000 -5900000 -7500000 EARNINGS PER SHARE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.5 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.51 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.5 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Stock options, restricted stock units, and market-based restricted stock units to purchase an aggregate of 6.7 million and 3.6 million common shares for the three months ended June 30, 2023 and 2022, respectively, and 5.9 million and 2.6 million shares for the six months ended June 30, 2023 and 2022, respectively, were outstanding, but were not included in the computation of diluted earnings per share for such periods because the effect would have been anti-dilutive. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.5 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.51 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26 </span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.9 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.5 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.65 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.06 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.24 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 307100000 406400000 647600000 780000000.0 606900000 620900000 607200000 621500000 0.51 0.65 1.07 1.26 307100000 406400000 647600000 780000000.0 606900000 620900000 607200000 621500000 3400000 5800000 3400000 6600000 610300000 626700000 610600000 628100000 0.50 0.65 1.06 1.24 6700000 3600000 5900000 2600000 INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective income tax rates were 9.7% and 12.5% for the three months ended June 30, 2023 and 2022, respectively, and 12.4% and 13.4% for the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended June 30, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022, respectively. The decrease in the effective rate between the six months ended June 30, 2023 and 2022 is primarily due </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to an increase in the benefit from the federal research and development credit and the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation. In addition, the effective rates for the six months ended June 30, 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective rates include a tax benefit from employee share-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compensation of $9.3 million and $19.8 million for the three months ended June 30, 2023 and 2022, respectively, and $12.3 million and $33.2 million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended June 30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2022, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Internal Revenue Service (“IRS”) and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 and December 31, 2022, the gross liability recorded for income taxes associated with uncertain tax positions was $520.0 million and $475.3 million, respectively. The Company estimates that these liabilities would be reduced by $205.1 million and $182.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $314.9 million and $293.2 million, respectively, if not required, would favorably affect the Company's effective tax rate. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively “Surgical/TAVR”) intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all of the APAs which cover transactions with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. The execution of some or all of these APA renewals depends on many variables outside of the Company's control. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters. The IRS began its examination of the 2018 through 2020 tax years during the first quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The audits of the Company's material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010 and on. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015-2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed an increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $220 million and reflects a significant departure from the transfer pricing methods the Company had previously agreed upon with the IRS for these types of transactions. The Company disagreed with the NOPA and submitted a formal protest on the matter during the fourth quarter of 2021. During the second quarter of 2022, the Company received the IRS's rebuttal to the Company's protest and was notified that the case had been transferred to the IRS Independent Office of Appeals ("Appeals"). The opening conference was held with Appeals during March 2023 and discussions with Appeals continued throughout the second quarter of 2023. While Appeals still maintains </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">jurisdiction over the matter as of June 30, 2023, the Company and Appeals have now concluded that a satisfactory resolution of this matter at the administrative level is not possible. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company now plans to vigorously contest the proposed adjustments through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate based on prior experience and interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOPA received or as a result of the Appeals proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018-2023 tax years. While no payment of any amount related to the NOPA has yet been required, the Company made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any potential deficiency that may be ultimately sustained.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018-2023 that were not resolved under the APA program remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of June 30, 2023. The Company has considered this information, as well as information regarding the NOPA, the rebuttal and Appeals discussions described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.</span></div> 0.097 0.125 0.124 0.134 -9300000 -19800000 -12300000 -33200000 520000000 475300000 205100000 182100000 314900000 293200000 220000000 SEGMENT INFORMATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523.2 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,977.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734.4 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701.8 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,977.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(961.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(869.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and litigation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enterprise-wide Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523.2 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,977.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734.4 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701.8 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,977.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,792.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(492.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(961.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(869.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and litigation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">737.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 895300000 800800000 1744400000 1550300000 336000000.0 309800000 671400000 609900000 109700000 145100000 214000000.0 286000000.0 182200000 145900000 347800000 288200000 1523200000 1401600000 2977600000 2734400000 592400000 549500000 1155800000 1061000000 177700000 164500000 359400000 331100000 63400000 95900000 126800000 195400000 80100000 54600000 150600000 114300000 913600000 864500000 1792600000 1701800000 1523200000 1401600000 2977600000 2734400000 7000000.0 -27700000 12200000 -19300000 1530200000 1373900000 2989800000 2715100000 913600000 864500000 1792600000 1701800000 492400000 450400000 961300000 869800000 147900000 6100000 191400000 13200000 -26900000 -20900000 -26200000 -23800000 27000000.0 30600000 49500000 55700000 327200000 459500000 715600000 898300000 11300000 5200000 21500000 2500000 338500000 464700000 737100000 900800000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">991.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,715.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 895300000 800800000 1744400000 1550300000 336200000 302800000 667300000 613900000 117900000 122900000 232000000.0 258400000 180800000 147400000 346100000 292500000 1530200000 1373900000 2989800000 2715100000 991600000 906900000 1939500000 1788200000 47600000 27900000 89200000 54900000 256300000 228500000 504500000 449300000 234700000 210600000 456600000 422700000 1530200000 1373900000 2989800000 2715100000 On May 30, 2023, Daveen Chopra, Corporate Vice President of TMTT, entered into a 10b5-1 trading plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the potential sale of 20,500 shares of the Company’s stock commencing September 6, 2023. The Plan terminates on the earlier of March 6, 2024 or the date all shares are sold. May 30, 2023 Daveen Chopra Corporate Vice President of TMTT true false false false 20500 EXCEL 93 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 94 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 95 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 96 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 362 363 1 false 78 0 false 6 false false R1.htm 0000001 - Document - COVER Sheet http://www.edwards.com/role/COVER COVER Cover 1 false false R2.htm 0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS CONSOLIDATED CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 7 false false R8.htm 0000008 - Disclosure - BASIS OF PRESENTATION Sheet http://www.edwards.com/role/BASISOFPRESENTATION BASIS OF PRESENTATION Notes 8 false false R9.htm 0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Notes 9 false false R10.htm 0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSE INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE Notes 10 false false R11.htm 0000011 - Disclosure - INVESTMENTS Sheet http://www.edwards.com/role/INVESTMENTS INVESTMENTS Notes 11 false false R12.htm 0000012 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES Sheet http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES INVESTMENTS IN VARIABLE INTEREST ENTITIES Notes 12 false false R13.htm 0000013 - Disclosure - BUSINESS COMBINATION Sheet http://www.edwards.com/role/BUSINESSCOMBINATION BUSINESS COMBINATION Notes 13 false false R14.htm 0000014 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 14 false false R15.htm 0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Notes 15 false false R16.htm 0000016 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 16 false false R17.htm 0000017 - Disclosure - ACCELERATED SHARE REPURCHASE Sheet http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE ACCELERATED SHARE REPURCHASE Notes 17 false false R18.htm 0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 0000019 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS ACCUMULATED OTHER COMPREHENSIVE LOSS Notes 19 false false R20.htm 0000020 - Disclosure - EARNINGS PER SHARE Sheet http://www.edwards.com/role/EARNINGSPERSHARE EARNINGS PER SHARE Notes 20 false false R21.htm 0000021 - Disclosure - INCOME TAXES Sheet http://www.edwards.com/role/INCOMETAXES INCOME TAXES Notes 21 false false R22.htm 0000022 - Disclosure - SEGMENT INFORMATION Sheet http://www.edwards.com/role/SEGMENTINFORMATION SEGMENT INFORMATION Notes 22 false false R23.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 23 false false R24.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 24 false false R25.htm 9954701 - Disclosure - BASIS OF PRESENTATION (Policies) Sheet http://www.edwards.com/role/BASISOFPRESENTATIONPolicies BASIS OF PRESENTATION (Policies) Policies 25 false false R26.htm 9954702 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Tables http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS 26 false false R27.htm 9954703 - Disclosure - INVESTMENTS (Tables) Sheet http://www.edwards.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://www.edwards.com/role/INVESTMENTS 27 false false R28.htm 9954704 - Disclosure - BUSINESS COMBINATION (Tables) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONTables BUSINESS COMBINATION (Tables) Tables http://www.edwards.com/role/BUSINESSCOMBINATION 28 false false R29.htm 9954705 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.edwards.com/role/FAIRVALUEMEASUREMENTS 29 false false R30.htm 9954706 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Tables http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES 30 false false R31.htm 9954707 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.edwards.com/role/STOCKBASEDCOMPENSATION 31 false false R32.htm 9954708 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables) Sheet http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables ACCELERATED SHARE REPURCHASE (Tables) Tables http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE 32 false false R33.htm 9954709 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Tables http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS 33 false false R34.htm 9954710 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.edwards.com/role/EARNINGSPERSHARETables EARNINGS PER SHARE (Tables) Tables http://www.edwards.com/role/EARNINGSPERSHARE 34 false false R35.htm 9954711 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONTables SEGMENT INFORMATION (Tables) Tables http://www.edwards.com/role/SEGMENTINFORMATION 35 false false R36.htm 9954712 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Inventory (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Inventory (Details) Details 36 false false R37.htm 9954713 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Accrued Liabilities and Long Term Liabilities (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Accrued Liabilities and Long Term Liabilities (Details) Details 37 false false R38.htm 9954714 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) Details 38 false false R39.htm 9954715 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) Details 39 false false R40.htm 9954716 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE - Narrative (Details) Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE - Narrative (Details) Details http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSE 40 false false R41.htm 9954717 - Disclosure - INVESTMENTS - Investments in Debt Securities (Details) Sheet http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails INVESTMENTS - Investments in Debt Securities (Details) Details 41 false false R42.htm 9954718 - Disclosure - INVESTMENTS - Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Sheet http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails INVESTMENTS - Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Details 42 false false R43.htm 9954719 - Disclosure - INVESTMENTS - Investments in Continuous Loss Position (Details) Sheet http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails INVESTMENTS - Investments in Continuous Loss Position (Details) Details 43 false false R44.htm 9954720 - Disclosure - INVESTMENTS - Investments in Unconsolidated Entities (Details) Sheet http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails INVESTMENTS - Investments in Unconsolidated Entities (Details) Details 44 false false R45.htm 9954721 - Disclosure - INVESTMENTS - Narrative (Details) Sheet http://www.edwards.com/role/INVESTMENTSNarrativeDetails INVESTMENTS - Narrative (Details) Details 45 false false R46.htm 9954722 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) Sheet http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) Details http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES 46 false false R47.htm 9954723 - Disclosure - BUSINESS COMBINATION - Narrative (Details) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails BUSINESS COMBINATION - Narrative (Details) Details 47 false false R48.htm 9954724 - Disclosure - BUSINESS COMBINATION - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails BUSINESS COMBINATION - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) Details 48 false false R49.htm 9954725 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails FAIR VALUE MEASUREMENTS - Narrative (Details) Details 49 false false R50.htm 9954726 - Disclosure - FAIR VALUE MEASUREMENTS - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails FAIR VALUE MEASUREMENTS - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Details 50 false false R51.htm 9954727 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in Fair Value of Contingent Consideration Obligation (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails FAIR VALUE MEASUREMENTS - Changes in Fair Value of Contingent Consideration Obligation (Details) Details 51 false false R52.htm 9954728 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) Details 52 false false R53.htm 9954729 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Details 53 false false R54.htm 9954730 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) Details 54 false false R55.htm 9954731 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) Details 55 false false R56.htm 9954732 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) Details 56 false false R57.htm 9954733 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedge Effects on Statement of Operations (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedge Effects on Statement of Operations (Details) Details 57 false false R58.htm 9954734 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details) Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details) Details 58 false false R59.htm 9954735 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 59 false false R60.htm 9954736 - Disclosure - STOCK-BASED COMPENSATION - Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) Sheet http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails STOCK-BASED COMPENSATION - Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details) Details 60 false false R61.htm 9954737 - Disclosure - ACCELERATED SHARE REPURCHASE (Details) Sheet http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails ACCELERATED SHARE REPURCHASE (Details) Details http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables 61 false false R62.htm 9954738 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES 62 false false R63.htm 9954739 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Details 63 false false R64.htm 9954740 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Details 64 false false R65.htm 9954741 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails EARNINGS PER SHARE - Computation of Basic and Diluted Earnings Per Share (Details) Details 65 false false R66.htm 9954742 - Disclosure - EARNINGS PER SHARE - Narrative (Details) Sheet http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails EARNINGS PER SHARE - Narrative (Details) Details 66 false false R67.htm 9954743 - Disclosure - INCOME TAXES (Details) Sheet http://www.edwards.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://www.edwards.com/role/INCOMETAXES 67 false false R68.htm 9954744 - Disclosure - SEGMENT INFORMATION - Information about Reportable Segments (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails SEGMENT INFORMATION - Information about Reportable Segments (Details) Details 68 false false R69.htm 9954745 - Disclosure - SEGMENT INFORMATION - Reconciliations of Segment Net Sales to Consolidated Net Sales and Segment Pre-Tax Income to Consolidated Pre-Tax Income (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails SEGMENT INFORMATION - Reconciliations of Segment Net Sales to Consolidated Net Sales and Segment Pre-Tax Income to Consolidated Pre-Tax Income (Details) Details 69 false false R70.htm 9954746 - Disclosure - SEGMENT INFORMATION - Enterprise-Wide Information (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails SEGMENT INFORMATION - Enterprise-Wide Information (Details) Details 70 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: ecd:TrdArrDuration - ew-20230630.htm 4 ew-20230630.htm ew-20230630.xsd ew-20230630_cal.xml ew-20230630_def.xml ew-20230630_lab.xml ew-20230630_pre.xml ex-31110xqq22023.htm ex-31210xqq22023.htm ex-3210xqq22023.htm ew-20230630_g1.jpg ew-20230630_g10.jpg ew-20230630_g11.jpg ew-20230630_g12.jpg ew-20230630_g2.jpg ew-20230630_g3.jpg ew-20230630_g4.jpg ew-20230630_g5.jpg ew-20230630_g6.jpg ew-20230630_g7.jpg ew-20230630_g8.jpg ew-20230630_g9.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 99 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ew-20230630.htm": { "axisCustom": 0, "axisStandard": 30, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1262, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 10 }, "contextCount": 362, "dts": { "calculationLink": { "local": [ "ew-20230630_cal.xml" ] }, "definitionLink": { "local": [ "ew-20230630_def.xml" ] }, "inline": { "local": [ "ew-20230630.htm" ] }, "labelLink": { "local": [ "ew-20230630_lab.xml" ] }, "presentationLink": { "local": [ "ew-20230630_pre.xml" ] }, "schema": { "local": [ "ew-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] } }, "elementCount": 685, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 4, "http://xbrl.sec.gov/dei/2023": 5, "http://xbrl.sec.gov/ecd/2023": 1, "total": 10 }, "keyCustom": 25, "keyStandard": 338, "memberCustom": 24, "memberStandard": 52, "nsprefix": "ew", "nsuri": "http://www.edwards.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - COVER", "menuCat": "Cover", "order": "1", "role": "http://www.edwards.com/role/COVER", "shortName": "COVER", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE", "menuCat": "Notes", "order": "10", "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSE", "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - INVESTMENTS", "menuCat": "Notes", "order": "11", "role": "http://www.edwards.com/role/INVESTMENTS", "shortName": "INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES", "menuCat": "Notes", "order": "12", "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES", "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - BUSINESS COMBINATION", "menuCat": "Notes", "order": "13", "role": "http://www.edwards.com/role/BUSINESSCOMBINATION", "shortName": "BUSINESS COMBINATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - FAIR VALUE MEASUREMENTS", "menuCat": "Notes", "order": "14", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "menuCat": "Notes", "order": "15", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "16", "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - ACCELERATED SHARE REPURCHASE", "menuCat": "Notes", "order": "17", "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE", "shortName": "ACCELERATED SHARE REPURCHASE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "18", "role": "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS", "menuCat": "Notes", "order": "19", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "shortName": "CONSOLIDATED CONDENSED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - EARNINGS PER SHARE", "menuCat": "Notes", "order": "20", "role": "http://www.edwards.com/role/EARNINGSPERSHARE", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "21", "role": "http://www.edwards.com/role/INCOMETAXES", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - SEGMENT INFORMATION", "menuCat": "Notes", "order": "22", "role": "http://www.edwards.com/role/SEGMENTINFORMATION", "shortName": "SEGMENT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "menuCat": "Notes", "order": "23", "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "shortName": "Pay vs Performance Disclosure", "subGroupType": "", "uniqueAnchor": null }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-360", "decimals": null, "first": true, "lang": "en-US", "name": "ecd:MtrlTermsOfTrdArrTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995445 - Disclosure - Insider Trading Arrangements", "menuCat": "Notes", "order": "24", "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "shortName": "Insider Trading Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-360", "decimals": null, "first": true, "lang": "en-US", "name": "ecd:MtrlTermsOfTrdArrTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954701 - Disclosure - BASIS OF PRESENTATION (Policies)", "menuCat": "Policies", "order": "25", "role": "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies", "shortName": "BASIS OF PRESENTATION (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954702 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954703 - Disclosure - INVESTMENTS (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.edwards.com/role/INVESTMENTSTables", "shortName": "INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954704 - Disclosure - BUSINESS COMBINATION (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONTables", "shortName": "BUSINESS COMBINATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954705 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954706 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954707 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables", "shortName": "STOCK-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954708 - Disclosure - ACCELERATED SHARE REPURCHASE (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables", "shortName": "ACCELERATED SHARE REPURCHASE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954709 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954710 - Disclosure - EARNINGS PER SHARE (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.edwards.com/role/EARNINGSPERSHARETables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954711 - Disclosure - SEGMENT INFORMATION (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONTables", "shortName": "SEGMENT INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954712 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Inventory (Details)", "menuCat": "Details", "order": "36", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954713 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Accrued Liabilities and Long Term Liabilities (Details)", "menuCat": "Details", "order": "37", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Accrued Liabilities and Long Term Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxesPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954714 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details)", "menuCat": "Details", "order": "38", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxesPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954715 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details)", "menuCat": "Details", "order": "39", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-74", "decimals": null, "first": true, "lang": "en-US", "name": "ew:IntellectualPropertyAgreementTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954716 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE - Narrative (Details)", "menuCat": "Details", "order": "40", "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails", "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-74", "decimals": null, "first": true, "lang": "en-US", "name": "ew:IntellectualPropertyAgreementTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954717 - Disclosure - INVESTMENTS - Investments in Debt Securities (Details)", "menuCat": "Details", "order": "41", "role": "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails", "shortName": "INVESTMENTS - Investments in Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954718 - Disclosure - INVESTMENTS - Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "menuCat": "Details", "order": "42", "role": "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "shortName": "INVESTMENTS - Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954719 - Disclosure - INVESTMENTS - Investments in Continuous Loss Position (Details)", "menuCat": "Details", "order": "43", "role": "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails", "shortName": "INVESTMENTS - Investments in Continuous Loss Position (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954720 - Disclosure - INVESTMENTS - Investments in Unconsolidated Entities (Details)", "menuCat": "Details", "order": "44", "role": "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails", "shortName": "INVESTMENTS - Investments in Unconsolidated Entities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "lang": "en-US", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954721 - Disclosure - INVESTMENTS - Narrative (Details)", "menuCat": "Details", "order": "45", "role": "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "shortName": "INVESTMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-91", "decimals": "-5", "lang": "en-US", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OtherPaymentsToAcquireBusinesses", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954722 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)", "menuCat": "Details", "order": "46", "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-95", "decimals": "-5", "lang": "en-US", "name": "ew:EquitySecuritiesFVNIPromissoryNoteOutstanding", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-107", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954723 - Disclosure - BUSINESS COMBINATION - Narrative (Details)", "menuCat": "Details", "order": "47", "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "shortName": "BUSINESS COMBINATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-107", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954724 - Disclosure - BUSINESS COMBINATION - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details)", "menuCat": "Details", "order": "48", "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "BUSINESS COMBINATION - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-107", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-151", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954725 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)", "menuCat": "Details", "order": "49", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-151", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME", "menuCat": "Statements", "order": "5", "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME", "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954726 - Disclosure - FAIR VALUE MEASUREMENTS - Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "menuCat": "Details", "order": "50", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "shortName": "FAIR VALUE MEASUREMENTS - Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-113", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-4", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954727 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in Fair Value of Contingent Consideration Obligation (Details)", "menuCat": "Details", "order": "51", "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails", "shortName": "FAIR VALUE MEASUREMENTS - Changes in Fair Value of Contingent Consideration Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-4", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-163", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954728 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)", "menuCat": "Details", "order": "52", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-163", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954729 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "menuCat": "Details", "order": "53", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingLiabilitiesTableTextBlock", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-173", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954730 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)", "menuCat": "Details", "order": "54", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-167", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingLiabilitiesTableTextBlock", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-173", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954731 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)", "menuCat": "Details", "order": "55", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingLiabilitiesTableTextBlock", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-173", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-198", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954732 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)", "menuCat": "Details", "order": "56", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-198", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954733 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedge Effects on Statement of Operations (Details)", "menuCat": "Details", "order": "57", "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedge Effects on Statement of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-202", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954734 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details)", "menuCat": "Details", "order": "58", "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails", "shortName": "STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954735 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)", "menuCat": "Details", "order": "59", "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-3", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-229", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954736 - Disclosure - STOCK-BASED COMPENSATION - Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)", "menuCat": "Details", "order": "60", "role": "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "shortName": "STOCK-BASED COMPENSATION - Weighted-Average Assumptions for Options and ESPP Subscriptions Granted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-229", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-237", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954737 - Disclosure - ACCELERATED SHARE REPURCHASE (Details)", "menuCat": "Details", "order": "61", "role": "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails", "shortName": "ACCELERATED SHARE REPURCHASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-237", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "reportCount": 1, "unique": true, "unitRef": "lawsuit", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954738 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "menuCat": "Details", "order": "62", "role": "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "reportCount": 1, "unique": true, "unitRef": "lawsuit", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-4", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954739 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "menuCat": "Details", "order": "63", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954740 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "menuCat": "Details", "order": "64", "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-283", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954741 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted Earnings Per Share (Details)", "menuCat": "Details", "order": "65", "role": "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails", "shortName": "EARNINGS PER SHARE - Computation of Basic and Diluted Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "lang": "en-US", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-295", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954742 - Disclosure - EARNINGS PER SHARE - Narrative (Details)", "menuCat": "Details", "order": "66", "role": "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails", "shortName": "EARNINGS PER SHARE - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-295", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954743 - Disclosure - INCOME TAXES (Details)", "menuCat": "Details", "order": "67", "role": "http://www.edwards.com/role/INCOMETAXESDetails", "shortName": "INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954744 - Disclosure - SEGMENT INFORMATION - Information about Reportable Segments (Details)", "menuCat": "Details", "order": "68", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "shortName": "SEGMENT INFORMATION - Information about Reportable Segments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-316", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954745 - Disclosure - SEGMENT INFORMATION - Reconciliations of Segment Net Sales to Consolidated Net Sales and Segment Pre-Tax Income to Consolidated Pre-Tax Income (Details)", "menuCat": "Details", "order": "69", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails", "shortName": "SEGMENT INFORMATION - Reconciliations of Segment Net Sales to Consolidated Net Sales and Segment Pre-Tax Income to Consolidated Pre-Tax Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-316", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-47", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY", "menuCat": "Statements", "order": "7", "role": "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "shortName": "CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-53", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-5", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954746 - Disclosure - SEGMENT INFORMATION - Enterprise-Wide Information (Details)", "menuCat": "Details", "order": "70", "role": "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails", "shortName": "SEGMENT INFORMATION - Enterprise-Wide Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-344", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - BASIS OF PRESENTATION", "menuCat": "Notes", "order": "8", "role": "http://www.edwards.com/role/BASISOFPRESENTATION", "shortName": "BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "menuCat": "Notes", "order": "9", "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ew-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 78, "tag": { "country_JP": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "JAPAN", "terseLabel": "Japan" } } }, "localname": "JP", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r925" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r958" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r923" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r923" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r923" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r997" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r923" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r923" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r923" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r923" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r922" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r924" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.edwards.com/role/COVER" ], "xbrltype": "tradingSymbolItemType" }, "ecd_Additional402vDisclosureTextBlock": { "auth_ref": [ "r959" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "localname": "Additional402vDisclosureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToCompAmt": { "auth_ref": [ "r965" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "localname": "AdjToCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AdjToCompAxis": { "auth_ref": [ "r965" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "localname": "AdjToCompAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "auth_ref": [ "r965" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "localname": "AdjToNonPeoNeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToPeoCompFnTextBlock": { "auth_ref": [ "r965" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "localname": "AdjToPeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AggtErrCompAmt": { "auth_ref": [ "r930", "r941", "r951", "r976" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "localname": "AggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "auth_ref": [ "r933", "r944", "r954", "r979" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "localname": "AggtErrCompNotYetDeterminedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AllAdjToCompMember": { "auth_ref": [ "r965" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "localname": "AllAdjToCompMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllExecutiveCategoriesMember": { "auth_ref": [ "r972" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "localname": "AllExecutiveCategoriesMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllIndividualsMember": { "auth_ref": [ "r937", "r945", "r955", "r972", "r980", "r984", "r992" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "localname": "AllIndividualsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllTradingArrangementsMember": { "auth_ref": [ "r990" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "localname": "AllTradingArrangementsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "domainItemType" }, "ecd_AwardExrcPrice": { "auth_ref": [ "r987" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "localname": "AwardExrcPrice", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "perShareItemType" }, "ecd_AwardGrantDateFairValue": { "auth_ref": [ "r988" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "localname": "AwardGrantDateFairValue", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AwardTmgDiscLineItems": { "auth_ref": [ "r983" ], "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "localname": "AwardTmgDiscLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "auth_ref": [ "r983" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMethodTextBlock": { "auth_ref": [ "r983" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "localname": "AwardTmgMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMnpiCnsdrdFlag": { "auth_ref": [ "r983" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "localname": "AwardTmgMnpiCnsdrdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardTmgMnpiDiscTextBlock": { "auth_ref": [ "r983" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "localname": "AwardTmgMnpiDiscTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgPredtrmndFlag": { "auth_ref": [ "r983" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "localname": "AwardTmgPredtrmndFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardUndrlygSecuritiesAmt": { "auth_ref": [ "r986" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "localname": "AwardUndrlygSecuritiesAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_AwardsCloseToMnpiDiscIndName": { "auth_ref": [ "r985" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "localname": "AwardsCloseToMnpiDiscIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTable": { "auth_ref": [ "r984" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "localname": "AwardsCloseToMnpiDiscTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "auth_ref": [ "r984" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "localname": "AwardsCloseToMnpiDiscTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ChangedPeerGroupFnTextBlock": { "auth_ref": [ "r963" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "localname": "ChangedPeerGroupFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CoSelectedMeasureAmt": { "auth_ref": [ "r964" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "localname": "CoSelectedMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_CoSelectedMeasureName": { "auth_ref": [ "r964" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "localname": "CoSelectedMeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "auth_ref": [ "r969" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "auth_ref": [ "r968" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "localname": "CompActuallyPaidVsNetIncomeTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "auth_ref": [ "r970" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "auth_ref": [ "r967" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "auth_ref": [ "r966" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompAnalysisTextBlock": { "auth_ref": [ "r930", "r941", "r951", "r976" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "localname": "ErrCompAnalysisTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompRecoveryTable": { "auth_ref": [ "r927", "r938", "r948", "r973" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "localname": "ErrCompRecoveryTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ExecutiveCategoryAxis": { "auth_ref": [ "r972" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "localname": "ExecutiveCategoryAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "auth_ref": [ "r934", "r945", "r955", "r980" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "auth_ref": [ "r934", "r945", "r955", "r980" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "auth_ref": [ "r934", "r945", "r955", "r980" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "auth_ref": [ "r934", "r945", "r955", "r980" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ForgoneRecoveryIndName": { "auth_ref": [ "r934", "r945", "r955", "r980" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "ForgoneRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_IndividualAxis": { "auth_ref": [ "r937", "r945", "r955", "r972", "r980", "r984", "r992" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "localname": "IndividualAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_InsiderTradingArrLineItems": { "auth_ref": [ "r990" ], "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "localname": "InsiderTradingArrLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTradingPoliciesProcLineItems": { "auth_ref": [ "r926", "r996" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "localname": "InsiderTradingPoliciesProcLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "auth_ref": [ "r926", "r996" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "localname": "InsiderTrdPoliciesProcAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "booleanItemType" }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "auth_ref": [ "r926", "r996" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "textBlockItemType" }, "ecd_MeasureAxis": { "auth_ref": [ "r964" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "localname": "MeasureAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_MeasureName": { "auth_ref": [ "r964" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "localname": "MeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_MnpiDiscTimedForCompValFlag": { "auth_ref": [ "r983" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "localname": "MnpiDiscTimedForCompValFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_MtrlTermsOfTrdArrTextBlock": { "auth_ref": [ "r991" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "localname": "MtrlTermsOfTrdArrTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "textBlockItemType" }, "ecd_NamedExecutiveOfficersFnTextBlock": { "auth_ref": [ "r965" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "localname": "NamedExecutiveOfficersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonGaapMeasureDescriptionTextBlock": { "auth_ref": [ "r964" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "localname": "NonGaapMeasureDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonNeosMember": { "auth_ref": [ "r934", "r945", "r955", "r972", "r980" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "localname": "NonNeosMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "auth_ref": [ "r962" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoAvgTotalCompAmt": { "auth_ref": [ "r961" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "localname": "NonPeoNeoAvgTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoMember": { "auth_ref": [ "r972" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "localname": "NonPeoNeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonRule10b51ArrAdoptedFlag": { "auth_ref": [ "r991" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "localname": "NonRule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_NonRule10b51ArrTrmntdFlag": { "auth_ref": [ "r991" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "localname": "NonRule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_OtherPerfMeasureAmt": { "auth_ref": [ "r964" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "localname": "OtherPerfMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_OutstandingAggtErrCompAmt": { "auth_ref": [ "r932", "r943", "r953", "r978" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "localname": "OutstandingAggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryCompAmt": { "auth_ref": [ "r935", "r946", "r956", "r981" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "localname": "OutstandingRecoveryCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryIndName": { "auth_ref": [ "r935", "r946", "r956", "r981" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "OutstandingRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PayVsPerformanceDisclosureLineItems": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "localname": "PayVsPerformanceDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_PeerGroupIssuersFnTextBlock": { "auth_ref": [ "r963" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "localname": "PeerGroupIssuersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_PeerGroupTotalShareholderRtnAmt": { "auth_ref": [ "r963" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "localname": "PeerGroupTotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoActuallyPaidCompAmt": { "auth_ref": [ "r962" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "localname": "PeoActuallyPaidCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoMember": { "auth_ref": [ "r972" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "localname": "PeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_PeoName": { "auth_ref": [ "r965" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "localname": "PeoName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_PeoTotalCompAmt": { "auth_ref": [ "r961" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "localname": "PeoTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PvpTable": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "localname": "PvpTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PvpTableTextBlock": { "auth_ref": [ "r960" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "localname": "PvpTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "auth_ref": [ "r927", "r938", "r948", "r973" ], "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "localname": "RecoveryOfErrCompDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_RestatementDateAxis": { "auth_ref": [ "r928", "r939", "r949", "r974" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "localname": "RestatementDateAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_RestatementDeterminationDate": { "auth_ref": [ "r929", "r940", "r950", "r975" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "localname": "RestatementDeterminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "dateItemType" }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "auth_ref": [ "r936", "r947", "r957", "r982" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "localname": "RestatementDoesNotRequireRecoveryTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_Rule10b51ArrAdoptedFlag": { "auth_ref": [ "r991" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "localname": "Rule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_Rule10b51ArrTrmntdFlag": { "auth_ref": [ "r991" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "localname": "Rule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "auth_ref": [ "r931", "r942", "r952", "r977" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "localname": "StkPrcOrTsrEstimationMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TabularListTableTextBlock": { "auth_ref": [ "r971" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "localname": "TabularListTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TotalShareholderRtnAmt": { "auth_ref": [ "r963" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "localname": "TotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "auth_ref": [ "r970" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TradingArrAxis": { "auth_ref": [ "r990" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "localname": "TradingArrAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TradingArrByIndTable": { "auth_ref": [ "r992" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "localname": "TradingArrByIndTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrAdoptionDate": { "auth_ref": [ "r993" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "localname": "TrdArrAdoptionDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrDuration": { "auth_ref": [ "r994" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "localname": "TrdArrDuration", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "durationItemType" }, "ecd_TrdArrIndName": { "auth_ref": [ "r992" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "localname": "TrdArrIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrIndTitle": { "auth_ref": [ "r992" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "localname": "TrdArrIndTitle", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrSecuritiesAggAvailAmt": { "auth_ref": [ "r995" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "localname": "TrdArrSecuritiesAggAvailAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "sharesItemType" }, "ecd_TrdArrTerminationDate": { "auth_ref": [ "r993" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "localname": "TrdArrTerminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_UndrlygSecurityMktPriceChngPct": { "auth_ref": [ "r989" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "localname": "UndrlygSecurityMktPriceChngPct", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "pureItemType" }, "ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount", "terseLabel": "Value of Shares as % of Contract Value" } } }, "localname": "AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "percentItemType" }, "ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 10.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual for Property Payroll and Other Taxes Other than Income Taxes Current", "terseLabel": "Property, payroll, and other taxes" } } }, "localname": "AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedAndOtherLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued And Other Liabilities, Current", "label": "Accrued And Other Liabilities, Current", "terseLabel": "Accrued and other liabilities (Note 2)", "totalLabel": "Total accrued and other liabilities" } } }, "localname": "AccruedAndOtherLiabilitiesCurrent", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedAndOtherLiabilitiesCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued And Other Liabilities, Current", "label": "Accrued And Other Liabilities, Current [Member]", "terseLabel": "Accrued and other liabilities" } } }, "localname": "AccruedAndOtherLiabilitiesCurrentMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "ew_AccruedLitigationAndInsuranceReserves": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 6.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Litigation And Insurance Reserves", "label": "Accrued Litigation And Insurance Reserves", "terseLabel": "Legal and insurance" } } }, "localname": "AccruedLitigationAndInsuranceReserves", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedRebates": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 7.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates.", "label": "Accrued Rebates", "terseLabel": "Accrued rebates" } } }, "localname": "AccruedRebates", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_AccruedRelocationCostsCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 9.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Relocation Costs, Current", "label": "Accrued Relocation Costs, Current", "terseLabel": "Accrued relocation costs" } } }, "localname": "AccruedRelocationCostsCurrent", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net", "label": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net", "negatedTerseLabel": "Less: Noncontrolling interest" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment", "label": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment", "terseLabel": "Noncontrolling interest, option adjustment" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "ew_ContingentConsiderationLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent Consideration Liability", "label": "Contingent Consideration Liability [Member]", "terseLabel": "Contingent Consideration" } } }, "localname": "ContingentConsiderationLiabilityMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_ConvertiblePromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Promissory Note", "label": "Convertible Promissory Note [Member]", "terseLabel": "Convertible Promissory Note" } } }, "localname": "ConvertiblePromissoryNoteMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "ew_CriticalCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the critical care product line.", "label": "Critical Care [Member]", "terseLabel": "Critical Care" } } }, "localname": "CriticalCareMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_DaveenChopraMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Daveen Chopra", "label": "Daveen Chopra [Member]" } } }, "localname": "DaveenChopraMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "domainItemType" }, "ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]", "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ew_EmployeeAndNonemployeeStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.", "label": "Employee and Nonemployee Stock Options [Member]", "verboseLabel": "Option Awards" } } }, "localname": "EmployeeAndNonemployeeStockOptionsMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "ew_EquityMethodInvestmentsInvestmentPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investments, Investment Period", "label": "Equity Method Investments, Investment Period", "terseLabel": "Investments taken period" } } }, "localname": "EquityMethodInvestmentsInvestmentPeriod", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_EquitySecuritiesFVNIInvesteeAdditionalAmountDrawn": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Investee, Additional Amount Drawn", "label": "Equity Securities, FV-NI, Investee, Additional Amount Drawn", "terseLabel": "Investee drew additional amount" } } }, "localname": "EquitySecuritiesFVNIInvesteeAdditionalAmountDrawn", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment", "label": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment", "terseLabel": "Maximum additional option to acquire investment" } } }, "localname": "EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIMaximumAdditionalRequired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Maximum Additional Required", "label": "Equity Securities, FV-NI, Maximum Additional Required", "terseLabel": "Maximum additional required investment" } } }, "localname": "EquitySecuritiesFVNIMaximumAdditionalRequired", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Maximum Secured Promissory Note", "label": "Equity Securities, FV-NI, Maximum Secured Promissory Note", "terseLabel": "Maximum secured promissory note" } } }, "localname": "EquitySecuritiesFVNIMaximumSecuredPromissoryNote", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIOptionToAcquireInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Option To Acquire Investment", "label": "Equity Securities, FV-NI, Option To Acquire Investment", "terseLabel": "Investment option to acquire" } } }, "localname": "EquitySecuritiesFVNIOptionToAcquireInvestment", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "ew_EquitySecuritiesFVNIPromissoryNoteOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI Promissory Note Outstanding", "label": "Equity Securities, FV-NI Promissory Note Outstanding", "terseLabel": "Secured promissory note" } } }, "localname": "EquitySecuritiesFVNIPromissoryNoteOutstanding", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "ew_EuropeSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Europe reportable segment of the entity.", "label": "Europe Segment [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeSegmentMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 2023 Stock Repurchase Program Shares Sold In March 2023", "label": "February 2023 Stock Repurchase Program Shares Sold In March 2023 [Member]", "terseLabel": "February 2023 Stock Repurchase Program Shares Sold in March 2023" } } }, "localname": "February2023StockRepurchaseProgramSharesSoldInMarch2023Member", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "domainItemType" }, "ew_IncreaseDecreaseInLegalSettlementAccrual": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Legal Settlement Accrual", "label": "Increase (Decrease) In Legal Settlement Accrual", "terseLabel": "Intellectual property agreement accrual" } } }, "localname": "IncreaseDecreaseInLegalSettlementAccrual", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ew_InitialDeliveryOfSharesSettledFebruary2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Delivery Of Shares Settled February 2023", "label": "Initial Delivery Of Shares Settled February 2023 [Member]", "terseLabel": "Initial Delivery of Shares Settled February2023" } } }, "localname": "InitialDeliveryOfSharesSettledFebruary2023Member", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "domainItemType" }, "ew_InitialDeliveryOfSharesSettledJanuary2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Delivery Of Shares Settled January 2022", "label": "Initial Delivery Of Shares Settled January 2022 [Member]", "terseLabel": "Initial Delivery of Shares Settled January 2022" } } }, "localname": "InitialDeliveryOfSharesSettledJanuary2022Member", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "domainItemType" }, "ew_IntellectualPropertyAgreementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intellectual Property Agreement Term", "label": "Intellectual Property Agreement Term", "terseLabel": "Intellectual property agreement term" } } }, "localname": "IntellectualPropertyAgreementTerm", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_IntellectualPropertyLitigationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the net amount of judgment or settlement awarded to (against) the entity and legal, forensic, accounting, investigative fees and other expenses related to intellectual property litigation.", "label": "Intellectual Property Litigation Expense", "negatedLabel": "Intellectual property agreement and litigation expense" } } }, "localname": "IntellectualPropertyLitigationExpense", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January 2022 Stock Repurchase Program Shares Sold In February 2022", "label": "January 2022 Stock Repurchase Program Shares Sold In February 2022 [Member]", "terseLabel": "January 2022 Stock Repurchase Program Shares Sold in February 2022" } } }, "localname": "January2022StockRepurchaseProgramSharesSoldInFebruary2022Member", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "domainItemType" }, "ew_JapanSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Japan reportable segment of the entity.", "label": "Japan Segment [Member]", "terseLabel": "Japan" } } }, "localname": "JapanSegmentMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_LoansReceivablesMaximumLendingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loans Receivables, Maximum Lending Capacity", "label": "Loans Receivables, Maximum Lending Capacity", "terseLabel": "Loans receivables, maximum lending amount" } } }, "localname": "LoansReceivablesMaximumLendingCapacity", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number", "label": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number", "terseLabel": "Number of lawsuits that if settled could have a material adverse impact on net income or cash flows" } } }, "localname": "LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIESDetails" ], "xbrltype": "integerItemType" }, "ew_MarketBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market Based Restricted Stock Units", "label": "Market Based Restricted Stock Units [Member]", "terseLabel": "Market Based Restricted Stock Units" } } }, "localname": "MarketBasedRestrictedStockUnitsMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "ew_MeasurementInputProbabilityOfMilestoneAchievementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input, Probability Of Milestone Achievement [Member]", "label": "Measurement Input, Probability Of Milestone Achievement [Member]", "terseLabel": "Probability of Milestone Achievement" } } }, "localname": "MeasurementInputProbabilityOfMilestoneAchievementMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_MedicalDeviceCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical Device Company", "label": "Medical Device Company [Member]", "terseLabel": "Medical Device Company", "verboseLabel": "Investee" } } }, "localname": "MedicalDeviceCompanyMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "ew_MedicalTechnologyCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical Technology Company", "label": "Medical Technology Company [Member]", "terseLabel": "Medical Technology Company" } } }, "localname": "MedicalTechnologyCompanyMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "ew_MedtronicIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medtronic Inc", "label": "Medtronic Inc [Member]", "terseLabel": "Medtronic Inc" } } }, "localname": "MedtronicIncMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_NewMarketsTaxCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Markets Tax Credit", "label": "New Markets Tax Credit [Member]", "terseLabel": "New Markets Tax Credit" } } }, "localname": "NewMarketsTaxCreditMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "ew_OptionToAcquireInvestmentAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Option To Acquire Investment, Amount", "label": "Option To Acquire Investment, Amount", "terseLabel": "Option to acquire investment amount" } } }, "localname": "OptionToAcquireInvestmentAmount", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options", "label": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options", "negatedTerseLabel": "Business combination, net of cash (Note 6)" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ew_ResearchAndDevelopmentAccruals": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 5.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials.", "label": "Research And Development Accruals", "terseLabel": "Research and development accruals" } } }, "localname": "ResearchAndDevelopmentAccruals", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ew_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the geographic areas of the world other than the United States, Europe and Japan.", "label": "Rest of World [Member]", "terseLabel": "Rest of World" } } }, "localname": "RestOfWorldMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_RestOfWorldSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World).", "label": "Rest of World Segment [Member]", "terseLabel": "Rest of World" } } }, "localname": "RestOfWorldSegmentMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period", "terseLabel": "Performance period (years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Shares Expected To Be Granted As Percentage Of Target", "terseLabel": "Shares expected to be granted as percentage of target (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesExpectedToBeGrantedAsPercentageOfTarget", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "percentItemType" }, "ew_ShareInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Information [Abstract]", "terseLabel": "Share information" } } }, "localname": "ShareInformationAbstract", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "ew_SurgicalHeartValveTherapyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents the surgical heart valve therapy product line.", "label": "Surgical Heart Valve Therapy [Member]", "terseLabel": "Surgical Structural Heart" } } }, "localname": "SurgicalHeartValveTherapyMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_TranscatheterAorticValveReplacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transcatheter Aortic Valve Replacement [Member]", "label": "Transcatheter Aortic Valve Replacement [Member]", "terseLabel": "Transcatheter Aortic Valve Replacement" } } }, "localname": "TranscatheterAorticValveReplacementMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_TranscatheterMitralAndTricuspidTherapiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transcatheter Mitral And Tricuspid Therapies [Member]", "label": "Transcatheter Mitral And Tricuspid Therapies [Member]", "terseLabel": "Transcatheter Mitral and Tricuspid Therapies" } } }, "localname": "TranscatheterMitralAndTricuspidTherapiesMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "ew_UnitedStatesSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the United States reportable segment of the entity.", "label": "United States Segment [Member]", "terseLabel": "United States" } } }, "localname": "UnitedStatesSegmentMember", "nsuri": "http://www.edwards.com/20230630", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "ew_VariableInterestEntitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments in Variable Interest Entities", "label": "Variable Interest Entities [Abstract]" } } }, "localname": "VariableInterestEntitiesAbstract", "nsuri": "http://www.edwards.com/20230630", "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r289", "r569", "r570", "r574", "r575", "r633", "r858", "r1068", "r1071", "r1072" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r289", "r569", "r570", "r574", "r575", "r633", "r858", "r1068", "r1071", "r1072" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r289", "r332", "r343", "r344", "r345", "r346", "r347", "r349", "r353", "r446", "r447", "r448", "r449", "r451", "r452", "r454", "r456", "r457", "r1069", "r1070" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r289", "r332", "r343", "r344", "r345", "r346", "r347", "r349", "r353", "r446", "r447", "r448", "r449", "r451", "r452", "r454", "r456", "r457", "r1069", "r1070" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r287", "r288", "r462", "r479", "r632", "r871", "r874" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r401", "r402", "r403" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [ "r1104", "r1106", "r1107", "r1108" ], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r441", "r442", "r443", "r444", "r503", "r667", "r732", "r761", "r762", "r818", "r820", "r822", "r823", "r839", "r859", "r860", "r880", "r891", "r899", "r907", "r1073", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r441", "r442", "r443", "r444", "r503", "r667", "r732", "r761", "r762", "r818", "r820", "r822", "r823", "r839", "r859", "r860", "r880", "r891", "r899", "r907", "r1073", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r355", "r668", "r726", "r727", "r728", "r729", "r730", "r731", "r861", "r892", "r906", "r1002", "r1066", "r1067", "r1074", "r1098" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r355", "r668", "r726", "r727", "r728", "r729", "r730", "r731", "r861", "r892", "r906", "r1002", "r1066", "r1067", "r1074", "r1098" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r441", "r442", "r443", "r444", "r495", "r503", "r532", "r533", "r534", "r640", "r667", "r732", "r761", "r762", "r818", "r820", "r822", "r823", "r839", "r859", "r860", "r880", "r891", "r899", "r907", "r910", "r1059", "r1073", "r1087", "r1088", "r1089", "r1090", "r1091" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r441", "r442", "r443", "r444", "r495", "r503", "r532", "r533", "r534", "r640", "r667", "r732", "r761", "r762", "r818", "r820", "r822", "r823", "r839", "r859", "r860", "r880", "r891", "r899", "r907", "r910", "r1059", "r1073", "r1087", "r1088", "r1089", "r1090", "r1091" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r287", "r288", "r462", "r479", "r632", "r873", "r874" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r401", "r402", "r403" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r357", "r358", "r752", "r756", "r758", "r819", "r821", "r825", "r840", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r862", "r893", "r910", "r1074", "r1098" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r357", "r358", "r752", "r756", "r758", "r819", "r821", "r825", "r840", "r847", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r862", "r893", "r910", "r1074", "r1098" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "AOCI Attributable to Parent, Net of Tax" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesDateAxis": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Information by date of execution of accelerated share repurchases.", "label": "Accelerated Share Repurchases, Date [Axis]", "terseLabel": "Accelerated Share Repurchases, Date [Axis]" } } }, "localname": "AcceleratedShareRepurchasesDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesDateDomain": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Date upon which the accelerated share repurchase agreement was executed.", "label": "Accelerated Share Repurchases, Date [Domain]", "terseLabel": "Accelerated Share Repurchases, Date [Domain]" } } }, "localname": "AcceleratedShareRepurchasesDateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.", "label": "Accelerated Share Repurchases, Final Price Paid Per Share", "terseLabel": "Final settlement per share price (in dollars per share)" } } }, "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.", "label": "Accelerated Share Repurchases, Initial Price Paid Per Share", "terseLabel": "Initial delivery, price per share (in dollars per share)" } } }, "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_AcceleratedShareRepurchasesTextBlock": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.", "label": "Accelerated Share Repurchases [Table Text Block]", "terseLabel": "Schedule of Accelerated Share Repurchases" } } }, "localname": "AcceleratedShareRepurchasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r33", "r905" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r360", "r361" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowances of $8.1 and $7.9, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r136", "r194" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 12.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 8.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Accrued marketing expenses" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 4.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued professional services" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r7", "r18", "r45", "r1019", "r1020", "r1021" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Unrealized Pension Credits" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r262", "r271", "r272", "r573", "r875", "r1019" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "terseLabel": "Unrealized Gain on Hedges", "verboseLabel": "Gain on hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r258", "r259", "r260", "r262", "r271", "r272", "r1019" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "terseLabel": "Unrealized Loss on Available-for-sale Investments", "verboseLabel": "Loss on available-for-sale investments" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [ "r270", "r271", "r616", "r618", "r619", "r620", "r621", "r622" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "verboseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r44", "r45", "r151", "r245", "r698", "r737", "r738" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss (Note 12)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r270", "r271", "r616", "r618", "r619", "r620", "r621", "r622" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r4", "r18", "r45", "r585", "r588", "r629", "r733", "r734", "r1019", "r1020", "r1021", "r1030", "r1031", "r1032" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r6", "r18", "r45", "r271", "r272", "r618", "r619", "r620", "r621", "r622", "r1019" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustments", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]", "terseLabel": "Amounts included in the measurement of lease liabilities:" } } }, "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r139" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r541", "r542", "r543", "r748", "r1030", "r1031", "r1032", "r1079", "r1102" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r83", "r84", "r506" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r536", "r544" ], "calculation": { "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Expense, after Tax", "totalLabel": "Total stock-based compensation expense, net of tax" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r246", "r362", "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Anti-dilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r894", "r1039", "r1043", "r1047" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-Backed Securities [Member]", "terseLabel": "Asset-backed securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r192", "r237", "r285", "r330", "r345", "r351", "r404", "r446", "r447", "r449", "r450", "r451", "r453", "r455", "r457", "r458", "r569", "r574", "r610", "r694", "r784", "r905", "r921", "r1069", "r1070", "r1084" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r231", "r250", "r285", "r404", "r446", "r447", "r449", "r450", "r451", "r453", "r455", "r457", "r458", "r569", "r574", "r610", "r905", "r1069", "r1070", "r1084" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r129" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r371" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r372" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r368", "r414", "r693" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "totalLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale [Abstract]", "terseLabel": "Available-for-sale" } } }, "localname": "AvailableForSaleSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Available-for-Sale Securities, Debt Maturities [Abstract]", "terseLabel": "Available-for-Sale" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": { "auth_ref": [ "r1040" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "auth_ref": [ "r1040" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis": { "auth_ref": [ "r1042" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Amortized Cost", "terseLabel": "Due after 5\u00a0years through 10\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue": { "auth_ref": [ "r1042" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in rolling sixth through tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Fair Value", "terseLabel": "Due after 5\u00a0years through 10\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": { "auth_ref": [ "r1041" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "auth_ref": [ "r1041" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "auth_ref": [ "r1038", "r1039" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "terseLabel": "Instruments not due at a single maturity date" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r374", "r691", "r1038" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Instruments not due at a single maturity date" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r369", "r414", "r682", "r1036" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale", "terseLabel": "Fair Value", "totalLabel": "Fair Value", "verboseLabel": "Available-for-sale investments:" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r113", "r118" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BankTimeDepositsMember": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.", "label": "Bank Time Deposits [Member]", "terseLabel": "Bank time deposits" } } }, "localname": "BankTimeDepositsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r564", "r897", "r898" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r86", "r88", "r564", "r897", "r898" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of interest acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "terseLabel": "Noncontrolling interest, gross" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r567", "r1024" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "negatedLabel": "Change in fair value of contingent consideration liabilities", "terseLabel": "Change in fair value of contingent consideration liabilities (Note 7)", "verboseLabel": "Change in fair value of contingent consideration liabilities (Note 7)" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r1", "r92", "r566" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent consideration liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": { "auth_ref": [ "r601" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure contingent consideration liability from business combination.", "label": "Business Combination, Contingent Consideration, Liability, Measurement Input", "terseLabel": "Contingent consideration liability measurement input" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r2", "r92" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration liabilities (Note 7)" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r181", "r565" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "BUSINESS COMBINATION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r90" ], "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "terseLabel": "Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r90" ], "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "negatedLabel": "Liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r90" ], "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r89", "r90" ], "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "In-process research and development" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r90" ], "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "totalLabel": "Total purchase price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r90" ], "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Fair value of net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r56", "r57", "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Capital expenditures accruals" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired from Acquisition", "negatedTerseLabel": "Less: cash acquired" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r54", "r233", "r863" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r54", "r165", "r283" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r3", "r165" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r128" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months", "terseLabel": "Cash flow gain to be reclassified in the next twelve months" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "verboseLabel": "Cash flow hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing transactions:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "auth_ref": [ "r187" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "terseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "auth_ref": [ "r187" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "terseLabel": "Hedged items" } } }, "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r240", "r241", "r242", "r325", "r477", "r478", "r479", "r481", "r484", "r489", "r491", "r740", "r741", "r742", "r743", "r891", "r999", "r1027" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r40", "r133", "r695", "r770" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note\u00a011)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r173", "r438", "r439", "r848", "r1062" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r908", "r909", "r910", "r912", "r913", "r914", "r915", "r1030", "r1031", "r1079", "r1100", "r1102" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r138", "r771" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r138", "r771", "r790", "r1102", "r1103" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Common stock, ending balance (in shares)", "periodStartLabel": "Common stock, beginning balance (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r138", "r697", "r905" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, $1.00 par value, 1,050.0 shares authorized, 649.1 and 646.3 shares issued, and 607.9 and 608.3 shares outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r46", "r267", "r269", "r276", "r686", "r711" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income attributable to Edwards Lifesciences Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r11", "r95", "r104", "r267", "r269", "r275", "r685", "r710" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Comprehensive loss attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r104", "r184", "r267", "r269", "r274", "r684", "r709" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r150", "r273", "r683", "r707" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r96", "r876" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r894", "r896", "r1099" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "netLabel": "Corporate debt securities", "terseLabel": "Corporate debt securities", "verboseLabel": "Corporate debt securities" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r24", "r344", "r345", "r346", "r347", "r353", "r1035" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate items" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r158", "r668" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "Cost of sales", "negatedTerseLabel": "Cost of sales", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales", "verboseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r155" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "negatedLabel": "Corporate items" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Cross currency swap contracts", "verboseLabel": "Cross currency swap contracts" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r31", "r135", "r136", "r193", "r195", "r289", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r623", "r886", "r887", "r888", "r889", "r890", "r1028" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r38", "r289", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r623", "r886", "r887", "r888", "r889", "r890", "r1028" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "auth_ref": [ "r213", "r418", "r883" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "terseLabel": "Fair value, 12 months or greater" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r213", "r418" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "negatedLabel": "Gross unrealized losses, 12 months or greater" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "auth_ref": [ "r213", "r418", "r883" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "terseLabel": "Fair value, less than 12 months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "auth_ref": [ "r213", "r418" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "negatedLabel": "Gross unrealized losses, less than 12 months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": { "auth_ref": [ "r211", "r416", "r883" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position", "totalLabel": "Fair value, total" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": { "auth_ref": [ "r212", "r417" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss", "negatedTotalLabel": "Gross unrealized losses, total" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [ "r210", "r883", "r1055" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": { "auth_ref": [ "r364", "r382", "r384", "r682" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss", "totalLabel": "Amortized Cost" } } }, "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "auth_ref": [ "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible" } } }, "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationPlanAssets": { "auth_ref": [ "r1014" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.", "label": "Deferred Compensation Plan Assets", "terseLabel": "Investments held for deferred compensation plans" } } }, "localname": "DeferredCompensationPlanAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r548", "r549" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r14", "r335" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "auth_ref": [ "r22", "r30", "r116", "r833", "r834" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset", "negatedLabel": "Gross Amounts Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeAssetFairValueGrossLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetFairValueNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral [Abstract]", "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeAssetFairValueNetAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": { "auth_ref": [ "r23", "r28", "r220" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset.", "label": "Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "negatedLabel": "Financial Instruments" } } }, "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative asset.", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r252", "r255", "r609", "r750", "r751", "r752", "r754", "r755", "r757", "r758", "r759", "r761", "r762", "r777", "r778", "r826", "r829", "r832", "r833", "r835", "r836", "r874", "r910", "r1101" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivatives", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "verboseLabel": "Fair value of derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Asset [Abstract]", "terseLabel": "Assets" } } }, "localname": "DerivativeAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeCollateralObligationToReturnCash": { "auth_ref": [ "r28", "r125", "r253", "r872" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.", "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset", "negatedLabel": "Cash Collateral Received" } } }, "localname": "DerivativeCollateralObligationToReturnCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeCollateralRightToReclaimCash": { "auth_ref": [ "r28", "r125", "r253", "r872" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.", "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset", "negatedLabel": "Cash Collateral Received" } } }, "localname": "DerivativeCollateralRightToReclaimCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r759", "r762", "r776", "r777", "r778", "r780", "r781", "r782", "r783", "r785", "r786", "r787", "r788", "r798", "r799", "r800", "r801", "r804", "r805", "r806", "r807", "r826", "r827", "r832", "r835", "r908", "r910" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r25", "r116", "r149", "r251", "r874" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Gross Amounts" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral": { "auth_ref": [ "r28", "r124" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.", "label": "Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction", "totalLabel": "Net Amount" } } }, "localname": "DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r25", "r116", "r149", "r251", "r874" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Gross Amounts" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral": { "auth_ref": [ "r28", "r124" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after effect of master netting arrangement and deduction of obligation to return financial collateral not offset and financial instrument subject to master netting arrangement not offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset. Includes derivative not subject to master netting arrangement or similar agreement.", "label": "Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction", "totalLabel": "Net Amount" } } }, "localname": "DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r1078" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Amount of Gain or (Loss) Recognized in Income on Derivative" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r114", "r117", "r119", "r121", "r759", "r762", "r776", "r777", "r778", "r780", "r781", "r782", "r783", "r785", "r786", "r787", "r788", "r798", "r799", "r800", "r801", "r804", "r805", "r806", "r807", "r826", "r827", "r832", "r835", "r874", "r908", "r910" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r186", "r582", "r591" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r20", "r114", "r119" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r20", "r114", "r119", "r121", "r126", "r127", "r581" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss)" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": { "auth_ref": [ "r590" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.", "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred", "terseLabel": "Amount of Gain or (Loss) Recognized in\u00a0Income on Derivative (Amount Excluded from Effectiveness Testing)" } } }, "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r252", "r255", "r609", "r750", "r751", "r752", "r754", "r757", "r758", "r759", "r761", "r762", "r785", "r787", "r788", "r827", "r828", "r829", "r832", "r833", "r835", "r836", "r874", "r1101" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivatives", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "verboseLabel": "Fair value of derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "DerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r252" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 3.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Fair value of derivatives" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "auth_ref": [ "r22", "r30", "r116", "r833", "r834", "r872" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset", "negatedLabel": "Gross Amounts Offset in the Consolidated Balance Sheet" } } }, "localname": "DerivativeLiabilityFairValueGrossAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": { "auth_ref": [ "r23", "r28", "r220" ], "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability.", "label": "Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "negatedLabel": "Financial Instruments" } } }, "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r1076", "r1077" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative notional amount", "verboseLabel": "Derivative liability, fair value" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r20", "r105", "r106", "r108", "r112", "r115", "r119", "r122", "r123", "r127", "r591" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives designated as hedging instruments", "verboseLabel": "Derivatives designated as hedging instruments" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r504", "r509", "r537", "r538", "r540", "r900" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r277", "r295", "r296", "r297", "r298", "r299", "r304", "r307", "r317", "r318", "r319", "r323", "r594", "r595", "r687", "r712", "r877" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Basic:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r277", "r295", "r296", "r297", "r298", "r299", "r307", "r317", "r318", "r319", "r323", "r594", "r595", "r687", "r712", "r877" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted earnings per share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted:" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r303", "r320", "r321", "r322" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARE" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]", "verboseLabel": "Gain (loss) on cash flow hedging relationships:" } } }, "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r615" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effect of Fair Value Hedges on Results of Operations [Abstract]", "terseLabel": "Gain (loss) on fair value hedging relationships:" } } }, "localname": "EffectOfFairValueHedgesOnResultsOfOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r551" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate (as a percent)" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 2.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employee compensation and withholdings" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Allocation of stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r539" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Total remaining unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized compensation cost, recognition period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r536" ], "calculation": { "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "negatedTerseLabel": "Income tax benefit" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "ESPP" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r19", "r227", "r270", "r271", "r272", "r290", "r291", "r292", "r294", "r300", "r302", "r324", "r405", "r406", "r492", "r541", "r542", "r543", "r557", "r558", "r584", "r585", "r586", "r587", "r588", "r589", "r593", "r616", "r618", "r619", "r620", "r621", "r622", "r629", "r733", "r734", "r735", "r748", "r811" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Financial Statement, Reported Amounts [Abstract]", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestmentFinancialStatementReportedAmountsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Investment percentage (in percent)" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r340", "r400", "r1013", "r1052" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails": { "order": 1.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Carrying value of equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r238", "r607", "r865" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails": { "order": 2.0, "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.", "label": "Equity Securities, FV-NI, Current", "terseLabel": "Carrying value of non-marketable equity securities" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r68", "r916", "r917", "r918", "r1105" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Equity Securities" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount", "terseLabel": "Decrease in non-marketable equity securities due to observable price changes" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": { "auth_ref": [ "r399" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount", "terseLabel": "Increase in non-marketable equity securities due to observable price changes" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r467", "r609", "r887", "r888" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "verboseLabel": "Estimate of Fair Value Measurement" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r597", "r598", "r603" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair value of financial instruments measured on a recurring basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r597", "r598", "r603" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "terseLabel": "Financial instruments" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r129", "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r467", "r496", "r497", "r498", "r499", "r500", "r501", "r598", "r637", "r638", "r639", "r887", "r888", "r894", "r895", "r896" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r130", "r188" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r26", "r129", "r467", "r887", "r888" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r597", "r598", "r600", "r601", "r604" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r467", "r887", "r888" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Fair value hedges" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r467", "r496", "r501", "r598", "r637", "r894", "r895", "r896" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r467", "r496", "r501", "r598", "r638", "r887", "r888", "r894", "r895", "r896" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r467", "r496", "r497", "r498", "r499", "r500", "r501", "r598", "r639", "r887", "r888", "r894", "r895", "r896" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": { "auth_ref": [ "r129", "r189" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of obligations measured on a recurring basis.", "label": "Obligations, Fair Value Disclosure", "terseLabel": "Contingent consideration liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r21", "r130" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r21", "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Changes in Fair Value of Contingent Consideration Obligation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Changes in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r467", "r496", "r497", "r498", "r499", "r500", "r501", "r637", "r638", "r639", "r887", "r888", "r894", "r895", "r896" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r596", "r604" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value on a Recurring Basis" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r113", "r115", "r126" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r408", "r409", "r410", "r411", "r412", "r415", "r419", "r420", "r475", "r489", "r591", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r708", "r883", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1048", "r1049", "r1050", "r1051" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r611", "r612", "r613", "r614", "r808" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "verboseLabel": "Foreign currency" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r874", "r894", "r903" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [ "r777", "r782", "r787", "r800", "r806", "r830", "r831", "r832", "r910" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign currency forward exchange contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r160", "r998" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "negatedTerseLabel": "Loss (gain) on investments, net" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r235", "r423", "r681", "r885", "r905", "r1057", "r1058" ], "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r157", "r285", "r330", "r344", "r350", "r353", "r404", "r446", "r447", "r449", "r450", "r451", "r453", "r455", "r457", "r458", "r610", "r879", "r1069" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r20", "r581" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HeldToMaturitySecurities": { "auth_ref": [ "r222", "r380", "r410", "r1054" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss", "totalLabel": "Amortized Cost" } } }, "localname": "HeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]", "terseLabel": "Held-to-maturity" } } }, "localname": "HeldToMaturitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "auth_ref": [ "r207", "r390" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "auth_ref": [ "r208", "r391" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Maturity [Abstract]", "terseLabel": "Held-to-Maturity" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in sixth through tenth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years, Fair Value", "terseLabel": "Due after 5\u00a0years through 10\u00a0years" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r209", "r392", "r691" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Instruments not due at a single maturity date" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount": { "auth_ref": [ "r384", "r690" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date", "terseLabel": "Instruments not due at a single maturity date" } } }, "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "auth_ref": [ "r206", "r389", "r682", "r693" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Fair Value", "terseLabel": "Fair Value", "totalLabel": "Fair Value" } } }, "localname": "HeldToMaturitySecuritiesFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Rolling Maturity [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesAmortizedCostRollingMaturityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost": { "auth_ref": [ "r1044", "r1093" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year", "terseLabel": "Due in 1\u00a0year or less" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost": { "auth_ref": [ "r1046", "r1095" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after 5 through 10 Years", "terseLabel": "Due after 5\u00a0years through 10\u00a0years" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost": { "auth_ref": [ "r1045", "r1094" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach.", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years", "terseLabel": "Due after 1\u00a0year through 5\u00a0years" } } }, "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r153", "r200", "r330", "r344", "r350", "r353", "r688", "r703", "r879" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r330", "r344", "r350", "r353", "r713", "r879" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "terseLabel": "Total before tax", "verboseLabel": "Segment operating income" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]", "terseLabel": "Segment Operating Income", "verboseLabel": "Pre-tax Income Reconciliation" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r433", "r435", "r795" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r435", "r795" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r286", "r546", "r552", "r555", "r556", "r559", "r561", "r562", "r563", "r745" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationEstimateOfPossibleLoss": { "auth_ref": [ "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Estimated amount of loss resulting from an adverse tax position.", "label": "Income Tax Examination, Estimate of Possible Loss", "terseLabel": "Additional federal tax" } } }, "localname": "IncomeTaxExaminationEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r214", "r223", "r301", "r302", "r338", "r550", "r560", "r714" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r1075" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "negatedTerseLabel": "Tax benefit from employee share-based compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r53", "r55" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "Increase (Decrease) in Accounts and Other Receivables", "negatedLabel": "Accounts and other receivables, net" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income taxes" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedLabel": "Deferred income taxes" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidRoyalties": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for royalties that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Royalties", "negatedLabel": "Long-term prepaid royalties (Note 3)" } } }, "localname": "IncreaseDecreaseInPrepaidRoyalties", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r308", "r309", "r310", "r319", "r508" ], "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Dilutive effect of stock plans (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r70", "r71" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net (Note 6)" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r202" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "negatedTerseLabel": "Interest income, net", "terseLabel": "Interest expense (income), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which reported facts about interest income have been included.", "label": "Interest Income [Member]", "terseLabel": "Interest income, net" } } }, "localname": "InterestIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r172", "r868" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "verboseLabel": "Finished products" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r247", "r864", "r905" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories (Note\u00a02)", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net [Abstract]", "verboseLabel": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r172", "r870" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "verboseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r172", "r869" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "verboseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r751", "r753", "r754", "r757", "r760", "r817", "r819", "r821", "r824", "r825", "r837", "r838", "r840", "r841", "r842", "r843", "r844", "r910" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r751", "r753", "r754", "r757", "r760", "r817", "r819", "r821", "r824", "r825", "r837", "r838", "r840", "r841", "r842", "r843", "r844", "r910" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]", "terseLabel": "Equity securities" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r1015" ], "calculation": { "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "totalLabel": "Total investments in unconsolidated entities" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinUnconsolidatedEntitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r190", "r204", "r205", "r224", "r363", "r366", "r605", "r606" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "INVESTMENTS" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "terseLabel": "INTELLECTUAL PROPERTY AGREEMENT AND LITIGATION EXPENSE" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSE" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r35", "r285", "r404", "r446", "r447", "r449", "r450", "r451", "r453", "r455", "r457", "r458", "r570", "r574", "r575", "r610", "r769", "r878", "r921", "r1069", "r1084", "r1085" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r143", "r197", "r701", "r905", "r1029", "r1053", "r1080" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r37", "r232", "r285", "r404", "r446", "r447", "r449", "r450", "r451", "r453", "r455", "r457", "r458", "r570", "r574", "r575", "r610", "r905", "r1069", "r1084", "r1085" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r129" ], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure", "totalLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "terseLabel": "Uncertain tax positions" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LimitedLiabilityCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legal form of business company offering limited liability to its owners (denoted by L.L.C. or LLC in the U.S.).", "label": "Limited Liability Company [Member]", "terseLabel": "Limited Liability Company" } } }, "localname": "LimitedLiabilityCompanyMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LitigationReserveCurrent": { "auth_ref": [ "r40", "r1063" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 13.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.", "label": "Estimated Litigation Liability, Current", "terseLabel": "Litigation settlement" } } }, "localname": "LitigationReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationReserveNoncurrent": { "auth_ref": [ "r40", "r1063" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.", "label": "Estimated Litigation Liability, Noncurrent", "terseLabel": "Litigation settlement accrual (Note 2)", "verboseLabel": "Litigation settlement accrual" } } }, "localname": "LitigationReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Litigation Settlement, Expense", "terseLabel": "Intellectual property agreement and litigation expense (Note 3)", "verboseLabel": "Intellectual property litigation expense" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r239" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r234" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-Term Investments", "terseLabel": "Long-term investments (Note\u00a04)" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [ "r440", "r441", "r442", "r445", "r1064", "r1065" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r440", "r441", "r442", "r445", "r1064", "r1065" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Reconciling items" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.", "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge", "terseLabel": "Changes due to currency rate movements and expenses expected to occur, maximum term" } } }, "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r599" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r43", "r196", "r285", "r404", "r446", "r449", "r450", "r451", "r457", "r458", "r610", "r700", "r773" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest (Note 6)" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Changes to noncontrolling interest" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_MunicipalBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.", "label": "Municipal Bonds [Member]", "netLabel": "Municipal securities", "terseLabel": "Municipal securities", "verboseLabel": "Municipal securities" } } }, "localname": "MunicipalBondsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r282" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r282" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r165", "r166", "r167" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r154", "r167", "r201", "r230", "r265", "r268", "r272", "r285", "r293", "r295", "r296", "r297", "r298", "r301", "r302", "r315", "r330", "r344", "r350", "r353", "r404", "r446", "r447", "r449", "r450", "r451", "r453", "r455", "r457", "r458", "r595", "r610", "r706", "r792", "r809", "r810", "r879", "r919", "r1069" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "totalLabel": "Net income attributable to Edwards Lifesciences Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r103", "r185", "r265", "r268", "r301", "r302", "r705", "r1021" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net loss attributable to noncontrolling interest (Note 6)" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r278", "r295", "r296", "r297", "r298", "r304", "r305", "r316", "r319", "r330", "r344", "r350", "r353", "r879" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "netLabel": "Net of tax", "terseLabel": "Net income attributable to Edwards Lifesciences Corporation" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r278", "r306", "r311", "r312", "r313", "r314", "r316", "r319" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "verboseLabel": "Net income attributable to Edwards Lifesciences Corporation" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net investment hedges" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Standards Not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r93", "r492", "r1030", "r1031", "r1032", "r1102" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives not designated as hedging instruments" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r161" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Non-operating income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableFairValueDisclosure": { "auth_ref": [ "r34" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of notes payable.", "label": "Notes Payable, Fair Value Disclosure", "terseLabel": "Notes payable fair value disclosure" } } }, "localname": "NotesPayableFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableGross": { "auth_ref": [ "r222", "r225", "r226", "r244", "r410", "r413", "r881", "r882", "r1010", "r1054" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.", "label": "Financing Receivable, before Allowance for Credit Loss", "terseLabel": "Financing receivable" } } }, "localname": "NotesReceivableGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "OCI, before Reclassifications, before Tax, Attributable to Parent", "terseLabel": "Other comprehensive gain (loss) before reclassifications" } } }, "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]", "terseLabel": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]", "terseLabel": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTableTextBlock": { "auth_ref": [ "r147", "r254" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Assets [Table Text Block]", "verboseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets" } } }, "localname": "OffsettingAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OffsettingDerivativeAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offsetting Derivative Assets [Abstract]", "terseLabel": "Derivative assets" } } }, "localname": "OffsettingDerivativeAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingDerivativeLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offsetting Derivative Liabilities [Abstract]", "terseLabel": "Derivative liabilities" } } }, "localname": "OffsettingDerivativeLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "auth_ref": [ "r147", "r254" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.", "label": "Offsetting Liabilities [Table Text Block]", "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Liabilities" } } }, "localname": "OffsettingLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r330", "r344", "r350", "r353", "r879" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Consolidated operating income", "totalLabel": "Operating income, net" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r625" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r625" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r626", "r627" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r624" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r1025" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "terseLabel": "Non-cash operating lease cost" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r343", "r344", "r345", "r346", "r347", "r353" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r168", "r169", "r170", "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 1.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r249", "r905" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r236" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets (Note 5)" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r256", "r261" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Unrealized gain (loss) on hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r256", "r261", "r577", "r578", "r583" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r261", "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "terseLabel": "Amount of gain (loss) reclassified from accumulated OCI into income" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r221", "r261", "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": { "auth_ref": [ "r257", "r261", "r263", "r579" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax", "verboseLabel": "Amount excluded from effectiveness testing recognized in earnings based on an amortization approach" } } }, "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r5" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)" } } }, "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r19", "r29", "r266", "r269", "r273", "r616", "r617", "r622", "r683", "r707", "r1019", "r1020" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r11", "r17", "r184", "r266", "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive loss, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "verboseLabel": "Other comprehensive loss, net of tax (Note\u00a012):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r8", "r151" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Unrealized pension credits (costs)" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "auth_ref": [ "r10", "r151", "r264", "r397" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "negatedTerseLabel": "Reclassification of realized investment losses to earnings" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "auth_ref": [ "r11", "r17", "r184" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "negatedTerseLabel": "Deferred income tax benefit (expense)" } } }, "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r258", "r261", "r397" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "terseLabel": "Unrealized gain (loss) on available-for-sale investments" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": { "auth_ref": [ "r1017" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.", "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross", "terseLabel": "Finished products inventories held on consignment" } } }, "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of other liabilities.", "label": "Other Liabilities, Fair Value Disclosure", "terseLabel": "Other liability" } } }, "localname": "OtherLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r113", "r126" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Other liability" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSChangesinFairValueofContingentConsiderationObligationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r167" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r162" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other income, net", "terseLabel": "Other income, net", "verboseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other income, net", "verboseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgeEffectsonStatementofOperationsDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherPaymentsToAcquireBusinesses": { "auth_ref": [ "r50" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.", "label": "Other Payments to Acquire Businesses", "negatedTerseLabel": "Payment for acquisition options (Note 5)", "verboseLabel": "Payment for option to acquire company" } } }, "localname": "OtherPaymentsToAcquireBusinesses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r243", "r779" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other Receivables", "terseLabel": "Other receivables" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Edwards Lifesciences Corporation Stockholders' Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Accrued and other liabilities" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForLegalSettlements": { "auth_ref": [ "r12" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.", "label": "Payments for Legal Settlements", "terseLabel": "Payments for legal settlements" } } }, "localname": "PaymentsForLegalSettlements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r1000", "r1022" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r51" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchases of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r49", "r279", "r365" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments to Acquire Debt Securities, Available-for-Sale", "negatedLabel": "Purchases of available-for-sale investments (Note 4)" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "terseLabel": "Total purchase price, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": { "auth_ref": [ "r49", "r365" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.", "label": "Payments to Acquire Held-to-Maturity Securities", "negatedLabel": "Purchases of held-to-maturity investments (Note 4)" } } }, "localname": "PaymentsToAcquireHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r164" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireReceivables": { "auth_ref": [ "r163" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the purchase of all receivables.", "label": "Payments to Acquire Receivables", "negatedLabel": "Issuances of notes receivable" } } }, "localname": "PaymentsToAcquireReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r137", "r477" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r137", "r771" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r137", "r771", "r790", "r1102", "r1103" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r137", "r696", "r905" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r248", "r421", "r422", "r866" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidRoyalties": { "auth_ref": [ "r867", "r884", "r1056" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Royalties", "terseLabel": "Prepaid royalty asset" } } }, "localname": "PrepaidRoyalties", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDLITIGATIONEXPENSENarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromCollectionOfNotesReceivable": { "auth_ref": [ "r47" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Collection of Notes Receivable", "terseLabel": "Collections of notes receivable" } } }, "localname": "ProceedsFromCollectionOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r1001", "r1023" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": { "auth_ref": [ "r279", "r280", "r1037" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale", "terseLabel": "Proceeds from available-for-sale investments (Note 4)" } } }, "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": { "auth_ref": [ "r47", "r1037" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.", "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities", "terseLabel": "Proceeds from held-to-maturity investments (Note 4)" } } }, "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r9" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from Stock Plans", "terseLabel": "Proceeds from stock plans" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r230", "r265", "r268", "r281", "r285", "r293", "r301", "r302", "r330", "r344", "r350", "r353", "r404", "r446", "r447", "r449", "r450", "r451", "r453", "r455", "r457", "r458", "r568", "r571", "r572", "r595", "r610", "r688", "r704", "r747", "r792", "r809", "r810", "r879", "r901", "r902", "r920", "r1021", "r1069" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r15", "r692", "r702", "r905" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant, and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "terseLabel": "Affected Line on Consolidated Condensed Statements of Operations" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent", "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss" } } }, "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Amount Reclassified from Accumulated Other Comprehensive Loss" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]", "verboseLabel": "Unallocated amounts:" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r502", "r630", "r631", "r764", "r765", "r766", "r767", "r768", "r789", "r791", "r816" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r502", "r630", "r631", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r764", "r765", "r766", "r767", "r768", "r789", "r791", "r816", "r1083" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "terseLabel": "Repayments of pre-existing notes" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r134", "r545", "r1092" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r1012", "r1026" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash included in other current assets" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r215", "r1014", "r1026" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash included in other assets" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r1016", "r1060", "r1061" ], "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails": { "order": 11.0, "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Accrued realignment reserves" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSAccruedLiabilitiesandLongTermLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r140", "r178", "r699", "r736", "r738", "r744", "r772", "r905" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r227", "r290", "r291", "r292", "r294", "r300", "r302", "r405", "r406", "r541", "r542", "r543", "r557", "r558", "r584", "r586", "r587", "r589", "r593", "r733", "r735", "r748", "r1102" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r331", "r332", "r343", "r348", "r349", "r355", "r357", "r359", "r493", "r494", "r668" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Segment Net Sales", "verboseLabel": "Net Sales Reconciliation" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Enterprise-Wide Information" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r628", "r904" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued and Other Liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r45", "r1081", "r1082" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [ "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-Sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r86", "r88", "r564" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of Supplemental Cash Flow Information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r114", "r119", "r581" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "verboseLabel": "Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r1033" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of Stock-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r597", "r598" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.", "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]", "verboseLabel": "Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets" } } }, "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r32", "r144", "r145", "r146" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates.", "label": "Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]", "terseLabel": "Schedule of Investments in Unconsolidated Affiliates" } } }, "localname": "ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Summary of Fair Values of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r27", "r191", "r1097" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Restricted Cash" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r67", "r156" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Enterprise-Wide Information" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r67", "r152" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONEnterpriseWideInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r63", "r64", "r65", "r69" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r63", "r64", "r65", "r69" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Information about Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r505", "r507", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions for ESPP Subscriptions Granted" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Assumptions for Options Granted" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r72", "r73", "r74", "r75", "r76", "r77", "r78", "r176", "r177", "r178", "r240", "r241", "r242", "r325", "r477", "r478", "r479", "r481", "r484", "r489", "r491", "r740", "r741", "r742", "r743", "r891", "r999", "r1027" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "auth_ref": [ "r97", "r98", "r99", "r100", "r101", "r569", "r570", "r574", "r575", "r648", "r649", "r650" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table]", "terseLabel": "Schedule of Variable Interest Entities [Table]" } } }, "localname": "ScheduleOfVariableInterestEntitiesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r327", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r353", "r359", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r436", "r437", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r885", "r1002", "r1098" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r326", "r327", "r328", "r329", "r330", "r342", "r347", "r351", "r352", "r353", "r354", "r355", "r356", "r359" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONReconciliationsofSegmentNetSalestoConsolidatedNetSalesandSegmentPreTaxIncometoConsolidatedPreTaxIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r159" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general, and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r13" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation (Note\u00a09)" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Restricted stock units granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility", "verboseLabel": "Expected volatility (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate", "verboseLabel": "Average risk-free interest rate (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r505", "r507", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Options granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Fair value, per option (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price of options granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "verboseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/STOCKBASEDCOMPENSATIONWeightedAverageAssumptionsforOptionsandESPPSubscriptionsGrantedDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r198", "r199", "r1018" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-Term Investments", "terseLabel": "Short-term investments (Note\u00a04)" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r229", "r327", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r353", "r359", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r434", "r436", "r437", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r885", "r1002", "r1098" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONInformationaboutReportableSegmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r19", "r41", "r227", "r270", "r271", "r272", "r290", "r291", "r292", "r294", "r300", "r302", "r324", "r405", "r406", "r492", "r541", "r542", "r543", "r557", "r558", "r584", "r585", "r586", "r587", "r588", "r589", "r593", "r616", "r618", "r619", "r620", "r621", "r622", "r629", "r733", "r734", "r735", "r748", "r811" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r290", "r291", "r292", "r324", "r668", "r739", "r749", "r763", "r764", "r765", "r766", "r767", "r768", "r771", "r774", "r775", "r776", "r777", "r778", "r780", "r781", "r782", "r783", "r785", "r786", "r787", "r788", "r789", "r791", "r793", "r794", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r811", "r911" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r290", "r291", "r292", "r324", "r668", "r739", "r749", "r763", "r764", "r765", "r766", "r767", "r768", "r771", "r774", "r775", "r776", "r777", "r778", "r780", "r781", "r782", "r783", "r785", "r786", "r787", "r788", "r789", "r791", "r793", "r794", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r811", "r911" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockAppreciationRightsSARSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "localname": "StockAppreciationRightsSARSMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r1034" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-Based Payment Arrangement [Member]", "terseLabel": "Stock compensation plan" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/EARNINGSPERSHARENarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r19", "r137", "r138", "r178" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued under stock plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r81", "r137", "r138", "r178" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued under stock plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Amount Paid" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r138", "r141", "r142", "r171", "r773", "r790", "r812", "r813", "r905", "r921", "r1029", "r1053", "r1080", "r1102" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Edwards Lifesciences Corporation stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r93", "r94", "r102", "r227", "r228", "r271", "r290", "r291", "r292", "r294", "r300", "r405", "r406", "r492", "r541", "r542", "r543", "r557", "r558", "r584", "r585", "r586", "r587", "r588", "r589", "r593", "r616", "r618", "r622", "r629", "r734", "r735", "r746", "r773", "r790", "r812", "r813", "r845", "r920", "r1029", "r1053", "r1080", "r1102" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r175", "r284", "r476", "r478", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r490", "r492", "r592", "r814", "r815", "r846" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity [Text Block]", "terseLabel": "ACCELERATED SHARE REPURCHASE" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASE" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r1011" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Cash paid during the year for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrentAndNoncurrent": { "auth_ref": [ "r136", "r194", "r1096" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.", "label": "Taxes Payable", "terseLabel": "Taxes payable" } } }, "localname": "TaxesPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r475", "r489", "r591", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r708", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1048", "r1049", "r1050", "r1051" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "periodEndLabel": "Treasury stock, ending balance (in shares)", "periodStartLabel": "Treasury stock, beginning balance (in shares)", "terseLabel": "Treasury stock (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETSParenthetical", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r42", "r79", "r80" ], "calculation": { "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "negatedLabel": "Treasury stock, at cost, 41.2 and 38.0 shares, respectively" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r19", "r138", "r178" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Purchases of treasury stock (in shares)", "verboseLabel": "Shares Received (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/ACCELERATEDSHAREREPURCHASEDetails", "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r19", "r79", "r178" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Purchases of treasury stock" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r689", "r894", "r1099" ], "lang": { "en-us": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "netLabel": "United States government and agency securities", "terseLabel": "U.S. government and agency securities", "verboseLabel": "U.S. government and agency securities" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinContinuousLossPositionDetails", "http://www.edwards.com/role/INVESTMENTSInvestmentsinDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unrealized gains and losses on investments.", "label": "Unrealized Gain (Loss) on Investments [Table Text Block]", "terseLabel": "Schedule of Investments in Debt Securities" } } }, "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r547", "r553" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Liability for income taxes associated with uncertain tax positions" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r554" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Net amounts that would favorably affect effective tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INCOMETAXESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r60", "r61", "r62", "r216", "r217", "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BASISOFPRESENTATIONPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.", "label": "Variable Interest Entity Disclosure [Text Block]", "terseLabel": "INVESTMENTS IN VARIABLE INTEREST ENTITIES" } } }, "localname": "VariableInterestEntityDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityLineItems": { "auth_ref": [ "r569", "r570", "r574", "r575", "r648", "r649", "r650" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Variable Interest Entity [Line Items]", "terseLabel": "Variable Interest Entity [Line Items]" } } }, "localname": "VariableInterestEntityLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "terseLabel": "Variable Interest Entity, Not Primary Beneficiary" } } }, "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "auth_ref": [ "r97", "r569", "r570", "r574", "r575" ], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Primary Beneficiary [Member]", "terseLabel": "Variable Interest Entity, Primary Beneficiary" } } }, "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSummaryofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r306", "r319" ], "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Dilutive weighted-average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted-average number of common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r304", "r319" ], "calculation": { "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1000": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1001": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1002": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1003": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1004": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1005": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1006": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1007": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1008": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1009": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1010": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1404", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1011": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "https://asc.fasb.org//210/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1012": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1013": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1014": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1015": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1016": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1017": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1018": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1019": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1020": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1021": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1022": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1023": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1024": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1025": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1026": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1027": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1028": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1029": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1030": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1031": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1032": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1033": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1034": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1035": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1036": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1037": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1038": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1039": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1040": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1041": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1042": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1043": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1044": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1045": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1046": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1047": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1048": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1049": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1050": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1051": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1052": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1053": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1054": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1055": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1056": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1057": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1058": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1059": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1060": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1061": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1062": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1063": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1064": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1065": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1066": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1067": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1068": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1069": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1070": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1071": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1072": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1073": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1074": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1075": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1076": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1077": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1078": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1079": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1080": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1081": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1082": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1083": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1084": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1085": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1086": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1087": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1088": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1089": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1090": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1091": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1092": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1093": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1094": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1095": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1096": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1097": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1098": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1099": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1101": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1108": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "https://asc.fasb.org//220/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org//250/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481138/505-30-25-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org//805/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org//815/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org//940-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Subparagraph": "b.", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//942-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org//946-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(1)(ii)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(1)(i)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(dd)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20,22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org//320/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "6B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "6B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org//320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column G))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column H))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column I))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column J))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column K))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column F))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(5)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-79", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-80", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r922": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r923": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r924": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r925": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r926": { "Name": "Form 20-F", "Paragraph": "a", "Publisher": "SEC", "Section": "16", "Subsection": "J", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r927": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r928": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r929": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "A", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "B", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r931": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "C", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r932": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "D", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r933": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "E", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r934": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r935": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "iii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r936": { "Name": "Form 20-F", "Paragraph": "2", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r937": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r938": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r939": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r940": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r941": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r942": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r943": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r944": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r945": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r946": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r947": { "Name": "Form 40-F", "Paragraph": "b", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r948": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r949": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r950": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r951": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r952": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r953": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r954": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r955": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r956": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r957": { "Name": "Form N-CSR", "Paragraph": "b", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r958": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r959": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r960": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r961": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r962": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r963": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r964": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "vi", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r965": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "3", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r966": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "4", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r967": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r968": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r969": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r970": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r971": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r972": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r973": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r974": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r975": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r976": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "B", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r977": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r978": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r979": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r980": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r981": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r982": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r983": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r984": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r985": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r986": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r987": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r988": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r989": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "F", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r990": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r991": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r992": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "A", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r993": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "B", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r994": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "C", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r995": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "D", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r996": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r997": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r998": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r999": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" } }, "version": "2.2" } ZIP 100 0001099800-23-000034-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001099800-23-000034-xbrl.zip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